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De visschers weten dat de zee gevaarlijk is, en de storm geducht, maar hebben nooit 
kunnen inzien dat de gevaren redenen waren om op 't strand te blijven kuieren. 
 
The fishermen know that the sea is dangerous and the storm terrible, but they have never 
found these dangers sufficient reason for remaining ashore. 
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Involuntary weight loss in older people reflecting of a decline in appetite and energy, mainly 
protein, intake, is associated with the development of undernutrition and increased morbidity 
and mortality, and is termed the ‘anorexia of ageing’. A common strategy for management 
of undernutrition in older people is the use of nutritional supplements which are usually high-
energy drinks, rich in whey protein. 
In younger adults, whey protein, when compared to other proteins, is perceived as a ‘fast-
acting’ protein, with a rapid satiating effect. Given that protein is the most satiating 
macronutrient in younger people, and its substitution for other macronutrients is often 
advocated to promote weight loss, it is possible that the satiating effects of increased protein 
ingestion could counteract some, or all, of the positive effects of increased protein ingestion 
in older people on muscle mass and function. Despite the increasing use of protein-rich 
drinks by older people, information about their effects on energy intake, appetite and 
underlying gastrointestinal mechanisms in this age group is limited. The primary aim of this 
thesis was to determine the effects of dietary protein on energy intake, appetite and 
underlying gastrointestinal mechanisms, including antropyloroduodenal motility, gastric 
emptying and plasma gut hormone concentrations in healthy older when compared to 
younger adults. 
The studies produced clear-cut results - ingestion of whey protein was less suppressive of 
feeding behaviour in older than younger adults, so that there was an increase in total energy 
intake in the elderly. Younger adults showed suppression of perception of appetite after 
protein ingestion when compared to control, while older adults increased their appetite. 
Energy intake at a buffet meal was not affected by the timing of protein ingestion before the 
meal. Young women, in contrast to men, did not show suppression of ad libitum energy 




intake after oral protein preloads. Older compared to younger adults, and women compared 
to men, had slower gastric emptying of whey protein drinks. Ageing appears especially to 
affect the initial phase of gastric emptying of protein. In older adults, plasma CCK and GIP 
concentrations after protein ingestion were higher compared to young adults. 
In conclusion, the regulation of appetite and energy intake is impaired in the elderly. In 
particular, the acute suppression of energy intake by whey protein is less in healthy older, 
than younger, adults, resulting in increased overall energy intake in the older adults. 
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CHAPTER 1: THESIS OVERVIEW 
 




OUR POPULATION IS AGEING 
The world population, including that of Australia, is ageing. The percentages of Australia’s 
population older than 65 increased from 9% in 1976 to 15% in 2016. By 2056, it is 
anticipated that these percentages will further increase to 22% of Australia’s population (1). 
Currently, Australian life expectancy is 82.1 years for men and women combined, which is 
the sixth highest among countries within the Organisation for Economic Co-operation and 
Development (OECD) (2). 
Much of the health expenditure and burdens of poor health in Australia and other developed 
countries relates to people over the age of 65 years (3), and health expenditure is expected 
to increase seven-fold for those aged over 65 years, and twelve-fold for those aged over 85 
years between 2010 and 2050 (4). Undernutrition in older people is associated with 
substantial reductions in functional independence and quality of life with increases in health 
care utilization. Optimising the health of older people is, therefore, important to limit 
increasing health care costs. 
 
 ENERGY INTAKE IN OLDER PEOPLE – THE ‘ANOREXIA OF 
AGEING’  
With healthy ageing, mean food and energy intake decrease (5), which has been termed the 
‘anorexia of ageing’ (6). For example, in a cross sectional study, older people aged 72 years 
(range: 65 - 94 years) old had a ~30% lower energy intake than younger adults aged 26 years 
(19-35 years) old (7). A longitudinal study of seven years follow up of 156 healthy older 
individuals reported a decrease in energy intake of 19 kcal/day/year in women and 25 
kcal/day/year in men (8). 




CHANGES IN BODY WEIGHT AND COMPOSITION WITH AGEING 
– UNDERNUTRITION IN OLDER PEOPLE 
Weight loss is more common than weight gain in older people (9) and may lead to 
undernutrition (10, 11); between 20-85% (depending on the diagnostic method used) of the 
ageing population in nursing homes and acute hospital care and 5-20% of the community-
dwelling population, are undernourished (10, 12). Low body weight and weight loss, 
especially if involuntary, are strong predictors of poor outcomes in older people. Weight loss 
is associated with a 70% increase in mortality, whereas weight stability and weight gain are 
not associated with increased mortality (12). The adverse effects of being overweight and of 
obesity are also less in older than young people; a BMI of ~27-30 kg/m2 in older people is 
associated with maximum life expectancy compared to a BMI of 20-25 kg/m2 for young 
adults (13). A major factor contributing to the development of undernutrition and associated 
adverse effects is that weight loss in older people predominantly reflects loss of skeletal 
muscle (14), accounting for functional impairments including reduced grip strength and gait 
speed, greater rates and durations of hospitalisation, a higher number of individuals moving 
from home into supported accommodation and increased mortality (10). 
 
EFFECTS OF AGEING ON MUSCLE PROTEIN SYNTHESIS 
In older adults, insufficient protein intake facilitates muscle loss by limiting muscle 
anabolism (15). Furthermore, older people may experience ‘anabolic resistance’, which 
increases the threshold of protein ingestion that is needed to stimulate postprandial protein 
anabolism (16). Importantly, providing sufficient amounts of protein and essential amino 
acids are ingested [including free essential amino acids (17, 18), whey (19), casein (20) or 
meat protein (21)], ageing does appear to not impair the capacity for muscle protein 
synthesis, Muscle protein synthesis dose-dependently increases after ingestion of 2.5, 5 or 




10 g of essential amino acids (22) and 10, 20 or 35 g of whey protein (23). The highest rate 
of muscle protein synthesis was reported after the highest loads; 10 g essential amino acid 
and 35 g whey protein. Whole-body muscle protein synthesis (synthesis minus breakdown) 
was reported to be increased in older adults after protein ingestion of 1.5 g/kg/day (~120 
g/day) compared to 0.8 g/kg/day (~70 g/day) (24). A consensus statement by the PROT-
AGE study group set up by European Union Geriatric Medicine Society, in cooperation with 
other scientific organisations, to review dietary protein needs with ageing, recommended 
that dietary protein intake in older people should be increased from 0.8-1.0 g/kg body 
weight (the recommendation for younger adults) to 1.2-1.5 g/kg for older adults (25). 
 
EFFECTS OF DIETARY PROTEIN ON MUSCLE MASS AND 
FUNCTION IN OLDER PEOPLE 
A Cochrane review of protein and energy supplementation studies in older people (n = 3,058) 
concluded that protein-energy supplementation resulted in a small weight gain and reduced 
mortality, but only when participants were undernourished, or when supplementation was ≥ 
400 kcal/day (26). No firm conclusions could be made regarding the potential benefits of 
protein-energy supplementation in a community population as the studies included differed 
substantially in design and the outcomes assessed. A systemic review of body composition 
measurements in older people (n = 1,287) concluded that nutritional supplementation has 
some protective, and beneficial, effects on muscle mass and strength, which are increased 
further when combined with physical exercise (27). In undernourished elderly, protein-rich 
supplementation after hospital discharge produced modest increases in handgrip strength (~1 
kg at 8 weeks) (28). In frail older people (n = 65), dietary protein supplementation (120 
kcal/day for 24 weeks) improved physical performance by 10-20% (29). In sarcopenic 
patients (n = 130), intake of a whey-protein supplement (20 g twice daily for 13 weeks) 




compared to control resulted in a larger improvement in muscle mass (protein vs. control 
group: + 0.17 kg) and function (repeated chair stands; protein vs. control group: -1.01 s) 
(30). 
 
PROTEIN INTAKE IN OLDER PEOPLE 
Due to the increasing awareness of the major muscle loss that accompanies weight loss in 
older people, and its particular adverse effects, there has been a recent, and substantial, 
increase in the preferential administration of protein in these supplements in an attempt to 
preserve, or even increase, muscle mass and function (26, 27). A wide range of high-protein 
supplements, usually whey-protein, are being used increasingly frequently with the aim of 
increasing energy-protein intake in (undernourished) older people in both institutionalised 
and community-dwelling populations (26, 31).  
Whey is a milk protein and major protein source (in dairy) within the diet. It is a liquid by-
product of the cheese making process. Whey protein has a high essential amino acid content, 
particularly leucine. Protein metabolism appears to be dependent on the quantity of essential 
amino acids ingested – there was no difference in muscle synthesis after older people 
ingested either 18 g essential amino acids or 40 g balanced amino acids (18 g essential amino 
acids plus 22 g non-essential amino acids) (32). Leucine, in particular, may play an important 
role – muscle protein synthesis in older people was not increased after a 6.7 g essential amino 
acid mixture containing 26% of leucine, but increased when the leucine content was 
increased to 42% (33). Whey protein, compared to casein and casein hydrolysate (all 20 g), 
resulted in higher muscle protein synthesis in healthy older adults (19). In younger adults 
whey empties from the stomach relatively quickly when compared to casein (34), so that the 
absorption of amino acids into the circulation and the onset of satiety is rapid, but relatively 
short-lived (28). 




EFFECTS OF DIETARY PROTEIN ON APPETITE, ENERGY INTAKE 
AND BODY WEIGHT IN YOUNG ADULTS 
There has been substantial interest in the mechanisms underlying the effects of protein 
ingestion on body weight and body composition in young adults, driven primarily by 
attempts of overweight young adults to lose weight, and evidence that high protein diets 
promote weight loss by increasing satiety (35). Short-term studies of the effect of oral 
preloads (36-39) in young adults have shown that protein is more satiating than carbohydrate 
and lipid, resulting in greater reduction of hunger and increase of fullness and in decreased 
energy intake after a protein preload compared to carbohydrate and fat preloads (36). The 
landmark study of Weigle et al. indicated that a diet containing 30% of protein was more 
satiating, associated with decreased energy intake and greater weight loss over time, than an 
iso-caloric diet containing 15% of protein (40). 
 
THE GAP IN KNOWLEDGE AND AIMS OF THE THESIS 
Given that protein is the most satiating macronutrient in young people, and its substitution 
for other macronutrients is often advocated to promote weight loss in overweight young 
adults, it is possible that the satiating effects of increased protein ingestion could counteract 
some, or all, of positive effects on muscle in older people. Yet, despite the increasing use of 
protein-rich drinks by older people, information about their effects on energy intake in this 
age group is lacking.  
The primary aim of this thesis was to determine the effects of dietary protein on energy 
intake, appetite and underlying gastrointestinal mechanisms, including antropyloroduodenal 
motility, gastric emptying and plasma gut hormone concentrations in healthy older when 
compared to younger adults. 




OUTLINE OF THE THESIS 
The acute effects of dietary protein intake on energy intake are largely unknown. This thesis 
will explore the age-related physiological changes in energy intake and appetite and related 
gastrointestinal mechanisms after whey protein ingestion, with the aim of developing an 
optimal strategy for protein supplementation to increase energy intake and muscle mass and 
function in older people, particular those at risk of undernutrition. Chapter 2 summarises 
the current literature relating to the effects of ageing on antropyloroduodenal motility, gastric 
emptying and gut hormones associated with appetite and energy intake regulation. Chapter 
3 presents a meta-analysis aiming to determine the effect of ageing on appetite and energy 
intake. In chapter 4, the techniques used of the studies in this thesis are presented. Chapters 
5 and 6 describe the load effects of intraduodenally administered (thereby bypassing oro-
gastric effects) whey protein, on energy intake, antropyloroduodenal motility, perceptions 
of appetite and gastrointestinal symptoms, glucose, gut hormone and amino acid 
concentrations. Chapter 7 presents a study relating to the effects of oral whey protein loads 
on energy intake, gastric emptying, perceptions of appetite and gastrointestinal symptoms. 
Chapter 8 describes the effect of timing of whey protein intake before the meal on 
subsequent energy intake and perceptions of appetite and gastrointestinal symptoms. 
Chapters 9 and 10 present the gender effects of whey protein intake on energy intake, 
perceptions of appetite and gastrointestinal symptoms, gastric emptying, glucose and gut 
hormone concentrations after oral loads in younger and older adults. Chapter 11 examines 
the effects of ageing on blood glucose and plasma insulin, glucagon, ghrelin, CCK, GIP and 
GLP-1 in response to oral protein loads. Chapter 12 describes the effects of substitution, or 
addition, of carbohydrate and fat to whey protein on energy intake, perceptions of appetite 
and gastrointestinal symptoms, gastric emptying, glucose and gut hormone concentrations 




in older men. Finally, this thesis concludes with a general discussion (Chapter 13) and 














CHAPTER 2: EFFECT OF AGEING ON ENERGY 
INTAKE REGULATION – A LITERATURE REVIEW 
 





The regulation of appetite and energy intake is complex, and influenced by the interaction 
of both central and peripheral mechanisms, all of which are potentially affected by ageing. 
The co-ordination between interrelated intragastric and small intestinal sensory and motor 
mechanisms is precise, and triggered by the interaction with ingested nutrients. Intragastric 
mechanisms include slowing of gastric emptying, increased antral area (distension of the 
distal stomach), and inhibition of plasma ghrelin concentrations. Small intestinal 
mechanisms include suppressed antral and duodenal motility and increased pyloric motility, 
which result in slowing of gastric emptying, and stimulated gut hormone secretion, i.e. 
cholecystokinin (CCK), glucagon-like-peptide-1 (GLP-1), peptide-tyrosine-tyrosine (PYY) 
and gastric-inhibitory-peptide (GIP). Blood glucose concentrations are mainly regulated 
through the secretion of insulin and glucagon in the post-prandial and post-absorptive phase. 
Intragastric, small intestinal, and blood glucose mechanisms are important factors in the 
regulation of appetite and subsequent energy intake. The age-related changes in the 
gastrointestinal mechanisms and glucose regulation influencing feeding are reviewed in this 
chapter. 
 
ENERGY INTAKE AND APPETITE IN YOUNG AND OLDER 
INDIVIDUALS 
It has been established clearly that there are differences in appetite and energy intake 
between young and older people. Fasting hunger ratings, measured by a visual analogue 
scale (VAS), are lower in healthy older when compared to young individuals (41-46), 
whereas fasting fullness ratings appear comparable between the age groups (42-44, 47-52). 
On average, daily energy intake in older individuals is less when compared to young 
individuals (42, 44, 45, 48, 53-56). Interestingly, there is evidence that, after a nutrient 




preload, energy intake at a subsequent meal is less suppressed in older compared to young 
adults (42, 46, 48, 57), and there is a linear decrease in energy intake compensation with age 
of approximately 2.4% per year of increased age (58). When older individuals are given a 
nutritional supplement prior to a meal, energy intake at a subsequent meal is not significantly 
different from energy intake without a nutritional supplement (59-62). Also in longer-term 
studies, after 21 days of overfeeding or underfeeding, older individuals do not compensate 
as well as young individuals for the increase or decrease in energy intake during subsequent 
ad libitum diet periods, compared to their energy intake during the baseline weight 
maintenance period (56, 63). Young people compensate for their body weight gain, or loss, 
by reducing, or increasing their energy intake during the ad libitum period, whereas older 
people sustain a higher energy intake after an overfeeding period, and a lower energy intake 
after an energy restriction period compared to energy intake during a weight maintenance 
period (63). These observations indicate that there is a reduction in the effectiveness of 
homeostatic mechanisms controlling appetite and food intake in the ageing population.  
 
INTRAGASTRIC MECHANISMS IN YOUNG AND OLDER ADULTS 
Intragastric mechanisms of relevance to appetite control include gastric emptying, antral area 
and concentration and activity of the orexigenic hormone ghrelin.  
 
Gastric emptying and antral area  
Gastric emptying is a coordinated activity of the proximal and distal stomach, the pylorus 
and the upper small intestine (Figure 2.1). During meal intake, the proximal stomach relaxes 
in order to increase space for the meal (Figure 2.2). Solid foods are redistributed from the 
proximal to the distal stomach, and ground by the antrum to small particles, called ‘lag 
phase’, whereas emptying of liquids does not usually involve a lag phase.  






















Figure 2.2: Motor patterns associated with gastric emptying (65). 
 
The distal stomach, i.e. antrum, grinds the solid food into smaller particles (< 2 mm) to form 
a semifluid partly digested food mass, called ‘chyme’. The antrum and the pylorus regulate 
the amount and rate of chyme that is transported from the stomach into the duodenum. The 
contractions of the distal stomach and the pylorus are regulated by pacemaker cells called 
‘interstitial cells of Cajal’ (66). The antral area reflects an interplay of passive and active 
forces favouring distension by volume and gravity and resistance to distension occurring as 
a result of muscular contractions. Because of the active regulation, the antral area/pylorus is 




the major determinant for the rate of gastric emptying (67), which typically ranges between 
1-4 kcal/min (68). Solid foods empty in an overall linear pattern after a lag phase and low 
energy liquids empty in an overall exponential pattern; the pattern becomes more linear as 
the energy content of the ingested material increases (69). Gastric emptying is related to 
feelings of fullness; a number of studies have shown a positive linear relationship between 
postprandial fullness and antral gastric distension, but not for proximal gastric distension 
and postprandial hunger (42, 70, 71). Antral content is relatively stable compared to the 
content of the proximal stomach; the proximal stomach progressively reduces its content 
after meal ingestion and releases the gastric distension faster than the antral stomach (42). 
The perception of fullness is triggered by gastric stretch receptors, located mainly in the 
distal stomach and activated by gastric distension (72). Because of the absence of a 
correlation between antral area, or distal stomach content and feelings of hunger, it has been 
suggested that hunger and fullness are regulated by different mechanisms (42, 70).  
Current evidence indicates that ageing is associated with a slowing, albeit modest, of gastric 
emptying, which may potentially contribute to reduced food intake in older people as a result 
of increased postprandial fullness (50). Older compared to young individuals, have been 
reported to have slower gastric emptying times after mixed nutrient (50, 51, 73-77), glucose 
(78) and lipid (79) preloads (solid or liquid) in some, but not all studies (42, 80, 81). One 
study reported no effect of ageing on gastric emptying of a solid mixed nutrient meal, but 
slower emptying in older, compared to young, adults for the gastric emptying of a glass of 
orange juice (82). Only one study reported an accelerating effect of ageing on gastric 
emptying (83). Cholecystokinin (CCK) plays an important role in the slowing of gastric 
emptying (see below), and fasting and postprandial concentrations are increased in older, 
compared to younger, adults (43, 48, 51, 53, 79). Gastric distribution of a meal may also be 
affected by ageing – increased retention in the distal stomach may result in increased antral 
distension, possibly as a result of autonomic dysfunction (50). Ageing is also associated with 




diminished perception of gastric distension, which may contribute to the less precise control 
of food intake in older when compared to young people (84). The effect of ageing on gastric 
emptying of pure protein, and the relation between subsequent energy intake and gastric 
emptying in older people are unknown.  
 
Ghrelin  
Ghrelin is produced and released from the fundus of the stomach when the stomach is empty 
(Figure 2.3). It exerts its effect via the ‘growth hormone secretagogue’ receptor (GHS-R) 
and releases growth-hormone (85). GHS receptors are present in the hypothalamus, pituitary, 
adrenal, thyroid, pancreas, myocardium, spleen, ovary, enteric neurons and stomach tissue 
(86). Ghrelin stimulates food intake by increasing gastric acid production and gastric 
motility, and by inhibition of insulin via neuropeptide Y (NPY) and its production of agouti-
related peptide (AgRP), which stimulate appetite via central effects. Plasma ghrelin levels 
are decreased in people with obesity and increased in those with cachexia or anorexia, when 
compared to healthy individuals (87).  
The majority of studies have found that plasma active (acylated) ghrelin (52, 88) and total 
ghrelin (41, 48, 52, 88-90) concentrations during fasting are not affected by increasing age. 
However, Di Fransesco et al. and Rigamonti et al. reported that older, compared with young 
adults, had lower levels of plasma active (91) and total (92) ghrelin concentrations during 
fasting, providing another possible mechanism for the ageing-associated decline in appetite 
and food intake. 
In young adults, plasma total ghrelin concentrations have been reported to decrease after an 
oral nutrient preload (41, 52, 91) and to start to increase again approximately two hours after 
preload administration (41, 91), whereas at this time they remain similar to baseline in older 
participants (52). This suggests altered ghrelin production or sensitivity in older individuals. 




Sturm et al., however, reported that the absolute decline in plasma total ghrelin 
concentrations after an oral mixed nutrient preload was comparable in both age groups (48).  
Higher plasma ghrelin concentrations have been observed in older compared to young 
individuals during an energy restricted period and a subsequent ad libitum period (55). 
Plasma total ghrelin concentrations were lower in young, than in older individuals after a 
two-week period of caloric restriction, but in both age groups there was an increase in plasma 
ghrelin concentrations during the ad libitum period compared to an energy balance period 
(55). These observations suggest that ghrelin sensitivity is decreased in this group i.e. higher 
levels may be required to achieve the same orexigenic effect as in young people. The effect 
of ageing on stimulation of ghrelin in response to protein is unknown. 
 
SMALL INTESTINAL MECHANISMS IN YOUNG AND OLDER 
ADULTS 
Small intestinal mechanisms include gut motility and concentrations and activity of the 
anorexigenic hormones.  
 
Gut motility 
Stomach and small intestinal motility consists of three phases which follow a pattern in the 
fasting state, called ‘the migrating motor complex (MMC)’; phase I, in which no motility is 
present (~40 min), phase II in which irregular contractions are present (~50 min) and phase 
III, which shows strong and regular contractions (~5-10 min) (93). The MMC is stimulated 
by different gut hormones and activation of the parasympathetic and enteric nervous system 
(94). Agents, including hormones, which induce phase III contractions with gastric origin 
include motilin (95), erythromycin (96), atropine (97) and ghrelin (98). Hormones that 




induce phase III contractions with duodenal origin include somatostatin (99) and xenin 
(100).  
Serotonin has no effects on the MMC when administered intraduodenally, however, it 
increases the frequency and migration velocity of phase II contraction when administered 
intravenously (101, 102).  
Studies performed employing recording with a balloon kymograph showed that gastric 
motor activity is inhibited after truncal vagotomy (103) but phase III contractions were still 
present in the small intestine (104) suggesting that the vagus nerve is involved in gastric 
motility, but not the motility of the small intestine. The latter is now thought to be regulated 
primarily by the enteric nervous system. Contraction of the smooth muscle cells of the 
gastrointestinal tract is initiated by the release of excitatory neurotransmitters from motor 
neurons of the enteric nervous system at the same time as slow waves generated by the 
interstitial cells of Cajal (94). During phase I, slow waves are present, but there is no 
secretion of an excitatory stimulus from the enteric nerve system so that no contractions 
occur during phase I. During phase II and III, both slow waves and excitatory stimuli are 
present, leading to the generation of contractions (94).  
After meal consumption, fasting motility changes to postprandial motility in the segments 
where the chyme is present; characterised by irregular antral contractions to enable mixing 
and digestion of the food consumed (105). These contractions last ~1 hour for each 200 kcal 
ingested. In the segments where no chyme is present, fasting motility continues (106). The 
transportation of (unabsorbed) nutrients from the stomach to the small intestine via the 
pylorus is associated with gastric acid production (107), pancreatic secretion (108) and 
inhibition of gastric and jejunal motility (109, 110). The latter effect is known as the ‘ileal 
brake’ effect and is exerted by gastrointestinal hormones (111) (Figure 2.1). Intraduodenal 
infusion of lipids (112), carbohydrates (113) and hydrolysed-whey protein (114) in young 
adults, suppresses subsequent energy intake (114) by increasing neural and hormonal 




feedback and stimulating increases in phasic (isolated pyloric pressure waves; IPPW’s) and 
tonic pressures of the pylorus, to regulate nutrient delivery to the intestine, resulting in 
slowing of the rate of gastric emptying. 
Healthy ageing is associated with increased small intestinal responses to nutrients, including 
greater stimulation of phasic pyloric pressure waves by intraduodenal lipid infusion (45), a 
greater satiating effect of intraduodenal glucose (44), and altered gut hormone responses (42, 
43, 48); all of these changes may contribute to the observed modest slowing in gastric 
emptying (53). The effect of ageing on small intestinal responses to intraduodenal protein 
has not been investigated. 
 
Anorexigenic hormones 
Another aspect of the small intestinal and gastrointestinal mechanisms influencing energy 
intake are the anorexigenic hormones [cholecystokinin (CCK), glucagon-like peptide 1 
(GLP-1), peptide tyrosine tyrosine 3-36 (PYY), gastric inhibitory polypeptide (GIP), insulin 
and glucagon] which are present in low concentrations in the peripheral blood during fasting 
conditions, with a substantial increase during and after meal intake associated with meal 
termination and suppression of subsequent energy intake (115). 
 
Cholecystokinin (CCK) 
CCK is released from L-cells in the mucosal epithelium of the duodenum in response to 
meals, particularly those containing fat or protein (Figure 2.3) (116-118). CCK is 
transported via the blood and has rapid, short-lived, effects (119) which effects are mediated 
by CCKA receptors, present in the pancreas and on the afferent vagus nerve and enteric 
neurons, and also CCKB receptors, present in the stomach and on the afferent vagus nerve 




(120, 121). Receptor binding influences gastric emptying, gut motility, secretion of gastric 
acid, enzyme secretion of the pancreas and contraction of the gallbladder (116-118).  
Figure 2.3: Hormone production sites. Adapted from (122). 
 
CCK acts to reduce hunger and suppress food intake: infusions of CCK reduce food intake 
in young and older adults (43) while administration of CCK antagonists results in increased 
hunger and food intake, indicative of a physiological role for this inhibitory effect (123). 
Older people appear to have higher plasma CCK concentrations, on average, than young 
adults under all conditions studied: during fasting (43, 48, 51, 53), after ingestion of an oral 
nutrient preload (51), during ID infusion of lipids and glucose (53), and during intravenous 
infusion of saline and exogenous CCK (43). Only one study failed to find any differences in 
CCK concentrations between young and older people (41). Older people seem to retain their 
sensitivity to the satiating effects of CCK as the suppression of energy intake induced by 
intravenous infusion of CCK, compared to the control day, was higher in the older adults 
compared with the young adults (32% vs. 16%) (43). The effect of ageing on the CCK 
response to protein in unknown. 
 




Gastric inhibitory protein (GIP) 
GIP is secreted by K-cells located in the duodenum and proximal jejunum mainly as a 
response to intake of carbohydrates and lipids (Figure 2.3) (124). GIP has a very short half-
life time of 5-7 min, before it is rapidly degraded by dipeptidyl peptidase-4 (DPP-IV) (125). 
The amino acid sequence of GIP is almost identical to GLP-1 (see below) (124). GIP exerts 
its effects via GIP receptors, which are located on the pancreatic islands, gut, adipose tissue, 
heart, pituitary, adrenal cortex and in several regions of the brain.  
The effect of GIP on energy intake is not clear (126). Potentially GIP exerts an anorexigenic 
effect by stimulating insulin secretion (127), promoting ß-cell proliferation (128) and 
regulating fat metabolism in adipocytes (129) (incorporation of fatty acid into triglycerides 
and stimulation of lipoprotein lipase activity and stimulation of fatty acid synthesis). GIP 
stimulates the secretion of glucagon in a dose-dependent matter (130) and one study reported 
a modest acceleration of gastric emptying by peripheral infusion of GIP (131). The 
physiology of GIP is poorly understood because of the absence of a specific GIP receptor 
antagonist suitable for human use.  
Older compared with young people, have similar plasma GIP concentrations during fasting 
(132-134). After oral ingestion of glucose (132, 134, 135) and during a 1 kcal/min 
intraduodenal glucose infusion (baseline to 60 min) (133), GIP levels have been reported to 
be higher in older compared to young subjects and to also return to baseline slower (132). 
Higher post-nutrient GIP levels in older than young adults may reflect reduced DPP-IV 
levels in older compared to young people and/or alterations in glucose-induced insulin 
secretion and the β-cell response, potentially resulting in increased feelings of satiety (135). 
The sensitivity to GIP in the ageing population has not been evaluated, and the effect of 
ageing on the GIP response to protein in unknown. 
 




Glucagon-like peptide1 (GLP-1) 
GLP-1 is released from proglucagon L-cells located predominantly in the mucosal 
epithelium of the ileum and colon (Figure 2.3) (136). GLP-1 has a short half-life of 1-2 min 
as it is, like GIP, rapidly broken down by DPP-IV (137). GLP-1 exerts its effects primarily 
by the GLP-1 receptor, present on peripheral and neurons of the central nervous system 
(CNS), cells in the pancreatic islands, gastrointestinal tract, lungs, kidneys, and heart (138-
140).  
GLP-1 suppresses appetite and food intake probably in part by inhibiting gastrointestinal 
motility and thereby the transit of nutrients through the gastrointestinal tract, contributing to 
the ileal brake effect (141, 142), by glucose-dependent stimulatory and inhibitory effects on 
insulin and glucagon secretion, respectively (143). The physiological role of GLP-1 on 
gastric emptying was determined by a study using exendin 9-39 amide, a GLP-1 receptor 
antagonist. The study reported accelerated gastric emptying and increased postprandial 
glucose concentrations after a mixed nutrient preload during intravenous infusion of exendin 
9-39 amide compared to control. Exogenous infusion of GLP-1 slowed of gastric emptying 
and also reported decreased energy intake compared to a control saline infusion in young 
healthy men (144). 
In most studies, older and young adults have been reported to have comparable circulating 
plasma GLP-1 concentrations during fasting (48, 53, 133). However, Ranganath et al. 
reported higher concentrations in older compared with young females (132), while, in 
contrast, Trahair et al. found a trend towards lower fasting GLP-1 concentrations in older, 
compared to young, men and women (133). After a mixed nutrient oral preload (48) or 
during intraduodenal glucose or lipid infusion (53, 133) comparable GLP-1 plasma 
concentrations were observed in young and older individuals. In contrast, Ranganath et al. 
reported higher GLP-1 plasma concentrations in older compared with young people in 
response to oral carbohydrate (132). MacIntosh et al. reported an inverse relationship 




between hunger ratings and GLP-1 levels in young, but not in older, subjects (53), consistent 
with the concept that older people are less sensitive to the satiating effects of GLP-1. The 
sensitivity to GLP-1 in the older population has not been evaluated, and the effect of ageing 
on the GLP-1 response to protein is unknown. 
 
Peptide tyrosine-tyrosine (PYY) 
PYY is released from endocrine L-cells in the mucosal epithelium of the ileum and colon 
(Figure 2.3) (145) as PYY(1-36) and metabolised in to PYY(3-36) by DPP-IV (146, 147). 
PYY exerts its effects by binding to the NPY receptor family, and neuropeptide Y2 receptors 
(148, 149). PYY probably has a major role in the ileal brake effect, which may contribute to 
its anorexigenic effect (150, 151). Plasma PYY concentrations during fasting appear to be 
largely unaffected by ageing (51, 53), although, after an oral mixed-nutrient preload, meal-
induced rises may be more prolonged in older people (51), which may contribute to increased 
feelings of satiety. However, during a two hour intraduodenal glucose or lipid infusion, PYY 
concentrations in both age groups were comparable (53). This may be because in this study 
the nutrients were infused into the duodenum, and would, accordingly, be expected to be 
absorbed higher in the gastrointestinal tract, i.e. since PYY is produced in the colon, it is not 
surprising that only a low PYY response (and no difference between age groups) was 
observed (53). No studies have evaluated the sensitivity to PYY in an ageing population 
have been conducted. The effect of ageing on the PYY response to protein is unknown. 
 
Glucose regulation in young and older adults 
Glucose is the main form of fuel for the body. In response to food intake, particularly 
carbohydrates, blood glucose concentrations increase, and insulin released from the pancreas 
to promote incorporation of glucose into fat, liver and skeletal muscle cells. Glucagon has 
the opposite effect – when glucose concentrations are low glucagon stimulates the liver to 




convert glycogen intro glucose. Due to insulin resistance associated with ageing, older 
people have higher blood glucose concentrations compared to young adults (152).  
 
Insulin 
Insulin is released from ß-cells in the pancreas and is required for the transportation of 
glucose into the body cells (Figure 2.3) (153). Intranasal administration of insulin in young 
men (154) and women (155) suppressed subsequent energy intake, and increased insulin 
concentrations have been correlated with decreased food intake in various studies in young 
adults (156-159). Whey protein results in greater increases in insulin concentrations and 
more suppression of energy intake compared to other high-protein meals (tuna, egg and 
turkey) (160). Insulin may suppress energy intake via the stimulation of alpha-melanocyte-
stimulating hormone (αMSH) and cocaine- and amphetamine-regulated transcript (CART) 
neurons, by inhibiting NPY and AgRP production in the arcuate nucleus (161), and by 
decreasing ghrelin levels (162) (163) (164).  
Circulating insulin concentrations probably increase with increasing age. Plasma insulin 
concentrations in older compared to young individuals during fasting were higher in five 
studies (20, 48, 89, 133, 165), comparable in four studies (42, 44, 52, 132) and lower in one 
study (43). After oral mixed-nutrient preloads higher peak plasma insulin concentrations 
have been reported in older than young subjects (41, 89); a 9-fold increase in insulin 
concentrations was seen in the older group versus a 3-fold increase in the young group in 
one study (41). During intraduodenal glucose infusion, the rise in serum levels of insulin 
was reported to be greater in older than in young subjects (44). Two hours after an oral 
preload, higher insulin concentrations in older compared with young subjects were observed 
(52). Another study found increased insulin concentrations throughout a day in older than in 
young adults when subjects were given two standardised oral meals (166). However, four 
other studies found that after oral carbohydrate preloads, mixed nutrient preloads and during 




intraduodenal glucose infusion, there was no difference in insulin levels between older and 
young participants (42, 48, 132, 133), although levels returned slower to baseline in older 
compared with young subjects (132). Insulin resistance in the ageing population may be 
explained by an increase in visceral fat mass, rather than by age per se – intra-abdominal fat 
mass correlates significantly with insulin resistance regardless of gender (167). Increased 
insulin concentrations in older people could possibly result in a decreased appetite as insulin 
stimulates leptin production, and inhibits ghrelin expression. The effect of ageing on the 
insulin response to protein is unknown. 
 
Glucagon 
Glucagon is secreted from α-cells in the pancreas and released in the portal vein in fasting 
conditions and in response to exercise (Figure 2.3). Glucagon acts on the liver to promote 
glycogenolysis and gluconeogenesis to increase blood glucose levels (69). Glucagon 
mediates its effects via the glucagon receptor, which is expressed mainly in the liver and 
kidneys, but is also found in the gut, adrenal glands, brain, heart, pancreas, spleen and 
adipocytes (168).  
Exogenous administration of glucagon was found to suppress hunger and energy intake in 
multiple old studies (169-171). A recent study confirmed these results and reported 
decreased energy intake in response to intravenous infusion of glucagon, either by itself or 
in combination with GLP-1, in healthy young men (144). Glucagon had no effect on gastric 
emptying or appetite scores, indicating that glucagon suppresses energy intake through in an 
alternative way. A possible mechanism is though increasing glucose concentrations and 
reducing hunger contractions (172) although another studies has found the suppressive 
capacities of glucagon independent of glucose concentrations (169).  
Fasting glucagon concentrations have been reported to be similar between young and older 
people (173, 174) (175). Glucagon concentrations after intravenous glucose and arginine 




infusions (173), after 250 kcal, 500 kcal and 1000 kcal mixed nutrient meals (175), and 
during 2 hyperglycaemic clamps (basal plasma glucose + 5.4 mmol/L or basal plasma 
glucose + 12.8 mmol/L) (176), were also not different between younger and older age 
groups. One study found reduced glucagon responses after an oral glucose tolerance test in 
older compared to young men and women (134). The effect of ageing on the glucagon 
response to protein is unknown. 
 
CONCLUSIONS 
In conclusion, the literature suggests that ageing is associated with slower gastric emptying, 
greater stimulation of phasic pyloric pressure waves in response to intraduodenal infusion of 
lipid and glucose, and altered hormone responses, potentially contributing to increased 
satiety in the older population. The effect of ageing on the gastric emptying, 
antrapyloroduodenal motility, ghrelin, CCK, GLP-1, GIP, insulin, glucagon and glucose 








CHAPTER 3: AGEING IS ASSOCIATED WITH 
DECREASES IN APPETITE AND ENERGY INTAKE - A 
META-ANALYSIS IN HEALTHY ADULTS 
 
 
Giezenaar C, Chapman I, Luscombe-Marsh N, Feinle-Bisset C, Horowitz 
M, Soenen S 
 
 
Published in Nutrients 
2016 
  




STATEMENT OF AUTHORSHIP 
Principal Author 
Co-Author Contributions 
By signing the Statement of Authorship, each author certifies that: 
i) the candidate’s stated contribution to the publication is accurate (as detailed 
above); 
ii) permission is granted for the candidate in include the publication in the thesis; 
and 
iii) the sum of all co-author contributions is equal to 100% less the candidate’s stated 
contribution.  
Name of Co-Author Ian Chapman 
Title of the paper Ageing Is Associated with Decreases in Appetite and Energy 
Intake—A Meta-Analysis in Healthy Adults. 
Publication status Published 
Publication details Giezenaar C, Chapman I, Luscombe-Marsh N, Feinle-Bisset 
C, Horowitz M, Soenen S. Ageing Is Associated with 
Decreases in Appetite and Energy Intake--A Meta-Analysis in 
Healthy Adults. Nutrients 2016;8(1): 10.3390/nu8010028. 
Candidate Caroline Giezenaar 
Contribution Searching, identification and critical review of the literature 
data interpretation, statistical analysis and drafting the 
manuscript. 
Overall percentage  75% 
Certification This paper reports on original research I conducted during the 
period of my Higher Degree by Research candidature and is 
not subject to any obligations or contractual agreements with a 
third party that would constrain its inclusion in this thesis. I am 
the primary author of this paper. 
Signature Date October 2017 




Contribution Data interpretation and drafting of the manuscript. 
Signature Date October 2017 
Name of Co-Author Natalie D Luscombe-Marsh 




Date October 2017 
Name of Co-Author Christine Feinle-Bisset 
Contribution Data interpretation and drafting of the manuscript. 
Signature 
 
Date October 2017 
Name of Co-Author Michael Horowitz 
Contribution Data interpretation and drafting of the manuscript. 
Signature Date October 2017 
Name of Co-Author Stijn Soenen 
Contribution Searching, identification and critical review of the literature 
data interpretation, statistical analysis, drafting of the 
manuscript and overall responsibility for the study. 
Signature Date October 2017 
 
  





Background and aims: It is not well recognised that in the elderly weight loss is more 
common than weight gain. The aim of this analysis was to determine the effect of ageing on 
appetite (hunger/fullness) and energy intake, after overnight fasting and in a postprandial 
state, by meta-analyses of trials that included at least two age groups (> 18 years). We 
hypothesised that appetite and energy intake would be less in healthy older compared with 
younger adults.  
Methods: Following a PubMed-database systematic search up to 30 June 2015, 59 studies 
were included in the random-effects-model meta-analyses. 
Results: Energy intake was 16%–20% lower in older (n = 3574/~70 years/~71 kg/~25 
kg/m2) than younger (n = 4111/~26 years/~69 kg/~23 kg/m2) adults [standardised mean 
difference: −0.77 (95% confidence interval −0.90 to −0.64)]. Hunger was 25% [after 
overnight fasting; weighted mean difference (WMD): −17 (−22 to −13) mm) to 39% (in a 
postprandial state; WMD: −14 (−19 to −9) mm] lower, and fullness 37% [after overnight 
fasting; WMD: 6 mm (95% CI: 1 to 11 mm)] greater in older than younger adults.  
Conclusions: In conclusion, appetite and energy intake are less in healthy older than 
younger adults, suggesting that ageing per se affects food intake. 
 
  





The world population is ageing rapidly. For example, the proportion of the world's 
population over 60 years will double from 11% to 22% between 2000 and 2050. As 
healthcare costs are incurred largely by older people, this will have dramatic societal 
impacts, so that, largely as a result of population ageing, it is projected that government 
spending in Australia on health will increase tenfold per capita by 2055 (177). Reducing 
morbidity in the older population is, accordingly, a major public health goal. A very large 
proportion of the increases in healthcare costs are accounted for by increasing rates and 
duration of hospital admissions in older people. During hospitalisation nutritional status 
often declines in older patients, due to a lack of adequate energy intake (178). 
It is often not recognised that after age ~65 years weight loss, particularly lean tissue, is more 
common than weight gain - this has been well documented in cross-sectional and 
longitudinal studies (5, 8, 179-182). In the elderly, both low body weight and weight loss 
are strong predictors of poor outcomes (180, 183), including the development of pathological 
undernutrition and sarcopenia and reduced functional capacity and frailty (184). Data form 
animal studies suggest that caloric restriction, and probably more importantly diet 
composition, play a role in longevity by reducing the risk of developing type 2 diabetes, 
hypertension, cardiovascular disease and cancer which may be related to the body 
composition during life, i.e. less fat and more lean tissue (185, 186). The loss of body weight 
in older people is usually associated with disproportionate loss of lean body tissue, with 
average decreases of up to 3 kg of lean body mass, mainly skeletal muscle, per decade after 
the age of ~50 years (14). Furthermore, the adverse effects of overweight and obesity are 
much less in older than young adults, so that the body mass index (BMI) associated with 
maximum life expectancy increases with age; ~27-30 kg/m2 in people over 65 years 
compared to 20-25 kg/m2 in younger adults (13). There is no sound evidence that in people 




over 70 years a BMI > 30 kg/m2 is associated with any reduction in life expectancy. 
Consistent with this, the lower end of the ‘optimum’ BMI range is higher in older than young 
adults at about 22 kg/m2 (187). 
Weight loss in older people occurs because there is a decrease in daily energy intake (188) 
which is greater than the decrease in energy expenditure (189). The decrease in energy 
intake, and the reduction in appetite which underlies it, has been called the ‘physiological 
anorexia of ageing’ (6, 190). The reduction in energy expenditure in the elderly is due to 
reduced physical exercise, loss of energy-demanding lean tissue, and decreased metabolic 
cost of metabolizing the smaller amount of consumed food (191-193). The American 
National Health and Nutrition Examination Survey (NHANES) III cross sectional studies 
reported a decline in energy intake, between the ages of 20-29 and 70-79 years, of 38% (1138 
kcal/day) in men and 27% (522 kcal/day) in women and energy intake measured with 24-h 
recall interviews (179). We recently showed that energy intake was 16% lower in older than 
younger men, when energy intake was measured with a more accurate technique: of a single 
ad libitum buffet-style meal at the research facility (194). 
An important strategy for maintaining good health in older people is the prevention and 
management of weight loss in the elderly. It is important, therefore, to accurately 
characterise this problem. Many of the studies in the area have used different methods to 
measure energy intake and included relatively few subjects, so there is benefit in combining 
these data. The aim of this analysis was to determine (i) the magnitude of decrease in energy 
intake and appetite by ageing; (ii) whether the age-effect on energy intake is present both 
after overnight fasting and in the postprandial state; (iii) whether the age-effect on energy 
intake is affected by the method of energy-intake measurement, by meta-analyses of studies 
which included two age groups of healthy (younger and older) adults. We hypothesised that 
appetite and energy intake would be ~20-25% less in healthy older when compared with 
younger adults. 




MATERIALS AND METHODS 
Search strategy, study selection, data extraction and quality assessment 
We performed a search of English-language publications in the PubMed database for studies 
that reported original data of appetite and/or energy (food) intake in ‘healthy’ adults up to 
30 June 2015. We used ‘ageing/ageing’ in combination with ‘appetite’, ‘hunger’, ‘fullness’, 
and ‘food/energy intake’ as keywords (search terms: ("ageing"[MeSH Terms] OR 
"ageing"[All Fields] OR "ageing"[All Fields]) AND ("appetite"[MeSH Terms] OR 
"appetite"[All Fields]); ("ageing"[MeSH Terms] OR "ageing"[All Fields] OR "ageing"[All 
Fields]) AND ("hunger"[MeSH Terms] OR "hunger"[All Fields]);("ageing"[MeSH Terms] 
OR "ageing"[All Fields] OR "ageing"[All Fields]) AND fullness[All Fields]); 
("ageing"[MeSH Terms] OR "ageing"[All Fields] OR "ageing"[All Fields]) AND "energy 
intake"[All Fields]); ("ageing"[MeSH Terms] OR "ageing"[All Fields] OR "ageing"[All 
Fields]) AND "food intake"[All Fields]) with filters for animal and non-English publications. 
We searched for a broad and heterogeneous range of studies, and not only intervention 
studies, reporting data on appetite and energy intake in both younger and older adults. These 
data are often reported as ‘subject characteristics’ at baseline, particularly in the case of 
energy intake, and not as primary study outcomes. Two researchers (CG and SS) performed 
screening of studies by titles and abstracts and, subsequently, full texts. References from the 
retrieved publications and bibliographies of relevant reviews were checked to identify 
potential additional articles. Studies were included if they reported mean ± SD/SEM energy 
intake (kcal) and/or appetite (i.e., hunger and/or fullness) of at least two age groups - 
‘younger’ and ‘older’ adults. Study subjects were required to be ‘healthy’ and at least 18 
years old, without using age restrictions in defining the ‘younger’ and ‘older’ age groups. 
Usually the older groups were made up of people over 60-65 years. Animal studies and non-
English publications were excluded. Characteristics were extracted from the original reports 




using a standardised data extraction form. When SD’s or SEM’s of appetite or energy intake 
were missing in the publication or it was stated that these data were measured but not given, 
the investigators were contacted by e-mail with a request to provide these data - requested 
and received twice regarding data of appetite and once requested but not received regarding 
data of energy intake. We recorded the study’s author(s), year of publication, study design, 
number and gender distribution of the participants, and mean ± SD: age (years), body weight 
(kg), body mass index (BMI, kg/m2) for both age groups (Table 3.1, Appendix 1). The usual 
quality filters for randomised trials or observational epidemiologic studies did not apply 
since the primary aim of this meta-analysis was to determine the magnitude of decrease in 
energy intake and appetite by ageing rather than to determine the effect of an intervention. 
We determined whether studies reported inclusion and exclusion criteria and data on 
attrition, and whether potential confounders were considered, for example whether the 
younger and older groups were matched for body weight and/or BMI. When data of 
interventions were used, we reported whether randomization of study conditions was used 
and whether the study subjects and research personnel were blinded. This meta-analysis is 
reported in accordance with the recommendations and criteria outlined in the Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement (195). 
 
Data analysis 
Meta-analyses were performed with REVMAN software (version 5.2; the Cochrane 
Collaboration Oxford, United Kingdom) using the DerSimonian and Laird random-effects 
model with a 95% confidence interval, to account for measurement variability among the 
included studies. For this analysis, the number of participants’ means and SD’s of energy 
intake and hunger and fullness were extracted for both age groups, i.e., younger and older 
adults. For all data, the SD’s were calculated, when necessary, from SE’s, and when data 
were not provided in numerical form they were estimated from the figures. Cochran’s test 




for heterogeneity was used to determine whether the studies included in the meta-analysis 
were evaluating the same underlying sizes of effect. A threshold of P < 0.1 was used to 
decide whether heterogeneity (genuine variation in effect sizes) was present. I2, an estimate 
of the proportion of total observed variability that is due to genuine variation rather than 
random error within studies, was used to quantify the degree of inconsistency among studies; 
it was considered substantial when it was > 50% (196). Sensitivity analyses were performed 
on studies that may cause bias in the results. Differences in energy intake between younger 
and older adults were analysed using  
Standardised mean differences (SMD’s). The SMD is used when it is necessary to 
standardise the results of several studies to a uniform scale - when studies assess the same 
outcome (e.g., energy intake) but measure it in a variety of ways (e.g., kcal/meal or kcal/day 
for energy intake). The SMD expresses the size of the effect in each study relative to the 
variability observed in that study. The SMD is calculated by dividing the difference in mean 
outcome between groups (younger and older adults) by the SD of outcome among 
participants (196). Data relating to hunger and fullness were defined as mean difference 
between the younger and older adults. Percentage differences between the younger and older 
adults for the outcomes were calculated for each study and averaged. 
 
RESULTS 
The PubMed search identified 5044 potential articles. The review flow diagram is, following 
the recommendations of the PRISMA statement (195), depicted in Figure 3.1. We screened 
2703 titles or abstracts following exclusion of 2341 animal studies or non-English articles. 
We screened 88 publications in full text of which 59 studies fulfilled the inclusion criteria. 
There were 7 studies which included more than 2 age groups (197-203) - we extracted the 
data of energy intake and/or appetite of the youngest (≥ 18 years) and oldest age group for  





Figure 3.1: Flow diagram for the selection of studies. 
 
each of these studies. There were 14 studies which presented data of multiple groups within 
the younger and older study groups (7, 200, 204-215), i.e., gender, country, and/or level of 
physical activity - we combined the male and female or country or level of physical activity 
groups by calculating their mean energy intake/ appetite score and pooling their SD’s to 
create a single pair-wise comparison.  
No studies were excluded based on quality of study, although many studies did not report 
sufficient information for a clear bias assessment. All studies, except 4 (205, 216-218), 
reported inclusion and/or exclusion criteria, and stated that the participants met these criteria. 
Of the studies measuring energy intake (49 studies), 18 studies matched the younger and 
older participants for body weight (48, 54, 55, 194, 197, 209, 216, 218-228) and 13 studies 
for BMI (42-45, 49, 54, 207, 216, 218, 219, 226, 228, 229) and 11 studies considered gender 




as a confounder (7, 49, 200, 203-205, 208-210, 212, 214). No studies considered 
confounders for hunger or fullness. 
In crossover studies [17 studies (42-46, 48, 49, 57, 84, 194, 198, 201, 214, 215, 230-232)], 
selection bias and performance bias were possible sources of bias. Thirteen studies (42-46, 
48, 49, 84, 194, 201, 214, 215, 232) were randomised of which one (194) detailed a method 
through random numbers, in the other 6 randomization was not discussed. No studies 
reported the use of allocation concealment. Performance bias scored worse, 3 studies were 
double-blind (46, 49, 194) and 2 single-blind (44, 57), in the other 12 blinding was not 
discussed. In the studies measuring energy intake over a prolonged period of time, all studies, 
except 2 (63, 219), had a method to check compliance. 
 
Effect of age on energy intake 
Three different methods of measuring energy intake were distinguished: (i) energy intake of 
a single ad libitum buffet-style meal at the research facility after overnight fasting [during a 
‘control’ condition; e.g., no preload, water preload or saline intraduodenal infusion (43, 49, 
194)] and in a postprandial state after a nutrient preload [> 0 kcal; range 180 (194) - 729 
(201) kcal], administered orally or infused directly into the small intestine [i.e., 
intraduodenally (44, 194)] – all intervention crossover studies, (ii) energy intake of provided 
food items during a prolonged period (~4 days - 2 weeks) and, (iii) energy intake of weighed 
food records (~3-14 days), 24-hour food intake recalls, or food frequency questionnaires – 
we used the observational data for energy intake for the latter two categories. There were 3 
studies measuring energy intake of a buffet-style meal in a postprandial state which consisted 
of multiple nutrient-preload conditions (44, 46, 194) - we extracted the energy intake data of 
the condition which had the largest effect to suppress energy intake by the nutrient ingestion 
in the younger-subject group (i.e., the nutrient preload with the highest energy content). 




Forty-nine unique studies presented data on energy intake; (i) 10 studies (311 subjects) 
reported energy intake of ‘a buffet-style meal’ after overnight fasting (42, 43, 46, 48, 49, 84, 
194, 201, 214, 215) and 9 studies (266 subjects) in a postprandial state (42, 44-46, 48, 57, 
194, 201, 214) – of which 6 studies (203 subjects) measured energy intake both after 
overnight fasting and in a postprandial state (42, 46, 48, 194, 201, 214); (ii) 7 studies (339 
subjects) reported energy intake ‘during a prolonged period’ (7, 54-56, 63, 192, 219) and; 
(iii) 37 studies (7035 subjects) reported energy intake of weighed-food records [30 studies 
(42-44, 48, 49, 53, 191, 200, 204-212, 214, 215, 217, 218, 220-225, 227, 228, 233)], 24-hour 
food intake recalls [6 studies (197, 202, 203, 216, 226, 229)], or food frequency 
questionnaires [1 study (199)] - of which 8 studies also reported energy intake of a buffet-
style meal (42-45, 48, 49, 214, 215). 
Twenty-six studies were conducted in the United States (7, 46, 55, 56, 63, 191, 192, 200, 
204-206, 208, 211, 214, 215, 217, 219, 221-224, 226-230, 233), 10 in Europe (54, 57, 197, 
199, 201-203, 207, 212, 218), 8 in Australia (42-44, 48, 49, 53, 194), 2 in Asia (210, 216), 
2 in Canada (209, 220), and 1 in Chile (225). The oldest study was published in 1966 (217) 
and the most recent in 2014 (194). The largest study included 2685 subjects (229) and the 
smallest 10 subjects (84). The mean age of the youngest group within a study was 19 years 
(the older group in that study had a mean age of 55 years) (233) and of the oldest group 77 
years (the younger group in that study had a mean age of 22 years) (48). 
 
Energy intake in the total group 
In the total group of 7685 subjects, energy intake after overnight fasting was less in the older 
(n = 3574, ~70 years, body weight ~71 kg, BMI ~25 kg/m2) than the younger adults (n = 
4111, ~26 years, ~69 kg, ~23 kg/m2), with a SMD of -0.77 [95% CI: -0.90 to -0.64] (Figure 
3.2) and significant heterogeneity (I2 = 76%, P < 0.001). As a group, the older adults had on 
average 18 ± 9% (mean ± SD) lower energy intake than the younger adults. 

























Figure 3.2: Energy intake. Mean ± SD of energy intake (kcal) and a plot of the standardised 
mean difference (SMD; mm) of energy intake in older compared with younger subjects with 
the DerSimonian and Laird random-effect model. The horizontal lines denote the 95% 




confidence interval; ▀ point estimates (the size of the square corresponds to its weight); ♦ 
the pooled estimate of age effect. Three different methods of measuring energy intake were 
distinguished: (i) energy intake of a single ad libitum buffet-style meal at the research facility 
after overnight fasting and in a postprandial state after a nutrient preload, administered orally 
or infused directly into the small intestine; (ii) energy intake of provided food items during 
a prolonged period; and (iii) energy intake of weighed food records, 24-h food intake recalls, 
or food frequency questionnaires. In the total group of 7685 subjects, energy intake was less 
(SMD: −0.77 (95% CI −0.90 to −0.64), I2 = 76%, p < 0.001) in the older than the younger 
adults. * P < 0.05 energy intake significantly less in older than younger adults within the 
study; # data were derived from a figure of the original publication. 
 
Heterogeneity was not affected by introducing a maximum age of the younger and a 
minimum age of the older age groups (I2 = 78%, n = 6620 subjects, P < 0.001); i.e., after 
excluding studies in which the mean age or the maximum age, when age was reported as a 
range, of the younger adult group was > 40 years old [studies excluded: mean age of 61 
(212); age range of 30-49 (210), 42-54 (202), 20-64 (200)] and after excluding studies in 
which the mean age or the minimum age, when age was reported as a range, of the older 
adult group was < 65 years old [studies excluded: mean age of 55 (233), 57 (207), 59 (218), 
62 (211), 63 (224) years; age range of 36-53 (204), 50-69 (210)]. In the studies included in 
this sensitivity analysis energy intake was less in the older than the younger adults with a 
SMD of -0.87 [95% CI: -1.03 to -0.72]. As a group, the older adults (n = 2992) had on 
average 19 ± 9% lower energy intake than the younger (n = 3628) adults. 
Heterogeneity was not affected by excluding the ‘small-intestinal’ studies, i.e., subjects were 
intubated with a catheter to deliver the nutrients directly into the small intestine [I2 = 77%, 
n = 7617, P < 0.001; 3 studies excluded (43, 49, 194)]. In the studies included in this 
sensitivity analysis energy intake was less in the older than the younger adults with a SMD 
of -0.77 [95% CI: -0.90 to -0.63]. As a group, the older adults (n = 3540) had on average 17 
± 9% lower energy intake than the younger (n = 4077) adults. 
Heterogeneity was not affected by excluding the ‘larger’ studies, i.e. with > 100 subjects per 
age group [I2 = 59%, n = 2432, P < 0.001; 4 studies excluded (57, 201, 210, 231)]. In the 




studies included in this sensitivity analysis energy intake was less in the older than the 
younger adults with a SMD of -0.77 [95% CI: -0.92 to -0.63]. As a group, the older adults 
(n = 1212) had on average 18 ± 9% lower energy intake than the younger (n = 1220) adults. 
In 1555 females [17 studies (7, 48, 49, 199, 200, 203-205, 208-210, 212, 215, 218, 221, 223, 
233)], energy intake after overnight fasting was less in older (n = 763) than younger 
participants (n = 792), with a SMD of -0.70 [95% CI: -0.95 to -0.45] and significant 
heterogeneity (I2 = 73%, P < 0.001). As a group, the older females (1559 kcal) had on 
average 16 ± 9% lower energy intake than the younger females (1844 kcal). 
In 2030 males [28 studies (7, 44-46, 49, 54, 63, 84, 191, 194, 200, 202-212, 215, 217, 219, 
222, 224, 225)] energy intake after overnight fasting was less in older (n = 1045) than 
younger participants (n = 985), with a SMD of -0.95 [95% CI: -1.20 to -0.75] and significant 
heterogeneity (I2 = 73%, P < 0.001). As a group, the older males (2033 kcal) had on average 
18 ± 10% lower energy intake than the younger males (2486 kcal). 
Within an individual study, energy intake was significantly less in older than younger adults 
in 5 of 10 studies which determined energy intake of a single ad libitum buffet-style meal 
after overnight fasting at the research facility (43, 46, 49, 214, 215), 6 of 7 studies which 
determined energy intake by provided food items during a prolonged period (7, 54, 55, 63, 
192, 219), and 24 of 37 studies which determined energy intake by weighed-food records, 
24-hour food intake recalls, or food frequency questionnaires (42, 43, 45, 48, 49, 191, 197, 
199, 200, 202, 203, 205, 206, 208, 209, 211, 212, 216, 217, 220-223, 229) (Figure 3.2). 
There were no studies in which energy intake after overnight fasting was significantly higher 
in older than younger adults. 
 
Energy intake of a buffet-style meal 
In the subgroup of 311 subjects, in which energy intake was measured of a single ad libitum 
buffet-style meal at the research facility after overnight fasting (42, 43, 46, 48, 49, 84, 194, 




201, 214, 215), energy intake was less in the older than the younger adults, with a SMD of -
0.89 [95% CI: -1.42 to -0.36] (Figure 3.2) and significant heterogeneity (I2 = 77%, P < 
0.001). As a group the older adults (n = 145, energy intake of 819 kcal/meal), had on average 
20 ± 15% (~218 kcal/meal) lower energy intake of a buffet-style meal after overnight fasting 
than the younger adults (n = 166, energy intake of 1037 kcal/meal). 
In the subgroup of 266 subjects, in which energy intake was measured of a buffet-style meal 
during postprandial conditions (42, 44-46, 48, 57, 194, 201, 214), energy intake was less in 
the older than the younger adults, with a SMD of -0.37 [95% CI: -0.65 to -0.10] (Figure 3.2) 
and no significant heterogeneity (I2 = 15%, P = 0.31). As a group the older adults (n = 126, 
energy intake of 691 kcal/meal) had on average 16 ± 20% (~122 kcal/meal) lower energy 
intake of a buffet-style meal in a postprandial state than the younger adults (n = 140, energy 
intake of 814 kcal/meal). 
In the subgroup of 203 subjects, in which energy intake was measured of a buffet-style meal 
both after overnight fasting and in a postprandial state (42, 46, 48, 194, 201, 214), energy 
intake decreased less in the older adults (decrease in energy intake of on average 10% or ~79 
kcal from 798 kcal after overnight fasting to 719 kcal in the postprandial state) than in the 
younger adults (decrease in energy intake of on average 21% or ~212 kcal from 1000 kcal 
after overnight fasting to 788 kcal in the postprandial state). 
 
Energy intake during a prolonged period 
In the subgroup of 339 subjects, in which energy intake from provided food items was 
measured during a prolonged period (~4 days - 2 weeks) (7, 54-56, 63, 192, 219), energy 
intake was less in the older than the younger adults, with a SMD of -1.09 [95% CI: -1.42 to 
-0.76] (Figure 3.2) and non-significant heterogeneity (I2 = 42%, P = 0.11). As a group the 
older adults (n = 163, energy intake of 2241 kcal/24 h) had on average 19 ± 6% (~546 kcal/24 




h) lower energy intake during a prolonged period than the younger adults (n = 176, energy 
intake of 2787 kcal/24 h). 
 
Energy intake of weighed-food records, 24-hour food intake recalls, or food frequency 
questionnaires 
In the subgroup of 7035 subjects, in which energy intake was measured using weighed food 
records (42-44, 48, 49, 53, 191, 200, 204-212, 214, 215, 217, 218, 220-225, 227, 228, 233), 
24-hour food intake recall (197, 202, 203, 216, 226, 229), or food frequency questionnaires 
(199), energy intake was less in the older than the younger adults with a SMD of -0.69 [95% 
CI: -0.84 to -0.55] (Figure 3.2) and significant heterogeneity (I2 = 77%, P < 0.001). As a 
group the older adults (n = 3266, energy intake of 1969 kcal/24 h,) had on average 17 ± 8% 
(~407 kcal/24 h) lower energy intake than the younger adults (n = 3769, energy intake of 
2376 kcal/24 h). 
In the subgroup of 4311 subjects, in which energy intake was measured using weighed food 
records energy intake was less in the older than the younger adults with a SMD of -0.63 
[95% CI: -0.77 to -0.49] and significant heterogeneity (I2 = 49%, P = 0.001). In the subgroup 
of 2530 subjects, in which energy intake was measured using 24-hour food intake recalls 
energy intake was less in the older than the younger adults with a SMD of -0.63 [95% CI: -
0.77 to -0.49] and significant heterogeneity (I2 = 92%, P = 0.001). 
 
Effect of age on appetite  
Hunger 
Twenty studies (561 subjects) reported hunger after overnight fasting (41-46, 48-51, 84, 88-
90, 194, 198, 214, 215, 230, 231). Twelve of these studies (344 subjects) evaluated hunger 
also after nutrient ingestion (60 min after oral nutrient consumption/ start of the small 




intestinal nutrient infusion; i.e., a time point which was reported in the majority of the studies 
(41, 42, 44, 48, 50, 51, 89, 90, 194, 231) - 2 studies did not measure appetite up to 60 min 
and, therefore, the data of 30 min (214) and 15 min (46) were included); 10 studies (98 
subjects) after oral mixed macronutrient (protein, carbohydrate and fat) consumption (41, 
42, 46, 48, 50, 51, 89, 90, 214, 231) and 2 studies (46 subjects) during intraduodenal infusion 
of protein (194) or fat (44). All studies reporting hunger were intervention studies, 14 
crossover (42-46, 48, 49, 84, 194, 198, 214, 215, 230, 231) and 6 non-controlled studies (41, 
50, 51, 88-90), 
Nine studies were conducted in Australia (42-45, 48-50, 84, 194), 6 in Europe (41, 51, 88-
90, 231), and 5 in the United States (46, 198, 214, 215, 230). The largest study included 54 
subjects (214) and the smallest 10 subjects (84). The mean age of the youngest group within 
a study was 22 years (the older group in that study had a mean age of 77 years) and the oldest 
group 81 years (the young group in that study had a mean age of 38 years) (90). 
Hunger, measured after overnight fasting (41-46, 48-51, 84, 88-90, 194, 198, 214, 215, 230, 
231), was less in the older (n = 285, 74 years, 72 kg, 25 kg/m2) than the younger adults (n = 
276, 27 years, 69 kg, 24 kg/m2), with a weighted mean difference (WMD) of -17 mm [95% 
CI: -22 to -13 mm] (Figure 3.3) and significant heterogeneity (I2 = 52%, P = 0.004). 
Heterogeneity was not significant when the ‘small-intestinal’ studies were excluded (43-45, 
49, 194) (I2 = 51 %, n = 444 subjects, P = 0.010). As a group the older adults (43 mm) had  
  













Figure 3.3: Appetite. Mean ± SD of appetite [hunger and fullness; visual analogue scale 
(VAS; mm)] after overnight fasting and in a postprandial state and a plot of the weighted 
mean difference (WMD; mm) of appetite in older compared with younger subjects with the 
DerSimonian and Laird random-effect model. The horizontal lines denote the 95% 
confidence interval; ▀ point estimates (the size of the square corresponds to its weight); ♦ 
the pooled estimate of the age effect. Older compared to younger adults were less hungry 
(WMD: −17 mm (95% CI −22 to −13 mm), I2 = 52%, P = 0.004) and more full (WMD: 6 
mm 95% CI 1 to 11 mm, I2 = 76%, P < 0.001) after overnight fasting and less hungry (WMD: 
−14 mm (95% CI −19 to −9 mm), I2 = 53%, P = 0.01) in a postprandial state, whereas 
fullness was comparable (WMD: 6 mm (95% CI −2 to 14 mm), I2 = 54%, P = 0.02). * P < 
0.05 appetite (hunger/fullness) significantly different in older than younger adults within the 
study; # data were derived from a figure of the original publication; ^ data were provided by 
the investigators by e-mail upon request. 
 
on average 25 ± 24% (~16 ± 13 mm) lower hunger after overnight fasting than the younger 
adults (59 mm).  




Hunger, measured in a postprandial state (41, 42, 44, 46, 48, 50, 51, 89, 90, 194, 214, 231), 
was less in the older than the younger adults, with a WMD of -14 mm [95% CI: -19 to -9 
mm] (Figure 3.3) and significant heterogeneity (I2 = 53%, P = 0.010). As a group the older 
adults had on average 39 ± 30% (~15 ± 11 mm) lower hunger in a postprandial state than 
the younger adults. In the group of 344 subjects, hunger was decreased by 26 mm from 66 
mm after overnight fasting to 40 mm in a postprandial state in the younger adults and by 20 
mm from 45 mm after overnight fasting to 25 mm in a postprandial state in the older adults. 
Within an individual study, hunger was significantly less in older than younger adults in 12 
(41, 43-46, 49, 51, 84, 89, 90, 214, 215) of 20 studies after overnight fasting and 8 (41, 42, 
44, 48, 50, 51, 89, 90) of 12 studies in a postprandial state. There were no studies in which 
hunger was significantly higher in older than younger adults. 
 
Fullness 
Sixteen studies (501 subjects) reported fullness after overnight fasting (42, 44-46, 48-51, 84, 
88, 89, 194, 198, 214, 215, 232). Ten of these studies (335 subjects) evaluated fullness also 
after nutrient ingestion; 8 studies after oral mixed macronutrient consumption (42, 46, 48, 
50, 51, 89, 214, 232) and 2 studies during intraduodenal infusion of protein (194) or fat (44). 
All studies reporting fullness were intervention studies, 12 crossover (42, 44-46, 48, 49, 84, 
194, 198, 214, 215, 232) and 4 non-controlled studies (50, 51, 88, 89). 
Eight studies were conducted in Australia (42, 44, 45, 48-50, 84, 194), 4 in the United States 
(46, 198, 214, 215), 3 in Europe (51, 88, 89), and 1 in Asia (232). The largest study included 
95 subjects (232) and the smallest 10 subjects (84). The mean age of the youngest group was 
22 years and 77 years of the oldest group (48). 
Fullness, measured after overnight fasting, was greater in the older (n = 254, 73 years, 71 
kg, 25 kg/m2) than the younger adults (n = 247, 26 years, 67 kg, 23 kg/m2), with a WMD of 
6 mm [95% CI: 1 to 11 mm] and significant heterogeneity (I2 = 76%, P < 0.001; Figure 3.3). 




Heterogeneity was not affected by excluding the ‘small-intestinal’ studies (I2 =73%, n = 416 
subjects, P < 0.001; 4 studies excluded (44, 45, 49, 194). As a group the older adults (27 
mm) had on average 37 ± 73% (~8 ± 13 mm) higher fullness after overnight fasting than the 
younger adults (19 mm) adults. 
Fullness, measured in a postprandial state, was not significantly different between the older 
and the younger subjects with a WMD of 6 mm [95% CI: -2 to 14 mm] and significant 
heterogeneity (I2 = 54%, P = 0.020). In the group of 335 subjects, fullness was increased by 
23 mm from 18 mm after overnight fasting to 41 mm in a postprandial state in the younger 
adults and by 26 mm from 23 mm after overnight fasting to 49 mm in a postprandial state in 
the older adults. 
Heterogeneity decreased by introducing a maximum age of the younger and a minimum age 
of the older age groups (I2 = 0%, n = 240 subjects, P = 0.51); i.e., after excluding studies in 
which the mean age or the minimum age, when age was reported as a range, of the older 
adult group was < 65 years old [one study excluded: range of 50-59 (232)] - there were no 
studies in which the mean age or the maximum age, when age was reported as a range, of 
the younger adult group was > 40 years old. In the studies included in this sensitivity analysis 
fullness was significantly different between the older and the younger adults with a WMD 
of 9 mm [95% CI: 2 to 14]. As a group the older adults had on average 21 ± 32% (~9 ± 10 
mm) higher fullness in a postprandial state than the younger adults. 
Within an individual study, fullness was greater in older than younger adults in 6 (46, 49, 
88, 194, 215, 232) of 16 studies after overnight fasting. In contrast, fullness was less in older 
than younger adults in 1 (194) of 16 studies after overnight fasting and 1 (232) of 10 studies 
in a postprandial state. 
 





This meta-analysis examined the effect of ageing on appetite and energy intake in adults, 
including data from > 7500 subjects on energy intake and > 500 subjects on appetite derived 
from 59 studies. Energy intake was less in healthy older (~70 years) than younger (~26 years) 
adults. The calculated reduction fell into quite a narrow range at 16-20%, despite studies 
being done in the fasting and fed state, and energy intake being calculated by a variety of 
methods, including intake at an acute study meal, during prolonged periods or using weighed 
food records, 24-hour food intake recalls, and food frequency questionnaires, i.e., a robust 
finding regardless of the method of intake evaluation. The results of this analysis show that 
older people (~73 years) feel less hungry than younger adults (~26 years), both fasting (25%) 
and after they have consumed some food (39%), and also feel more full in the fasting state 
(37%). These age-related differences are substantial, and likely to be a major cause of the 
reduced energy intake by older people. 
Our results indicate a reduction in energy intake of approximately 20% between the ages of 
26 and 70 years, i.e. about 0.5% per year. This is consistent with previous reports of reduced 
energy intake of approximately 30% between the ages of 20 and 80 years (7, 179), and with 
the results of individual prospective studies. For example, a 7-year New Mexico longitudinal 
study of 156 persons aged 64-91 years, reported a decrease of 19 kcal/day/year in women 
and 25 kcal/day/year in men (8), while a Swedish longitudinal study of 98 people found an 
even greater decline of energy intake of 610 kcal/day in men and 440 kcal/day in women, 
between the ages of 70 and 76 years (5). A population-based study indicated that older people 
aged 60-74 years consume ~500-700 kcal/day less than their younger counterparts aged 20-
39 years (179). Our gender analyses indicated that energy intake was less in both older than 
younger males (18%) and females (16%), to a similar extent in both sexes. 




The regulation of energy intake may be diminished in the elderly. Older subjects have a 
reduced suppression of energy intake after oral (46), or small intestinal nutrient (194), 
ingestion. In this meta-analysis in the subgroup of 203 subjects [6 studies (42, 46, 48, 194, 
201, 214)], in which energy intake was measured during a single ad libitum buffet-style meal 
at the research facility both after overnight fasting and in the postprandial state, energy intake 
decreased on average 11% less in the older than young adults. Older people do not show the 
ability to regulate food intake after prolonged over- or under-feeding as young individuals 
(56, 63). This indicates that after an anorectic insult (for example, major surgery), older 
people are likely to take longer than young adults to regain the weight lost, remain 
undernourished longer, and be more susceptible to subsequent superimposed illnesses, such 
as infections. 
Our results indicate a reduction in hunger of approximately 25% and increase in fullness of 
approximately 35% between the ages of 27 and 74 years, i.e. changes of about 0.5% per year 
for hunger and about 0.7% per year for fullness respectively. Scores for appetite are 
predictive of energy intake in both healthy young and older subjects (47). Appetite and 
energy intake are dependent on the precise co-ordination of interrelated intragastric (i.e., 
gastric emptying (68), antral area and motility (the distal stomach) (42, 68), and plasma 
ghrelin concentrations (48, 113, 234, 235) and ‘small intestinal’ mechanisms [pyloric 
motility (236) and gut hormone secretion including cholecystokinin (CCK) (235), glucagon-
like polypeptide-1 (GLP-1) (237), peptide tyrosine tyrosine (PYY) and gastric inhibitory 
polypeptide (GIP)]. These gastrointestinal mechanisms affecting appetite and energy intake 
are modulated by ageing (238). Healthy older people, as a group, have slightly slower gastric 
emptying (50) mediated by increased pyloric motility (42, 45, 48, 53), greater gastric antral 
area (42), decreased perception of gastric distension (84), lower plasma ghrelin (92) and 
higher CCK concentrations than young adults, differences that all favour reductions in 
appetite and energy intake. Ageing is associated with insulin resistance and impaired glucose 




tolerance (239) which may be influenced by changes in small intestinal hormone (GLP-1, 
GIP) secretion (133). Also, thyroid hormone concentrations are known to change with 
ageing which may be regarded as a physiologic process that can affect appetite (240, 241). 
There may be a decrease in appetite-stimulating free thyroid hormones with increasing age 
in men (242). Serum thyroid stimulating hormone (TSH) concentrations may be higher and 
free thyroid hormones lower in older, when compared to younger, men (243).  Older people 
have an increased prevalence of both hypo- (up to 5%) and hyperthyroidism (0.5-3%) than 
younger patients. In the elderly the symptoms of both conditions can overlap with other age-
related diseases (e.g., unexplained, weight loss, anorexia, weakness, fatigue, depression, 
constipation) (243). The senses of smell and taste deteriorate with age (244), leading to a 
reduced capacity to enjoy food and develop sensory-specific satiety, (198) the normal 
decline in pleasantness of the taste of a particular food after it has been consumed, leading 
to a decrease in its consumption and a tendency to shift consumption to other food choices 
during a meal. Age-related reduction in sensory-specific satiety favours a less varied, more 
monotonous diet, and the development of micronutrient deficiencies.  
Physiological anorexia and seemingly minor weight loss predisposes to the development of 
pathological under-nutrition, cachexia and adverse effects (245) and is, accordingly, 
associated with increased morbidity and mortality. For example, in a large study of 
community-dwelling Americans aged 65 years or older, weight loss in excess of 5% body 
weight over 3 years occurred in 17% and was associated with a 70% increase in mortality, 
irrespective of the initial weight, whereas weight stability and weight gain were not 
associated with increased mortality (246). Not uncommonly, pathological anorexia and 
weight loss are superimposed on the ‘physiological anorexia of ageing’ (190). This can be 
the result of a variety of conditions that become more frequent with age, including acute and 
chronic medical conditions (gastrointestinal disease, malabsorption syndromes, infection, 
hypermetabolism, micronutrient deficiencies, increased energy requirements), medications 




(which may cause malabsorption of nutrients, gastrointestinal symptoms, and loss of 
appetite), psychological factors (depression, dementia and Alzheimer’s disease, and 
bereavement), social factors (poverty, difficulties with shopping, meal preparation and self-
feeding, living alone, social isolation and loneliness) and physical factors (poor dentition 
leading to problems with chewing, immobility (stroke), Parkinson disease, and impaired 
vision). Because the majority of these factors are at least partly responsive to treatment, their 
recognition is important. For example, increased cytokine levels, due to the stress of ageing 
per se, or the amplified stressful effects of other pathologies, may provide an explanation for 
some of the decline in appetite and energy intake in older people (247). Increased cortisol 
and catecholamines stimulate the release of interleukin 6 and tumour necrosis factor alpha 
(248). 
Although only a limited number of studies have examined the effects of undernutrition on 
appetite and energy intake, there is evidence of substantial differences between 
undernourished and well-nourished older people, which may potentially result from being 
undernourished and/or contribute to the undernourished state (41, 48, 90). Undernourished 
older adults had significantly reduced hunger in the fasted state and in the postprandial state’ 
and significant greater fullness in the fasted state when compared to healthy older (90) and 
young adults (48, 90). In undernourished older women energy intake was not suppressed by 
a mixed-nutrient preload, unlike in well-nourished older and young women (48). In another 
study of undernourished older subjects, concentrations of CCK were higher than in well-
nourished older subjects (249), suggesting that increased CCK activity may be a cause of 
undernutrition in older people, and/or act to perpetuate it. 
Limitations of the meta-analysis are that we used a single database and that there is 
variability in study design and characteristics indicated by high heterogeneity - we 
performed a-priori determined meta-analyses depending on the method used to determine 




energy intake and sensitivity analyses when possible, i.e. effect of sex and age, and observed 
that the effects of ageing on appetite and energy intake were comparable in these analyses. 
In summary, this meta-analysis of 59 studies supports previous reports that appetite and 
energy intake are reduced in healthy older compared with younger adults, with a 16-20% 
lower energy intake, 25-39% lower hunger and 37% more fullness in those aged on average 
70-74 years compared to 26-27 years, a robust finding regardless of the method of intake 
evaluation. These age-related differences in healthy adults are consistent with a reduction of 
food intake with ageing i.e., a physiological anorexia of ageing. The reduction in energy 
intake in this analysis equates to approximately 0.5% per year of increasing age, and is likely 
to contribute to loss of weight in older people and the development of pathological under-















CHAPTER 4: METHODOLOGIES 
  





This chapter provides an overview of the methodologies used in the data collection for the 
studies presented in chapters 5-12 of this thesis. All of the methodologies are well 
established, including measurements of ad libitum energy intake using a standardised buffet 
meal (250, 251), perception of appetite and gastrointestinal symptoms by visual analogue 
scales (47), antropyloroduodenal motility by manometry (252), gastric emptying by 3-
dimensional (3D) ultrasonography (68) and stable isotope breath testing (253, 254), blood 
glucose concentrations and plasma concentrations of gut hormones including insulin, 
glucagon, ghrelin, cholecystokinin (CCK), gastric inhibitory polypeptide (GIP), glucagon-
like peptide 1 (GLP-1) and peptide tyrosine tyrosine (PYY) by radioimmunoassay (251, 255) 




All protocols for the studies described in this thesis were approved by the Royal Adelaide 
Hospital Human Research Ethics Committee. Each subject provided written, informed 
consent prior to their enrolment in the studies. All studies were conducted in accordance 
with the Declaration of Helsinki. Each study was registered on the Australia and New 




Subjects were recruited by advertisement on notice boards at the Royal Adelaide Hospital 
and the universities in Adelaide, through advertisement websites, and from an existing 
database of volunteers who had participated previously in research studies within our 




department. Subject demographics and inclusion and exclusion criteria are provided in each 




A buffet or cafeteria-style meal is commonly used to quantify ad libitum energy intake after 
preload ingestion (Chapters 5, 7, 8 -10, 12) (250, 251). A variety of food and drink items 
(Table 4.1, Figure 4.1) were presented to the subjects, in excess of what they were expected 
to consume. Subjects were instructed to consume food until they felt comfortably full in a 
room by themselves to limit external distractions (257).The amount of food eaten (g) was 
quantified by weighing each food item before and after consumption. Energy intake (kcal) 
and proportions of intake of protein, carbohydrate, and fat were calculated using 
commercially available software (Foodworks; Xyris Software Pty Ltd, Spring Hill, QLD, 
Australia). Energy intake (kcal) was calculated both as the intake at the meal and as the 
cumulative energy intake, defined as the sum of meal energy intake and preload/infusion 
energy content. Suppression of energy intake at the buffet meal by the preload/infusion was 












Figure 4.1: The ad libitum meal as presented to the study subjects. 
 



















Wholemeal bread, 4 slicesa 125   308 13.4 53.1   4.7 
White bread, 4 slicesa 125   304 10.8 59.5   2.6 
Cheese, slicedb  85   346 21.9   0.9 28.3 
Ham, slicedc 100     95 16.6   3.4   1.7 
Chicken, slicedd 100   104 18.8   3.6   1.6 
Margarinee  20   108   0.0   0.0 12.0 
Mayonnaisef  20   137   0.4   0.7 14.7 
Tomato, sliced 100     13   1.0   1.9   0.1 
Cucumber, sliced 100     11   0.5   1.9   0.1 
Lettuce 100       5   0.9   0.4   0.0 
Apple 170     89   0.5 21.3   0.2 
Banana 190   166   3.2 37.8   0.2 
Fruit saladg 140     81   0.4 17.1   1.3 
Strawberry yogurth 175   162   8.8 24.2   3.3 
Chocolate custardi 100   105   3.2 16.4   3.0 
Milkywayj  12     52   0.3   8.7   1.8 
Orange juice, unsweetenedk 300   117   1.8 21.9   2.6 
Iced coffeel 375   254 12.0 37.1   6.4 
Water 600       0   0.0   0.0   0.0 
Total 2937 2457 114.5 309.9 84.6 
aSunblest, Tiptop, George Weston Foods Ltd, Enfield, NSW, Australia; bCoon Tasty Cheese 
slices, Australian Cooperative Foods Ltd, Sydney Olympic Park, NSW, Australia; cKRC 
boneless leg ham, George Weston Foods Ltd, Enfield, NSW, Australia; dInghams chicken 




breast, Inhams Enterprises Pty Ltd, Burton, SA, Australia; eVita-Lite canola, Peerless 
Holdings Pty Ltd, Braybook, VIC, Australia; fMasterFoods, Mars Food Australia, Berkeley 
Vale, NSW, Australia; gGoulburn Valley, SPC, Ardmona Operations Ltd, Shepparton, VIC, 
Australia; hYoplait, LD&D Foods Pty Ltd, Docklands, VIC, Australia; iYogo, LD&D Foods 
Pty Ltd, Docklands, VIC, Australia; jMars Chocolate Australia, Wendouree, VIC, Australia; 
kNippy’s Fruit juices Pty Ltd, Regency Park, SA, Australia ; lFarmers Union, LD&D Foods 
Pty Ltd, Docklands, VIC, Australia. 
 
PERCEPTION OF APPETITE AND GASTROINTESTINAL  
SYMPTOMS 
Validated visual analogue scales (Chapters 5, 7, 8 -10, 12) are the most commonly used 
tool to measure perceptions of appetite and gastrointestinal symptoms in research studies 
(47, 258). Hunger, fullness, desire to eat, prospective food consumption, nausea and bloating 
were measured by visual analogue scales at baseline and at 15 min intervals throughout the 
studies. The questionnaires consisted of 100 mm horizontal lines, where 0 represented that 
the sensation was ‘not felt at all’ and 100 represented that the sensation was ‘felt the 
greatest’. Subjects placed a vertical mark on each horizontal line to indicate the strength of 




Manometry (Chapters 5 and 6) is a well-established technique to measure motility in the 
antral area of the stomach, the pylorus and the proximal area of the duodenum (252, 259). 
Contractions are measured using a manometric catheter which is perfused with degassed 
water and saline through side holes. The water column of the catheter transmits the detected 
changes in pressures to external transducers, where they are digitalised and displayed as 
pressure waves on a computer screen. 
 












Figure 4.2: Schematic representation of the manometric catheter used for intraduodenal 
protein infusion, incorporating six antral and seven duodenal side holes, spaced 1.5 cm apart, 
a pyloric sleeve sensor and an infusion port. 
 
The silicon rubber manometric catheter (Dentsleeve International, Mui Scientific, 
Mississauga, ON, Canada) has a total length of 1 m, a small-diameter of 3.5 mm and 16 side 
holes, each from a different channel, separated by 1.5 cm intervals. After correct positioning 
(Figure 4.2), the side holes of channels 1-6 are located in the antrum (stomach), a 4.5 cm  
sleeve sensor (channel 7) with channels 8 and 9 on the back of the sleeve are located across 
the pylorus, and channels 10-16 are located in the duodenum. The infusion port at the end  
of the catheter, an additional channel, is located in the proximal small intestine 14.5 cm from 
the pylorus and used for the administration of intraduodenal protein (114). 
Intubation was done via an anaesthetised nostril (Lignocaine 5%, Orion Laboratories Pty 
Ltd, Calcatta, WA, Australia) into the stomach, after which the catheter passed into the 
duodenum through peristalsis (260). The length of intubation was dependent on the height 
of the subject, but was not longer than 75 cm. Correct positioning of the catheter, with the 
sleeve sensor straddling the pylorus, was maintained by continuous measurement of the 
transmucosal potential difference (TMPD) between the most distal antral channel (channel 
6, ~-40 mV) and the most proximal duodenal channel (channel 10, ~0 mV) and a reference 




electrode attached to an intravenous cannula filled with sterile saline positioned 
subcutaneously in the left forearm (261). All manometric channels were perfused with 
degassed, distilled water at a rate of 0.15 mL/min, except for the two transmucosal-potential-
difference channels, which were perfused with degassed 0.9% saline (260). Baseline motility 
was recorded for 10 min after the occurrence of a phase III of the migrating motor complex 
(MMC), upon which the intraduodenal protein infusion was commenced. The set-up of the 












Figure 4.3: left: study set up with the infusion pump on the left and the manometry system 
on the right of the patient. Right top: the 3.5 mm silicone catheter; middle: a close up of the 
manometry system; bottom: a typical phase III of the migrating motor complex as displayed 
on the Flexisoft software. 
 
Antropyloroduodenal pressure waves were recorded continuously and digitised using a 
computer-based system that ran commercially available software (Flexisoft version 3; 
Oakfield Instruments Ltd, Eynsham, England) and were stored for subsequent analysis. Data 
were analysed for basal pyloric pressures, the number and amplitude of isolated pyloric 
pressure waves (IPPWs) and the number and amplitude of antral and duodenal pressure 




waves. Basal pyloric pressure was calculated by subtracting the mean basal pressure (with 
phasic pressures excluded) recorded at the most distal antral channel from the mean basal 
pressure recorded at the sleeve with custom-written software (A. Smout, University Medical 
Centre, Amsterdam, the Netherlands) modified to our requirements (252). Pressure waves 
were defined by an amplitude of 10 mm Hg or more with a minimum time interval of 15 s 
between peaks for IPPWs and antral pressure waves and 3 s for duodenal pressure waves 
(262). Baseline fasting values were calculated from 10 min before to the start of  
intraduodenal infusion as the mean of the study days. 
 
GASTRIC EMPTYING 
Gastric emptying (Chapters 7, 9, 10 and 12) was measured with a LogiqTM 9 
ultrasonography system (GE Healthcare Technologies, Sydney, NSW, Australia) with 
TruScan Architecture (i.e. built-in magnetically sensed 3D positioning and orientation 
measurement) including a 3D sensor, attached to a 3.5C broad-spectrum 2.5-4-MHz convex 
transducer, and a transmitter placed at the level of the stomach immediately behind the 
subject (Figure 4.4).  
3D ultrasonography has a good correlation with the ‘gold standard’ technique of scintigraphy 
(r = 0.92, P < 0.001) (68). 
The stomach was scanned by a continuous translational movement along its long axis (~10 
s). As the transmitter produces a spatially varying magnetic field that is distorted by 
conductive metals, all metal objects were removed from the subjects to minimise 
interference during image acquisition. During each scan, subjects were instructed to sit still 
and hold their breath at the end of inspiration. If gastric contractions were observed, the 
acquisition was paused until the contraction wave had passed. The raw data (original scan  














Figure 4.4: Set up of study subject and 3-D ultrasound machine. 
 
planes) were transferred for 3D reconstructions and volume estimation using EchoPAC-3D 
software (GE Vingmed Sound, Horten, Norway; Figure 4.5). Gastric retentions were 
calculated as total gastric volumes minus baseline ‘empty’ gastric volume at each time point 
expressed as a percentage of the maximal gastric volume (100%), i.e., volume of the ingested 
drink. When ultrasound images lacked sufficient clarity to determine the volume of the 
stomach, data were imputed by linear interpolation. The time at which 50% of the preload 
drink had emptied from the stomach (50% gastric emptying time; T50; min) and ‘complete’ 
emptying time (T100; min) of the drink, defined as the time when the residual volume of the 
drink in the stomach was ≤ 5%, were calculated (263). 
  





Figure 4.5: A) Ultrasonic image of the stomach with highlighted region of interested, and 
B) 3D reconstructed volumetric image of the stomach (68). 
 
CONCENTRATIONS OF BLOOD GLUCOSE AND PLASMA INSULIN, 
GLUCAGON, GHRELIN, CCK, GIP, GLP-1, PYY AND AMINO ACIDS  
For frequent blood sampling (Chapters 6, 9-12), an intravenous cannula was inserted into 
an antecubital vein. Venous blood samples were collected in EDTA-coated tubes. No 
inhibitors were added (264). Blood glucose (millimoles per liter) was determined 
immediately after collection by the glucose oxidase method using a portable glucometer 
(Optium Xceed, Abbott Laboratories, Australia). 
Plasma was obtained by centrifugation for 15 min at 3200 rpm at 4°C and samples were 
stored at -80°C for further analysis of hormone concentrations. 
Total plasma insulin (milliunits per liter) was measured by enzyme-linked immunosorbent 
assay (ELISA) immunoassay (10-1113; Mercodia, Uppsala, Sweden).  
Radioimmunoassays were used to measure plasma concentrations of total glucagon 
(detection limit of 20 pg/mL), total ghrelin (detection limit of 40 pg/mL), CCK-8 (detection 
limit of 1 pmol/L), total GIP (detection limit of 2 pmol/L), total GLP-1 (detection limit of 3 
pmol/L) and total PYY (detection limit of 1.5 pmol/L). Samples from individual subjects 




were measured in the same run. Intra- and inter-assay coefficients of variation are provided 
in chapters 6 and 9-12. 
Plasma concentrations (mmol/L) of free amino acids asparagine, aspartic acid, alanine, 
arginine, cysteine, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, 
methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine, were 
measured (Chapter 6) using precolumn derivatization with 6-aminoquinolyl-N 
hydroxysuccmimidyl carbamate (AQC) performed at the Australian Proteome Analysis’s 
Facility established under the Australian Government’s National Collaborative Research 









CHAPTER 5: EFFECTS OF INTRADUODENAL 
PROTEIN ON APPETITE, ENERGY INTAKE, AND 
ANTROPYLORODUODENAL MOTILITY IN HEALTHY 
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Background: Protein-rich supplements are used widely for the prevention and management 
of undernutrition in older people. The use of protein supplements in older people could, 
however, be counter-productive, by reducing appetite and overall energy intake. 
Objective: To determine whether ageing influences the effects of protein loads, 
administered directly into the small intestine, on energy intake, antropyloroduodenal motility 
and appetite. 
Design: Intraduodenal infusions (240 ml, 60 min) of saline (0 kcal/control) and (hydrolysed 
whey) protein loads of 30 kcal, 90 kcal and 180 kcal followed by ad libitum buffet meal in 
10 young (19-29 years) and 10 healthy older (68-81 years) men. Suppression of energy 
intake (kcal) at the meal by protein infusion compared to control was calculated. 
Results: In young subjects, there was dose-responsive suppression of energy intake at the 
buffet meal by protein (suppression at 30 kcal 7  8% P = 0.19; 90 kcal 17  8% P = 0.05; 
180 kcal 33  7% P = 0.002), whereas in older subjects there was suppression only after the 
180 kcal load (30 kcal 7  4% increase P = 0.13; 90 kcal 6  7% increase P = 0.29; 180 kcal 
176% suppression P = 0.016). Suppression of energy intake by protein was less in older 
than young subjects (P < 0.005). In young subjects total energy intake (meal + infusion) on 
the 180 kcal protein-infusion day was decreased compared to the control day (P = 0.041), 
whereas in older it was increased during the 30 kcal (P = 0.033) and 90 kcal (P = 0.016) 
days. 
Energy intake was inversely related to isolated pyloric pressure waves (r = -0.32 P = 0.013) 
and positively related to antral (r = 0.30 P = 0.021) and duodenal (r = 0.35 P = 0.006) 
pressure waves. Suppression of energy intake by protein was inversely related to the change 
in isolated pyloric pressure waves (r = -0.35 P = 0.027) and positively related to duodenal 
pressure waves (r = 0.32 P = 0.044). 




Conclusions: Intraduodenal protein suppresses appetite and energy intake less in healthy 
older than young adults. In older subjects intraduodenal protein at low doses increased 









As for young people, the number of older people who are overweight or obese increased 
substantially over recent decades (265). However, healthy ageing is associated with a 
reduction of appetite and energy, including protein, intake; the ‘anorexia of ageing’ (6, 7). 
These changes predispose older people to weight loss, particularly loss of skeletal muscle, 
and reduced functional capacity, and the development of pathological undernutrition, 
sarcopenia cachexia and frailty (6, 14, 180, 190, 266). The causes of the ‘anorexia of ageing’ 
are poorly defined, but likely to be multiple. Potential mechanisms include central and/or 
peripheral reductions in feeding drives and increased activity of central and/or peripheral 
satiety signals (267). Peripheral mechanisms, notably those related to the gastrointestinal 
tract, are important in regulating appetite and energy intake, particularly in the short-term 
after nutrient ingestion. They include interrelated ‘intragastric’ mechanisms, such as 
variations in the rate of gastric emptying and gastric distension (42, 50, 70, 74), and ‘small 
intestinal’ mechanisms, such as changes in antropyloroduodenal motility and the release of 
appetite-regulating hormones (70, 112-114, 234, 268). Changes in antropyloric motility in 
response to nutrient ingestion are independently related to subsequent energy intake in young 
subjects (269), and may therefore have a causative role. Compared to young adults, older 
people have a reduced perception of proximal gastric distension, and greater distension of 
the distal stomach, i.e. antral area, and slightly slower gastric emptying (42, 50, 74, 84), 
differences that would favour reductions in energy intake.  
A common strategy to increase energy intake and body weight in undernourished older 
people is the use of protein-enriched supplements, usually high-energy drinks rich in 
carbohydrates and whey protein (a major protein source in dairy). Despite the widespread 
use of such supplements by older people, evidence for their efficacy is limited, and their 
‘optimal’ composition unknown (26, 27, 31). The high satiating effects of dietary protein in 




younger adults have been extensively studied, driven primarily by attempts by overweight 
younger adults to lose weight (270). The effects of dietary protein on energy intake and 
underlying gastrointestinal mechanisms in older people are, however, largely unknown, 
which is surprising given the potential for protein-enriched supplements given to older 
people - to increase body weight and muscle mass - could reduce subsequent energy intake, 
which could counteract any associated protein-induced beneficial effects on muscle mass 
(20, 271, 272). 
In this study we aimed to characterise the effect of ageing on powerful ‘subgastric’ small 
intestinal mechanisms, by infusing hydrolysed (resembling partially digested protein) whey 
protein directly into the duodenum, and so ‘bypassing’ orosensory and gastric factors. We 
hypothesised that small intestinal administration of protein at loads lower than (0.5 
kcal/min), similar to (1.5 kcal/min) and at the upper end (3 kcal/min) of normal gastric 
emptying rates [1-4 kcal/min (273)] would reduce energy intake, antropyloroduodenal 
motility, and perceptions of appetite in a load-related fashion and, that the acute suppression 
of energy intake at a buffet meal would be less in healthy older persons than in young adults. 
 
SUBJECTS AND METHODS 
Subjects 
The study included 10 healthy young men [age (mean ± SEM): 23 ± 1 years (range 19-29 
years), body weight: 73 ± 2 kg (62-87 kg), height: 1.82 ± 0.02 m, BMI: 22 ± 1 kg/m2] and 
10 healthy older men [age: 74 ± 1 years (68-81 years), body weight: 79 ± 2 kg (66-92 kg), 
height: 1.74 ± 0.02 m, BMI: 26 ± 1 kg/m2]. Body weight of the two groups did not differ 
significantly. The older subjects had a lower height and, accordingly, higher BMI than young 
subjects (P < 0.05). Subjects were recruited by advertisement. Based on our previous work 
(114) we calculated that 10 subjects per group would allow us to detect a minimum 




suppression in energy intake after the higher protein preload (180 kcal over 60 min), 
compared to the control, infusion of 397 kcal, with α = 0.05 and power of 80%. Exclusion 
criteria were smoking, alcohol abuse, diabetes, gastrointestinal surgery (apart from 
uncomplicated appendectomy), significant gastrointestinal symptoms (pain, reflux, 
diarrhoea, or constipation) or use of medications known to potentially affect energy intake, 
appetite or gastrointestinal motor function, and for older people: impaired cognitive function 
[score < 25 on Mini Mental State (274)], depression [score > 11 on the Geriatric Depression 
Questionnaire (275)] and undernutrition [score < 24 on the Mini Nutritional Assessment 
(276)]. The Royal Adelaide Hospital Research Ethics Committee approved the study 
protocol, and the study was registered as a clinical trial with the Australia and New Zealand 
Clinical Trial Registry (www.anzctr.org.au, registration number 12612000906853). All 
subjects provided written informed consent prior to their inclusion in the study. 
 
Protocol 
Subjects were studied on 4 occasions, separated by at least 3 days, to determine the effects 
of three intraduodenal protein loads and a saline control, each infused for 60 min, on energy 
intake, antropyloroduodenal motility, perceptions of appetite and gastrointestinal symptoms 
in a randomised (by using the method of randomly permuted blocks; 
www.randomization.com), double-blind, crossover design. 
Protein solutions were prepared by dissolving whey protein hydrolysate powder (18.1% 
Hydrolysed Whey Protein 821, Fonterra Co-Operative Group Ltd., Palmerston North, New 
Zealand) in varying amounts of saline and water to achieve the desired loads; i.e. 0.5, 1.5 
and 3 kcal/min, which equated to 30, 90 and 180 kcal or 8, 24 and 48 g of protein or 0.11  
0.01 (range 0.09 – 0.13), 0.320.03 (0.26 – 0.39) and 0.63  0.06 (0.52 – 0.78) g of protein 
per kg body weight, and to ensure they were iso-osmotic (680 mOsmol/L). Infusions were 




prepared on the morning of each study by a research officer who was not involved in the 
data analysis. The infusion apparatus was covered at all times, so both the investigator and 
the subject were blinded to the treatment. The infusions were administered at a rate of 4 
mL/min (240 mL over 60 min).  
Subjects were provided with a standardised evening meal [beef lasagne (McCain Foods Pty 
Ltd, Wendouree, VIC, Australia), ~591 kcal] to consume on the night before each study, and 
instructed to fast overnight from solids and liquids and to refrain from strenuous physical 
activity until they attended the laboratory at the University of Adelaide Discipline of 
Medicine, Royal Adelaide Hospital, at ~08.30 h. On arrival, a small-diameter (3.5 mm) 16-
channel (side holes spaced at 1.5 cm intervals with channels 1-6: in the antrum, channel 7: a 
4.5 cm sleeve sensor - including channels 8 and 9 on the back of the sleeve - across the 
pylorus, channels 10-16: in the duodenum) manometric catheter (total length: 100 cm, 
Dentsleeve International, Mui Scientific, Mississauga, ON, Canada) was inserted into the 
stomach through an anesthetised nostril and allowed to pass into the duodenum by 
peristalsis. The correct positioning of the catheter, with the sleeve sensor straddling the 
pylorus, was maintained by continuous measurement of the transmucosal potential 
difference between the most distal antral channel (channel 6, ~-40 mV) and the most 
proximal duodenal channel (channel 10, ~0 mV), and a reference electrode attached to an 
intravenous cannula filled with sterile saline positioned subcutaneously in the left forearm. 
The infusion port of the catheter was located in the proximal small intestine 14.5 cm from 
the pylorus. All manometric channels were perfused with degassed, distilled water, except 
for the two transmucosal-potential-difference channels, which were perfused with degassed 
0.9% saline, at a rate of 0.15 mL/min. 
Once the catheter was positioned, fasting motility was observed until phase III of the 
interdigestive migrating motor complex occurred. Immediately after cessation of phase III 
activity, during motor quiescence (phase I of the migrating motor complex), a visual 




analogue scale (VAS) questionnaire to assess perceptions of appetite and gastrointestinal 
symptoms was completed and baseline antropyloroduodenal motility was measured for 15 
min upon which the intraduodenal infusion commenced. During the infusion, 
antropyloroduodenal motility was measured continuously, and VAS ratings were obtained 
at 15 min intervals. After 60 min the infusion was terminated and both the intraduodenal 
catheter and subcutaneous cannula were removed. Subjects were then presented with a 
standard, cold, buffet-style meal in excess of what they were expected to consume and 
instructed to eat freely for up to 30 min until comfortably full. The composition of the buffet 
meal is presented in Table 4.1. Immediately after completion of the meal (t = 90 min), final 




The amount eaten (g) was quantified by weighing the buffet meal before and after 
consumption. Energy intake (kcal) at the buffet meal and proportions of intake of protein, 
carbohydrate and fat were calculated using commercially available software (Foodworks; 
Xyris Software Pty Ltd, Spring Hill, QLD, Australia). Energy intake was calculated both as 
the intake at the buffet meal, and as total energy intake, defined as the sum of energy intake 
at the buffet meal and energy content of the intraduodenal infusion. Absolute and percentage 
suppression of energy intake (kcal) at the buffet meal by a given protein infusion compared 
to control was calculated. 
Perceptions of appetite and gastrointestinal function 
Perceptions of hunger, desire to eat, prospective consumption, and fullness, as well as nausea 
and bloating, were rated by using validated VAS questionnaires. These questionnaires 
consisted of 100 mm horizontal lines, where 0 represented that the sensation was ‘not felt at 




all’ and 100 represented that the sensation was ‘felt the greatest’. Subjects placed a vertical 
mark on each horizontal line to indicate the strength of each sensation felt at the specified 
time points. Baseline fasting ratings were calculated as mean of the four study days. Protein 
overall ratings were calculated as mean of the three protein-infusion study days. 
 
Antropyloroduodenal motility 
Antropyloroduodenal pressure waves were recorded continuously and digitised by using a 
computer-based system that ran commercially available software (Flexisoft v3; Oakfield 
Instruments, GS Hebbard) and stored for subsequent analysis. Data were analysed for basal 
pyloric pressures (BPPs) and number and amplitude of isolated pyloric pressure waves 
(IPPWs) and antral and duodenal pressure waves. BPP was calculated by subtracting the 
mean basal pressure (with phasic pressures excluded) recorded at the most distal antral 
channel from the mean basal pressure recorded at the sleeve with custom-written software 
modified to our requirements (272). Pressure waves were defined by an amplitude > 10 
mmHg with a minimum time interval of 15 sec between peaks for IPPWS and antral pressure 
waves and 3 sec for duodenal pressure waves. Baseline fasting values were calculated from 
10 min before to start of intraduodenal infusion as mean of the four study days. 
 
Data analysis 
Statistical analyses were performed using SPSS software (version 21, IBM). Between-
subject effects were determined by using ANOVA. Within-subject and interaction effects 
were determined by using repeated-measures ANOVA. Post-hoc comparisons, adjusted for 
multiple comparisons using Bonferroni's correction, were performed when ANOVAs 
revealed significant effects. Relations of energy intake with AUCs (which were calculated 
by using the trapezoidal rule) for antropyloroduodenal pressures and appetite were evaluated 




by between- and within-subject correlations (277, 278). Statistical significance was accepted 
at P < 0.05. All data are presented as mean ± SEM. 
 
RESULTS 
The study protocol was well tolerated by all subjects. 
 
Energy and macronutrient intakes 
Energy intake at the buffet meal 
 
Energy intake at the buffet meal after the intraduodenal infusions of saline (0 kcal, control) 
and protein loads of 30, 90 and 180 kcal was: 1270  150 kcal, 1123  151 kcal, 1028  163 
kcal and 851  161 kcal in young subjects and; 1068  93 kcal, 1129  91 kcal, 1123  98 
kcal and 899  103 kcal in older subjects. The lower (~16%) energy intake at the buffet meal 
during the control day in older compared with young subjects was not statistically significant 
(P = 0.27). The interaction effect of age x protein-load for energy intake at the buffet meal 
was significant (P = 0.039). Energy intake was dose-responsively suppressed by protein in 
the young subjects (suppression at 30 kcal 7  8% P = 0.19; 90 kcal 17  8% P = 0.05; 180 
kcal 33  8% P = 0.002, Figure 5.1); whereas there was suppression in the older subjects 
only with the 180 kcal infusion (30 kcal 7  4% increase in intake P = 0.13; 90 kcal 6  7% 
increase in intake P = 0.29; 180 kcal 17  6% suppression P = 0.016). Suppression of energy 









Figure 5.1: Data are means  SEMs. Energy intake (kcal) in young  (n = 10) and older 
 (n = 10) subjects after intraduodenal infusions  of saline (0 kcal, control) and whey 
protein loads of 30, 90 and 180 kcal for 60 min at 4 mL/min. In young subjects there was a 
dose-responsive suppression of energy intake at the buffet meal by protein compared to 
control, whereas in older subjects there was suppression only with the 180 kcal infusion. 
Between-subject effects were determined by using ANOVA. Within-subject and interaction 
effects were determined by using repeated-measures ANOVA. 
There was a significant age x protein-load interaction for energy intake at a buffet meal (P 
= 0.039) and total energy intake (buffet meal + infusion) (P = 0.039). 
* P < 0.05 Within age-group, lower energy intake at a buffet meal after protein-load infusion 
of 180 kcal compared to control in young and in older subjects. 
& P < 0.05 Within age-group, lower energy intake at a buffet meal after protein infusion of 
180 kcal compared to 30 kcal load in young and in older subjects. 
^ P < 0.05 Within age-group, lower energy intake at a buffet meal after protein infusion of 
180 kcal compared to 90 kcal load in older subjects. 
$ P < 0.05 Within age-group, lower total energy intake (energy intake at the buffet meal plus 
energy content of the infusion) during 180 kcal protein-load infusion day compared to 
control day in young subjects. 
# P < 0.05 Within age-group, higher total energy intake during 30 and 90 kcal protein-load 
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Figure 5.2: Data are means  SEMs. Suppression of energy intake (kcal) at the buffet meal 
in young  (n = 10) and older  (n = 10) subjects after intraduodenal infusions of whey 
protein loads of 30, 90 and 180 kcal compared to after intraduodenal infusion of saline (0 
kcal, control) for 60 min at 4 mL/min. Suppression of energy intake at the buffet meal by 
protein was less in older than young subjects. Main age and protein-load effects and 
interaction effects were determined by using repeated-measures ANOVA. The interaction 
age x protein-load was not significant (P = 0.57). Main effects of age (P < 0.05) and protein-
load (P < 0.001) were significant. 
 
Macronutrient intake 
Proportions of intake of protein, carbohydrate and fat at the buffet meal during the control 
day were not significantly different (P > 0.05) between young and older subjects (Table 5.1). 
The young subjects increased their proportion of carbohydrates and decreased their 
proportion of fat intake after the intraduodenal protein infusions reaching level of 
significance after the 180 kcal load when compared to control (P = 0.006 and P = 0.036). 
The interaction effect of age x protein-load for proportions of intake of protein (P = 0.23), 
carbohydrate (P = 0.07) and fat (P = 0.07) was not significant. 
 
Total energy intake 
In young subjects total energy intake (i.e. energy intake at the buffet meal plus energy 
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Table 5.1: Proportions of intake of protein, carbohydrate and fat at a buffet meal after 
intraduodenal protein infusions in young and older men 
 Young men (n = 10) Older men (n = 10) 
 0 kcal 30 kcal 90 kcal 180 kcal 0 kcal 30 kcal 90 kcal 180 kcal 
Protein (%) 201 211 201 181 211 201 201 201 
Carbohydrate (%) 443 472 493 5331 493 493 493 483 
Fat (%) 364 322 312 2931 302 312 312 322 
1 P < 0.05 Significantly different intake of carbohydrate and fat compared to control in young 
subjects. 
Intake of protein was not significantly different between protein loads (P > 0.05). 
Proportions of intake of protein, carbohydrate and fat at the buffet meal during the control 
day were not significantly different between age groups (P > 0.05). 
The interaction effect of age x protein-load for proportions of intake of protein (P = 0.23), 
carbohydrate (P = 0.07) and fat (P = 0.07) was not significant. 
 
 163 kcal, ↓~12% P = 0.20) protein-infusion days was non-significantly less than, total 
energy intake on the control day (1270  150 kcal), and significantly less on the 180 kcal 
day (1031  153 kcal, ↓~19% P = 0.041, Figure 5.1). In contrast, in older subjects total 
energy intake was significantly increased on the 30 kcal, (1159  91 kcal, ↑~9% P = 0.033) 
and 90 kcal (1213  98 kcal, ↑~14%, P = 0.016) protein-infusion days when compared to 
the control day (1068  88 kcal) and not significantly different on the 180 kcal day compared 
to the control day (1079  103 kcal, ↑~1%, P = 0.86). The interaction effect of age x protein-
load for total energy intake was significant (P = 0.039). 
 
Antropyloroduodenal motility 
Baseline isolated pyloric pressure wave (IPPW) number (young vs. old: 2  1vs. 6  1 per 
60 min, P = 0.024) and amplitude (young vs. old: 7  2 vs. 21  3 mmHg, P = 0.001) were 
higher in older than young subjects, while fasting basal pyloric pressures and, number and 




amplitude of IPPWs and antral and duodenal pressure waves were not significantly different 
between study days in both age groups (P > 0.05). 
In young and older subjects IPPW number was increased and antral and duodenal pressure 
wave number was decreased by the 180 kcal protein load compared to control (P < 0.05). 
Basal pyloric pressures of the protein loads were not different from control in both age 
groups (P > 0.05). Antral pressure wave amplitude was higher during the 30 kcal infusion in 
older than young subjects (P < 0.05, Table 5.2). Duodenal pressure wave amplitude was 
lower during the 180 kcal infusion in older than young subjects (P < 0.05). 
 
Perceptions of appetite and gastrointestinal symptoms 
Appetite 
Baseline ratings of hunger (young vs. old: 67  5mm vs. 45  9mm P = 0.042), desire to eat 
(young vs. old: 69  4mm vs. 37  8mm P < 0.002) and prospective food consumption 
(young vs. old: 70  4mm vs. 47  6mm P = 0.005) were lower in older than young subjects; 
fullness was not significantly different between the age groups (young vs. old: 11  3mm vs. 
6  2mm, P = 0.20). Ratings of hunger, desire to eat, prospective food consumption and 
fullness were not different from baseline during the infusions (t = 0-60 min) in both age 
groups (P > 0.05), with the exception of ratings of prospective food consumption (P = 0.020) 
being decreased by the 30 kcal infusion in young subjects (Figure 5.3). 
The age x protein-load interaction for hunger (P = 0.38), desire to eat (P = 0.51), prospective 
food consumption (P = 0.07) and fullness (P = 0.91) was not significant. Ratings of hunger, 
desire to eat and fullness during the intraduodenal infusions were not significantly different 
between age groups or protein loads (P > 0.05). 
Ratings of prospective food consumption (change AUC from baseline to 60 min) of the 30 
kcal protein load (372  192mm vs. 19  189mm P = 0.017) were significantly higher than 




Table 5.2: Number and amplitude of IPPWs and antral and duodenal pressure waves and 
basal pyloric pressures during 60 min intraduodenal protein infusions in young and older 
men 
 Young men (n = 10) Older men (n = 10)  
Protein 0 kcal 30 kcal 90 kcal 180 kcal 0 kcal 30 kcal 90 kcal 180 kcal P1 
IPPWs          
Number/60 min   4110  429   6512   76122   4411  5018  758   85142 0.980 
Amplitude 
(mmHg) 
  305   324   385   393   347   386  384   478 0.884 
BPP (mmHg)     12     12   -12     32      15     12   -11    -11 0.640 
Antral pressure waves       
Number/60 min   9317 10241   6721   35152  7326 11240   186    1762 0.604 
Amplitude   118   1275     83     06   286   76162,5   28123    1122,3 0.003 
Duodenal pressure waves      
Number/60 min 64181 565125 46162 380752 46785 54672 37672  223462 0.708 
Amplitude 
(mmHg) 
  2525   281   261   2525   3865   313   272    1622,3,4,5 0.005 
Data are mean  SEM. Intraduodenal infusions consisted of saline (0 kcal, control) and whey 
protein loads of 30, 90 and 180 kcal for 60 min at 4 mL/min. IPPWs, isolated pyloric pressure 
waves. BPP, basal pyloric pressure. Between-subject effects were determined by using 
ANOVA. Within-subject and interaction effects were determined by using repeated-
measures ANOVA. 
1 P age x protein-load interaction. 
2 P < 0.05 Significantly different from control. 
3 P < 0.05 Significantly different from 30 kcal protein load. 
4 P < 0.05 Significantly different from 90 kcal protein load. 
5 P < 0.05 Significantly different between young men and older men. 
 
control in older subjects; whereas ratings of prospective food consumption of the 30 kcal 
protein load were significantly lower than control in young subjects (-503  238 mm vs. -59 




 201 mm P = 0.007). Furthermore, in the older subjects mean prospective food consumption 
(change AUC from baseline to 60 min of the three protein loads vs. control: 230  215 mm 
vs. 19  189 mm P = 0.019) was increased by the protein loads compared to control; whereas 
in the young mean prospective food consumption decreased by the protein loads compared 
to control (protein vs. control: -326  213 mm vs. -59  201mm P = 0.020). 
Ratings of prospective food consumption (change AUC from baseline to 60 min) of the 30 
kcal protein load (young vs. older -503  238 mm vs. 372  192 mm P = 0.010) were 
significantly higher in older when compared with young subjects. Change in mean ratings 
of prospective food consumption (AUC young vs. old: -267  94 mm vs. 211  74 mm P = 
0.001) by the protein loads when compared with control was significantly less in older than 
young subjects. 
 
Nausea and bloating 
Ratings of nausea and bloating during the intraduodenal infusions were not significantly 
different between age groups or protein loads (P > 0.05, Table 5.3). The interaction effect 
of age x protein-load for ratings of nausea (P = 0.65) and bloating (P = 0.33) was not 
significant. Ratings of nausea and bloating were not different from baseline in both age 
groups (P > 0.05). 
 
  




Table 5.3: Ratings (AUC) of nausea and bloating during 60 min intraduodenal protein 
infusions in young and older men 
 Young men (n = 10) Older men (n = 10) 
 0 kcal 30 kcal 90 kcal 180 kcal 0 kcal 30 kcal 90 kcal 180 kcal 
Nausea (mm) 657227 773300 559178 922329 19661 18461 15145 24471 
Bloating (mm) 626187 803203 726203 546214 457168 470166 786292 641317 
Ratings of nausea (P = 0.06) and bloating (P = 0.79) were not significantly different between 
age groups. 
Ratings of nausea (P = 0.33) and bloating (P = 0.56) were not significantly different between 
protein-loads. 
The interaction effect of age x protein-load for ratings of nausea (P = 0.65) and bloating (P 
= 0.33) was not significant. 
 
Relations between antropyloroduodenal motility and perceptions of 
appetite with energy intake 
Energy intake at the buffet meal was, within-subjects, inversely related to IPPW number 
(r = -0.32 P = 0.013) and positively related to antral pressure wave number (r = 0.30 
P = 0.021) and duodenal pressure wave number (r = 0.35 P = 0.006) and, between-subjects, 
positively related to ratings of desire to eat (r = 0.47 P = 0.037) and prospective food 
consumption (r = 0.57 P = 0.008). 
Suppression of energy intake at the buffet meal by protein compared to control was, within-
subjects, inversely related to the change in IPPW number (r = -0.35 P = 0.027) and positively 
related to change in duodenal pressure wave number (r = 0.32 P = 0.044) and amplitude (r 
= 0.48 P = 0.002) by protein from control. 
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Figure 5.3: Data are means  SEMs. Change from fasting, baseline (t = 0 min) visual 
analogue scores (mm) of prospective food consumption (A and B) and fullness (C and D) 
in young (n = 10) and older (n = 10) subjects during intraduodenal infusions of saline (0 
kcal, control) and whey protein loads of 30, 90 and 180 kcal for 60 min and after the ad 
libitum buffet meal (t = 90 min). Between-subject effects were determined by using 
ANOVA. Within-subject, main age and protein-load effects and interaction effects were 
determined by using repeated-measures ANOVA. 
The age x protein-load interaction for prospective food consumption (P = 0.07) and fullness 
(P = 0.91) was not significant. 
Fullness was not significantly different between age groups (P = 0.63) or protein loads (P = 
0.42). 
# P < 0.05 Time effect (t = 0-60 min) for prospective food consumption. 
^ P < 0.05 Protein-load effect compared to control for prospective food consumption. 
* P < 0.05 Age effect (AUC t = 0-60 min) for prospective food consumption. 
 
DISCUSSION 
This study examined the influence of ageing on the effects of intraduodenal protein 
administration on appetite and subsequent ad libitum energy intake. The protein infusion 
rates (0.5, 1.5 and 3 kcal/min) were lower than, similar to, and at the upper end of normal 
gastric emptying rates, 1-4 kcal/min (273). Consistent with previous studies, older subjects 
were less hungry at baseline and ate less, 201 kcal or ~16%, on the control day than younger 
subjects (6). The major finding of our study was that protein-induced suppression of energy 
intake was significantly less in older than young subjects. In particular, while total energy 
intake (at buffet meal plus infusion) was suppressed by the intraduodenal protein infusions 
in young subjects, there was no suppression at any dose in older subjects, who actually had 
increased total energy intake. 
These results are consistent with previous results indicating a reduced responsiveness in 
older people to the suppressive effects of nutrients on appetite and energy intake (46, 63). In 
the fasting state healthy older people exhibit lower hunger and higher fullness ratings than 
young adults (41-46, 49, 88, 214, 215, 279). As in younger people, those hunger ratings are 
related positively and fullness ratings negatively to subsequent ad libitum energy intake 
(279). In response to oral or gastric nutrient administration, the reductions in hunger ratings 




and subsequent energy intake are less in older than young adults (46, 48). We have shown 
that in older people the suppression of hunger ratings by intraduodenal infusions of fat and 
carbohydrate are less than in young adults (45) and the current results which show less 
suppression of hunger ratings and subsequent energy intake by protein infusions are, 
accordingly, not surprising. As in previous studies appetite ratings were positively related to 
subsequent energy intake and, consistent with the effect of protein on energy intake, 
decreased less during the protein infusions in older than young subjects. Thus, while older 
people are less hungry and eat less than younger adults, they appear to be less susceptible to 
further suppression of appetite and eating behaviour by ingestion of energy and nutrients, 
including protein. This is consistent with the attenuated homeostatic mechanisms in older 
people as evidenced by an impaired ability to compensate for modifications in diet (63). 
The finding of an age-related reduction in the satiating effects of protein is important. In 
young adults protein is the most satiating macronutrient in young adults when orally ingested 
(280), and at least as satiating as fat when infused intraduodenally (112), and there is good 
evidence that high protein diets promote satiety and aid deliberate weight loss in overweight 
younger adults (281). While beneficial in those circumstances, protein-enriched nutritional 
supplements given to older people for management of undernutrition, could have unintended 
adverse effects if satiating effects are undiminished (or increased) by age, by increasing 
satiety and reducing ad libitum energy intake. The use of high protein supplements by older 
people for this purpose is widespread, and increasing, in response to greater awareness of 
the prevalence of undernutrition and sarcopenia in older people, and evidence that protein 
supplementation may increase muscle mass and function (20, 271). 
The reduction in suppression of appetite and feeding responses to protein in older people 
seen in the present study may, therefore, point to a beneficial effect of ageing. If timing and 
preparation are optimised, it may be possible to give enough protein to older people to 
preserve, or increase muscle mass and function, without suppressing energy intake. Indeed 




our observations suggest that optimal protein administration may increase overall energy 
intake in older people. All protein doses had a suppressive effect on total energy intake 
during the study (total of energy in the infusion plus that in the buffet meal) in young 
subjects, with a substantial 19% suppression at the highest dose. In contrast, total energy 
intake was not suppressed by any protein dose in the older subjects, and significantly 
increased with the 30 kcal (9%) and 90 kcal (14%) protein doses; 90 kcal of protein (22.5 g) 
increased total energy intake by ~145 kcal, and similar amounts of protein could reasonably 
be given as protein supplements several times during the day. This raises the intriguing 
possibility that appropriately designed protein supplements administered in divided doses, 
might act to increase energy intake in undernourished people by meaningful amounts (> 200-
300 kcal/day), without the need to encourage and supervise additional energy intake. 
We assessed antropyloroduodenal motility to examine potential mechanisms responsible for 
protein-induced suppression of feeding behaviour and potential age-related differences in 
that suppression. Gastrointestinal mechanisms involved in satiation are numerous and 
include variations in gastric distension (70), gastric emptying (261) - neither a factor in this 
intraduodenal infusion study - gut hormone secretion (e.g. cholecystokinin, glucagon-like 
peptide-1, peptide tyrosine tyrosine and gastric inhibitory peptide, ghrelin) (114), pancreatic 
signals (e.g. insulin) (39), plasma amino acid concentrations (e.g. branched-chain amino 
acids) (282), diet induced thermogenesis (283), and gluconeogenesis (284). Our group has 
shown that pyloric motility, particularly as reflected in the number of IPPWs, is an 
independent negative predictor of subsequent energy intake in young subjects (269). In the 
present study, pyloric motility (IPPWs) was modestly greater, in the short time period of the 
fasting state in the older than young subjects. In both age groups IPPW number increased 
and antral and duodenal pressure number decreased by the highest (180 kcal) protein load 
when compared with control. Furthermore in the combined subject group there was an 
inverse relationship between IPPW and energy intake, and a positive relationship between 




antral and duodenal pressures and energy intake, providing further support for a relation 
between antropyloroduodenal motor activity and feeding behaviour. 
This study has several limitations, which reduce our ability to draw stronger conclusions. 
The subject numbers were relatively small. Nevertheless the findings were clear-cut. In the 
current study protein was infused directly into the duodenum, to allow exploration of small 
intestinal effects by bypassing higher neural, oral and gastric mechanisms that may affect 
energy intake, including variations in nutrient taste, gastric distension and gastric emptying 
rate. It seems that the older men had a somewhat better tolerance to the intraduodenal protein 
infusion that the young men, i.e. lower ratings of nausea and bloating however not 
statistically significant. We studied only men, as they appear to have the greatest ability to 
regulate energy intake in response to energy manipulation (46), and in women particularly 
the menstrual cycle may have a confounding effect on appetite and energy intake. The results 
do not, therefore, necessarily apply to the effects of ageing in women. Further studies are 
needed to determine if this age-related reduction in protein’s satiating effect is also present 
in women, and when the protein is administered orally and as part of a mixed macronutrient 
supplement, with the ultimate aim of developing the most effective form of 
protein/nutritional supplement for older people, which combines the greatest anabolic effect 
on muscle with the least suppression of appetite and energy intake. Nevertheless, our 
findings provide support for the use of protein supplements in undernourished and/or 
sarcopenic older people, as they provide no evidence that they suppress feeding behaviour 
and counteract attempts to increase body weight. 
In summary, older men had less suppression of appetite and subsequent ad libitum energy 
intake by intraduodenal protein infusions than young men, associated with 
antropyloroduodenal motility. At lower doses protein administration to older people even 
increased overall energy intake. Future studies are needed to characterise the effects of 
different oral protein loads in direct comparison to saline and carbohydrate controls in older 




healthy and malnourished men and women compared with young subjects and, thereby, 
provide comprehensive insights into the underlying mechanisms. This should lead to 
improved, evidence-based, strategies for the use, i.e. type, dose and timing, of pure oral 
protein supplements, to increase energy intake in older undernourished individuals or to 
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Background: Protein-rich supplements are used widely for the prevention and management 
of malnutrition in older people. We have reported that healthy older, compared to younger, 
adults have less suppression of energy intake by whey-protein - effects on appetite-related 
hormones are unknown.  
Objective: To determine the effects of intraduodenally administered whey-protein on 
glucose, gut hormone and amino acid concentrations, and their relation to subsequent ad 
libitum energy intake at a buffet meal, in healthy older and younger men. 
Design: Hydrolysed whey-protein (30kcal, 90kcal and 180kcal) and a saline control (~0kcal) 
were infused intraduodenally for 60min in 10 younger (19-29y, 73±2kg, 22±1kg/m2) and 10 
older (68-81y, 79±2kg, 26±1kg/m2) healthy men in a randomised, double-blind fashion. 
Results: Plasma insulin, glucagon, gastric inhibitory peptide (GIP), glucagon-like peptide-
1 (GLP-1), peptide tyrosine-tyrosine (PYY) and amino acid concentrations, but not blood 
glucose, increased, while ghrelin decreased during the whey-protein infusions. Only plasma 
GIP concentrations were greater in older than younger men. Energy intake correlated 
positively with ghrelin and negatively with insulin, glucagon GIP, GLP-1, PYY and amino 
acids concentrations (all P <0.05).  
Conclusions: In conclusion, intraduodenal whey-protein infusions showed comparable 
load-dependent responses in plasma gut hormone and amino acid concentrations in healthy 
older and younger men, which correlated to subsequent energy intake. 
  





A growing awareness of the extent and adverse effects of aging-related muscle loss, 
including reduced functional capacity and decreased quality of life (6, 190, 285), has 
stimulated the development of nutritional strategies designed specifically to preserve and/or 
restore skeletal muscle mass and function. A ‘common’ nutritional strategy for management 
of malnutrition in older people is the use of nutritional supplements, which are usually high-
energy drinks rich in whey protein (e.g., 10-30 g protein) (26, 27, 286). In younger as well 
as older adults higher postprandial plasma amino acid concentrations induce greater muscle 
protein synthesis (17, 19, 23), which provides a rationale to increase protein intake in older 
people. Whey, when compared to casein or soy, protein results in greater muscle protein 
synthesis in young and older men (19). On the other hand, weight loss and under-nutrition 
are common in older adults, often associated with and/or caused by reduced appetite and 
food intake, termed the ‘anorexia of aging’ (6, 190), and associated with serious adverse 
effects. Given that protein is the most satiating macronutrient in young people, and its 
substitution for other macronutrients is often advocated to promote weight loss in overweight 
young adults (270, 287), the satiating and weight loss promoting effects of increased protein 
ingestion could potentially counteract some or all of the muscle benefits of increased protein 
ingestion in older people. Yet, despite the increasing use of protein-rich drinks by older 
people, information about their effects on appetite related gastrointestinal mechanisms in 
this age group is lacking. 
Potential mechanisms involved in the regulation of energy intake include variations in gut 
hormone release and action [e.g., ghrelin, glucose-dependent insulinotropic polypeptide/ 
gastric inhibiting polypeptide (GIP), glucagon-like polypeptide-1 (GLP-1) and peptide 
tyrosine tyrosine (PYY)], as well as plasma amino acid concentrations (112, 114, 288). We 
have recently shown that in young men there is a dose-dependent effect of intraduodenal 




whey protein infusion on plasma gut hormones (114) and amino acid concentrations (289). 
Older, compared to younger, adults had greater responses in plasma concentrations of insulin 
[in response to intraduodenal glucose infusions (44)], GIP [after oral glucose intake (132, 
135)] and GLP-1 [after oral glucose (132)] and mixed macronutrient intakes (231)], but not 
PYY [in response to intraduodenal infusions of glucose or lipid (53)]. Effects of aging on 
ghrelin after oral mixed macronutrient intakes were inconsistent (48, 52, 88, 89, 91). 
Healthy aging is associated with a reduced responsiveness to the suppressive effects of 
nutrients, including protein, on appetite and energy intake (46, 63). Consistent with this, we 
have recently demonstrated that suppression of energy intake by protein ingested either 
orally [30 g (120 kcal), 70 g (280 kcal) whey-protein loads (263)] or infused directly into 
the small intestine at rates encompassing the normal rate of gastric emptying of nutrients 
[0.5 kcal/min (7.5 g, 30 kcal), 1.5 kcal/min (22.5 g, 90 kcal), 3.0 kcal/min (45 g, 180 kcal) 
(194)], and thereby bypassing ‘oral’ and ‘gastric’ effects, is less in older than younger men. 
The aim of the study was to further characterise the effects of intraduodenal whey protein 
loads on blood glucose and plasma insulin, glucagon, ghrelin, GIP, GLP-1, PYY and amino 
acid concentrations and, their relationships including those with subsequent ad libitum 
energy intake, in older and younger men. We hypothesised that intraduodenally administered 
whey protein would result in load-related responses, related to subsequent energy intake, of 
glucose, gut hormones and amino acids, and that these responses would be greater in older 
than younger men. 
 
SUBJECTS AND METHODS 
Subjects 
Our original study characterised the effect of aging on energy intake, perceptions of appetite 
and gastrointestinal symptoms, and antropyloroduodenal motility in response to infusion of 




hydrolysed whey protein directly into the duodenum (thereby bypassing orosensory and 
gastric factors) at loads lower than (0.5 kcal/min), similar to (1.5 kcal/min) and at the upper 
end (3 kcal/min) of normal gastric emptying rates (1 – 4 kcal/min), and a saline control, at a 
rate of 4 mL/min for 60 min [previously published (194)]. We have now further characterised 
effects on blood glucose and plasma insulin, glucagon, ghrelin, GIP, GLP-1, PYY and amino 
acid concentrations and, their relationships, including those with subsequent energy intake. 
The Royal Adelaide Hospital Research Ethics Committee approved the study protocol 
(approval ID: 120504, approval date: 1 May 2012), and the study was registered as a clinical 
trial with the Australia and New Zealand Clinical Trial Registry (www.anzctr.org.au, 
ACTRN12612000906853). All subjects provided written informed consent prior to their 
inclusion in the study. 
 
Protocol 
Each subject was studied on 4 occasions, separated by 7 – 14 days, in randomised order. The 
protocol was described in detail previously (194). 
Subjects were provided with a standardised evening meal [beef lasagna (McCain Foods, 
Wendouree, VIC, Ausrtalia), ~591 kcal] to consume on the night before each study, and 
were instructed to fast overnight from solids and liquids and to refrain from strenuous 
physical activity until they attended the laboratory at the University of Adelaide, Discipline 
of Medicine, Royal Adelaide Hospital, at ~0830 am. On arrival, a small-diameter (3.5 mm) 
catheter (total length: 100 cm, Dentsleeve International, Mui Scientific) was inserted into 
the stomach through an anesthetised nostril and allowed to pass into the duodenum by 
peristalsis. The infusion port of the catheter was located in the proximal small intestine 14.5 
cm from the pylorus (194). 




The protein solutions were prepared by dissolving whey protein hydrolysate powder (18.1% 
Hydrolysed Whey Protein 821, Fonterra Co-Operative Group Ltd., Palmerston North, New 
Zealand) in varying amounts of saline and water to achieve the desired loads [i.e., 0.5, 1.5, 
and 3 kcal/min, which equates to 30, 90, and 180 kcal or 8, 24, and 48 g protein] and to 
ensure that they were iso-osmotic (640-680 mOsmol/L). The infusions were administered at 
a rate of 4 mL/min (240 mL over 60 min). The amino acid content of the hydrolysed 
(resembling partially digested protein) whey protein is presented in Figure 6.1. 
Immediately before and at 15-min intervals during the intraduodenal infusion, blood samples 
(an intravenous cannula was positioned intravenously in the right forearm) for measurement 
of glucose, insulin, glucagon, ghrelin, GIP, GLP-1, PYY and amino acids were taken (0, 15, 
30, 45 and 60 min). Blood samples were collected into ice-chilled ethylenediaminetetraacetic 
acid (EDTA) coated tubes. Plasma was obtained by centrifugation for 15 min at 3200 rpm 




Figure 6.1: Amino acid composition of the intraduodenally infused whey protein 
hydrolysate (A) and increase of amino acid concentrations at 60 min during the 180-kcal 




whey protein infusion as a percentage of baseline in healthy younger [n = 10 (n = 9 for 
histidine); black bars] and older (n = 10; grey bars) men (B), ranked in order of high to low 
amino acid content (g/100 g). Essential amino acids: histidine, isoleucine, leucine, lysine, 
methionine, phenylalanine, threonine, tryptophan and valine. Branched-chain amino acids: 
isoleucine, leucine and valine. 
Differences between older and younger men were determined using an independent sample 
t-test. Statistical significance was accepted at P < 0.05. 
* P < 0.05 older compared to younger men. 
 
Measurements of blood glucose and plasma gut hormone and amino acid 
concentrations 
Blood glucose (millimoles per liter) was determined immediately after collection by the 
glucose oxidase method using a portable glucometer (Optium Xceed, Abbott Laboratories, 
Doncaster, VIC, Australia). 
Total plasma insulin (milliunits per liter) was measured by Enzyme-linked immunosorbent 
assay (ELISA) immunoassay (10-1113; Mercodia, Uppsala, Sweden). The minimum 
detectable limit was 1.0 mU/L. Intra- and inter-assay coefficients of variation were 3.1 and 
9.4%. Homeostatic model assessment (HOMA) index at baseline was calculated according 
to the following formula: insulin concentration (microunits per liter) x glucose concentration 
(nanomoles per liter) / 22.5 (290). 
Total plasma glucagon (picograms per milliliter) was measured by RIA (GL-32K; Millipore, 
Billerica, MA, USA). The minimum detectable limit was 20 pg/mL. The intra- and inter-
assay coefficients of variation were 4.4 and 6.3%. The ratio of insulin to glucagon was 
calculated for each time point in each subject (291). 
Plasma total ghrelin (picograms per milliliter) was measured using a radioimmunoassay 
(RIA) with modifications to the previously published method (292). The radiolabel was 
supplied by Perkin Elmer (NEX388; Boston, MA, USA). The standard and samples were 
incubated with the antibody and radiolabel for 3-4 days at 4oC. The detection limit was 40 
pg/mL. Intra- and inter-assay coefficients of variation were 5.0 and 12.8%. 




Total plasma GIP (picomoles per liter) was measured by RIA with modifications to a 
previously published method (293). The standard curve was prepared in buffer rather than 
extracted charcoal stripped serum and the radio-iodinated label was supplied by Perkin 
Elmer (Boston, MA, USA). The minimum detectable limit was 2 pmol/L. The intra- and 
inter-assay coefficients of variance were 5.2 and 8.8%. GIP data are not available for one of 
the younger men. 
Total plasma GLP-1 (picomoles per liter) was measured by RIA (GLPIT-36HK; Millipore, 
Billerica, MA, USA). The detection limit was 3 pmol/L. Intra - and inter -assay coefficients 
of variance were 6.4 and 9.5%. 
Plasma total PYY (picomoles per liter) was measured using RIA (kindly donated by Dr. B 
Otto, Medizinische Klinik, Klinikum Innenstadt, University of Munich, Munich, Germany) 
against human peptide YY (1-36) (Sigma-Aldrich, St Lois, MO, USA) and raised in rabbits. 
This antisera showed < 0.001% cross reactivity with human pancreatic polypeptide and 
0.0025% cross reactivity with human neuropeptide Y. Standards (1.6-50 fmol/tube) or 
samples (200 µL plasma) were incubated in 200 µL assay buffer (50 mM NaPO4, 10 mM 
EDTA, 2 g/L gelatin, 0.1 g/L Na-Azide, pH = 7.4) and a 1/12000 dilution of antisera for 24 
hours. The standards and samples were further incubated with 10000 counts per minute 
tracer [Perkin Elmer (NEX3410; Boston, MA, USA)] for 24 hours. Separation of the 
antibody bound tracer from free tracer was by second antibody precipitation (i.e., 500 µL of 
1/100 dilution of sheep anti-rabbit immunoglobulin in wash buffer comprising 50 mM Tris-
base, 150 mM NaCl, 8% Polyethylene Glycol 6000, pH = 8.0 (Merck KGaA, Darmstadt, 
Germany), and 50 µL of normal rabbit serum diluted 1/50 in wash buffer), incubated 2 hours 
at room temperature then spun at 4000 rpm at 4˚C for at least 20 minutes, supernatants 
poured off and pellets counted in a gamma counter. The detection limit was 1.5 pmol/L. 
Intra- and inter-assay coefficients of variations were 8.4 and 13.7%. 




Plasma free amino acid concentrations (mmol/L) of asparagine, aspartic acid, alanine, 
arginine, cysteine, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, 
methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine, were 
analysed using precolumn derivatization with 6-aminoquinolyl-N hydroxysuccmimidyl 
carbamate (AQC) performed at the Australian Proteome Analysis’s Facility established 
under the Australian Government’s National Collaborative Research Infrastructure Strategy 
(NCRIS). The maximum increase in plasma amino acid concentration of the highest protein 
load (180 kcal; 3 kcal/min for 60 min) at 60 min was calculated as a percentage of the average 
baseline concentration. The derivatives were separated and quantified by reversed-phase 
high-performance liquid chromatography (HPLC). The amino acids (with the exception of 
tryptophan) were detected by fluorescence, whereas tryptophan required UV detection. 
Before derivatization, 100 μL of plasma samples were diluted 1:1 with internal standard 
solution (Norvaline) and deproteinised by ultra-filtration through a membrane with 10 kDa 
nominal molecular weight cutoff (Ultrfree MC with PL-10 membrane, Millipore, MA, 
USA). Amino acids contained in the filtrate (100 μL) were labeled using the Waters 
AccQTag™ chemistry and analysed using a Waters Acquity™ UPLC system (Waters 
Corporation, MA, USA) (21). Histidine data are not available for one of the younger men. 
 
Data analysis 
Statistical analyses were performed using SPSS software (version 21; IBM, Armonk, NY, 
USA. Main effects of protein load and age, and their interaction effects on blood glucose 
and plasma hormone concentrations and plasma amino acid concentrations at baseline 
(fasting; 0 min), 15 min after starting the infusion, immediately before the meal (60 min), 
and net area under the curve (AUC; calculated from baseline to 60 min using the trapezoidal 
rule), were determined using a repeated-measures mixed-effect model, with protein load as 




the within-subject factor and age as the between-subject factor, including baseline values at 
each treatment visit as a covariate. Post-hoc comparisons, adjusted for multiple comparisons 
using Bonferroni's correction, were performed when there were significant main or 
interaction effects. Within-subject correlations between energy intake [published previously 
(194)] and glucose, gut hormones and amino acid concentrations were determined by using 
a general linear model with fixed slope and random intercept (277). Assumptions of 
normality were verified for all outcomes before statistical analysis. 
The original study (194) was powered to detect a suppression in energy intake by protein 
compared to control in 10 subjects per group. We calculated that 10 subjects per group would 
allow detection of differences in area under the curve (AUC) of the orexigenic hormone 
ghrelin and the anorexigenic hormone GLP-1 (294) within-subjects (protein compared to 
control) of 400 pg/mL and 9.1 pmol/L and between age groups (older compared to younger) 
of 1408 pg/mL and 20.5 pmol/L, respectively, with power equal to 0.8, alpha equal to 0.05 
and 10% dropouts. Statistical significance was accepted at P < 0.05. Data are presented as 
mean ± SEM unless otherwise stated. 
 
RESULTS 
The study protocol was well tolerated by all subjects. Fasting concentrations of blood 
glucose (P = 0.67), and plasma insulin (P = 0.50), glucagon (P = 0.61), ratio of insulin to 
glucagon (P = 0.29), HOMA-IR (P = 0.55), ghrelin (P = 0.68), GIP (P = 0.15), GLP-1 (P = 
0.41) and PYY (P = 0.07) were comparable in healthy younger and older men. 
 





15-min and AUC (0-60 min) glucose concentrations were not affected by protein load (15 
min, AUC: P = 0.62, P = 0.60), age (P = 0.64, P = 0.07), or interaction of protein load by 
age (P = 0.95, P = 0.23; Figure 6.2). 
Glucose concentrations at 60 min, immediately before the buffet meal, were higher in older 
than younger men (mean 60-min concentration: younger: 5.0 ± 0.1 mmol/L, older: 5.4 ± 0.1 
mmol/L; effect of protein load: P = 0.19, effect of age: P = 0.031, interaction effect of protein 
load by age: P = 0.003). Interaction-effect post-hoc analyses revealed that 60-min glucose 
concentrations were lower after the 90-kcal and 180-kcal protein infusions compared to 
control in younger (P = 0.036 and P = 0.037) but not older men (P > 0.05) and, higher in 
older than younger men after the 90-kcal protein infusion (P = 0.001). 
 
Insulin 
Plasma insulin concentrations at 15 min were lower in older than younger men (mean 15-
min concentration: younger: 9 ± 1 mU/L, older: 5 ± 1 mU/L; effect of protein load: P < 
0.001, effect of age: P = 0.003, interaction effect of protein load by age: P = 0.08). Protein- 
load post-hoc analyses revealed that 15-min insulin concentrations were higher during all 
protein infusions compared to control (30 kcal: P = 0.003, 90 and 180 kcal: both P < 0.001). 
60-min and AUC insulin concentrations protein-load dependently increased in younger and 
older men (mean 60 min concentration: younger: 13 ± 2 mU/L, older: 12 ± 2 mU/L; 60 min, 
AUC: effect of protein load: both P < 0.001; effect of age: P = 0.97, P =0.26; interaction 
effect of protein load by age: both P = 0.71; Figure 6.2). Protein-load post-hoc analyses 
revealed that 60-min and AUC insulin concentrations were higher during the 90-kcal (60 
min, AUC: both P < 0.001) and 180-kcal (both P < 0.001) protein infusions compared to 
control. 
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Figure 6.2: Mean ( SEM) and area under the curve concentrations of blood glucose (A), 
plasma insulin (B), glucagon (C), and ratio of insulin to glucagon (D) in healthy younger (n 
= 10) and older (n = 10) men during intraduodenal infusions of saline (control; solid line 
with closed circles) and whey-protein loads of 30 kcal (7.5 g protein; dashed line with closed 
circles), 90 kcal (22.5 g protein; dashed line with open circles) and 180 kcal (45 g protein; 
dotted line with open circles). Effect of protein load, age and interaction effect of protein 
load by age were determined using a mixed-effect model with baseline concentrations as a 
covariate and post-hoc Bonferroni correction. Statistical significance was accepted at P < 
0.05. 
+ P < 0.05 Effect of protein load. Post-hoc tests: higher glucagon during 30 kcal protein 
infusion compared to control (P = 0.004); higher insulin, glucagon and ratio of insulin to 
glucagon during 90 kcal and 180 kcal protein infusions compared to control (insulin: both P 
< 0.001, glucagon: both P < 0.001, ratio of insulin to glucagon: P < 0.001 and P = 0.002). 
# P < 0.05 Effect of age. 
& P < 0.05 Interaction effect of protein load by age. a,b,c,d P < 0.05 Interaction effect post-
hoc tests: a different letter indicates a difference between protein loads (AUC 0-60 min); 
higher glucose in older than younger men at 60 min during 90-kcal protein infusion (P = 
0.001); lower glucagon in older than younger men at 15 min during 90- and 180-kcal protein 
infusions (P = 0.048 and P = 0.008); in younger and older men higher glucagon (AUC and 









older: P = 0.037, P = 0.020), 30-kcal (younger: both P < 0.001, older: P = 0.006, P = 0.001) 
and control infusions (younger: both P < 0.001, older: both P = 0.001), and 90-kcal protein 
infusion compared to 30 kcal (younger: P = 0.008, P = 0.004, older: P = 0.022, P = 0.001) 
and control infusions (younger: both P < 0.001, older: both P < 0.001); in younger, but not 
older, men higher glucagon (AUC and 60 min) during 30-kcal protein infusion compared to 
control (younger: P = 0.006, P = 0.028).  
 
Glucagon 
Plasma glucagon concentrations at 15 min were lower in older than younger men (mean 15-
min concentration: younger: 94 ± 12 pg/mL, older: 79 ± 4 pg/mL; effect of protein load: P 
< 0.001, effect of age: P = 0.023, interaction effect of protein load by age: P = 0.021). 
Interaction-effect post-hoc analyses revealed that 15-min glucagon concentrations were 
lower in older than younger men during the 90-kcal (P = 0.048) and 180-kcal (P = 0.008) 
protein infusions. In younger men, 15-min glucagon concentrations were higher during all 
protein infusions compared to control (30 kcal: P = 0.001, 90 and 180 kcal: both P < 0.001); 
in older men during the 30-kcal protein infusion (P = 0.003). 
60-min and AUC glucagon concentrations protein-load dependently increased in younger 
and older men (mean 60-min concentration: younger 133 ± 14 pg/mL, older 119 ± 7 pg/mL; 
60 min, AUC: effect of protein load: both P < 0.001, effect of age: P = 0.42, P = 0.21, 
interaction effect of protein load by age P = 0.007, P = 0.030; Figure 6.2). Interaction-effect 
post-hoc analyses revealed that 60-min and AUC glucagon concentrations were higher 
during all protein infusions compared to control in younger men (60-min, AUC: 30 kcal: P 
= 0.028, P = 0.006, 90 kcal: both P < 0.001, 180 kcal: both P < 0.001), and in older men 
during the 90-kcal and 180-kcal protein infusions compared to control (60-min, AUC: 30 
kcal: P = 0.47, P = 1.0, 90 kcal: both P < 0.001, 180 kcal: both P < 0.001). 
 




Ratio of insulin to glucagon 
The ratio of insulin to glucagon at 15 min was lower in older than younger men (mean 15-
min ratio: younger: 0.09 ± 0.01, older: 0.06 ± 0.01; effect of protein load: P = 0.001, effect 
of age: P = 0.045, interaction effect of protein load by age: P = 0.39). Protein-load post-hoc 
analyses revealed that the 15-min insulin to glucagon ratio was higher during all protein 
infusions compared to control (30 kcal: P = 0.021, 90 and 180 kcal: both P = 0.003). 
The 60-min and AUC ratio of insulin to glucagon protein-load dependently increased in 
younger and older men (mean 60-min ratio: younger: 0.10 ± 0.02, older: 0.08 ± 0.01; 60 min, 
AUC: effect of protein load: both P < 0.001, effect of age: P = 0.73, P = 0.55, interaction 
effect of protein load by age: P = 0.14, P = 0.69; Figure 6.2). Protein-load post-hoc analyses 
revealed that the 60-min and AUC ratios of insulin to glucagon were higher during the 90-
kcal (60-min, AUC: both P = 0.001) and 180-kcal (P < 0.001, P = 0.002) protein infusions 
compared to control. 
 
Ghrelin 
60-min ghrelin concentrations were higher in older than younger men (mean 60-min 
concentration: younger: 1235 ± 130 pg/mL, older: 1313 ± 156 pg/mL; 15 min, 60 min, AUC: 
effect of protein load: P = 0.047, P < 0.001, P < 0.001, effect of age: P = 0.97, P = 0.029, P 
= 0.98, interaction effect of protein load by age: P = 0.84, P = 0.57, P = 0.41; Figure 6.3). 
Protein-load post-hoc analyses revealed that 60-min and AUC ghrelin concentrations were 
lower during the 90-kcal (60 min, AUC: P < 0.001, P = 0.006) and 180-kcal (P = 0.015, P 
= 0.002) protein infusions compared to control. 
 





15-min, 60-min and AUC GIP concentrations protein-load dependently increased in younger 
and older men (mean 60-min concentration: younger: 23 ± 1 pmol/L, older: 34 ± 3 pmol/L; 
15 min, 60 min, AUC: effect of protein load all P < 0.001, effect of age P = 0.59, P = 0.002, 
P = 0.011, interaction effect of protein load by age P = 0.20, P = 0.007, P = 0.06; Figure 
6.3). Interaction effect post-hoc tests revealed that 60-min GIP concentrations were higher 
in older than younger men during the 90-kcal (P < 0.001) and 180-kcal (P = 0.013) protein 
infusions. Protein-load post-hoc analyses revealed that 15-min, 60-min and AUC GIP 
concentrations were higher during all protein infusions compared to control (all P < 0.001). 
 
GLP-1 
15-min, 60-min and AUC GLP-1 concentrations protein-load dependently increased in 
younger and older men (mean 60-min concentration: younger: 37 ± 3 pmol/L, older: 31 ± 4 
pmol/L; 15 min, 60 min, AUC: effect of protein load: P = 0.013, P < 0.001, P < 0.001, effect 
of age: P = 0.30, P = 0.34, P = 0.38, interaction effect of protein load by age: P = 0.27, P = 
0.41, P = 0.41; Figure 6.3). Protein-load post-hoc analyses revealed that 15-min GLP-1  
 
PYY 
Plasma PYY concentrations at 15 min were lower in older than younger men (mean 15-min 
concentration: younger: 37 ± 4 pmol/L, older: 26 ± 1 pmol/L; effect of protein load: P = 
0.005, effect of age: P = 0.009, interaction effect of protein load by age: P = 0.49). Protein-
load post-hoc analyses revealed that 15-min PYY concentrations were higher during the 90-
kcal protein infusion compared to control (P = 0.005). 
60-min and AUC PYY concentrations protein-load dependently increased in younger and 
older men (mean 60-min concentration: younger: 41 ± 5 pmol/L, older: 36 ± 3 pmol/L; 60 




min, AUC: effect of protein load: P = 0.018, P = 0.042, effect of age: both P = 0.59, 
interaction effect of protein load by age: P = 0.49, P = 0.45; Figure 6.3). 
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Figure 6.3: Mean ( SEM) and area under the curve concentrations of plasma ghrelin (A), 
GIP (B), GLP-1 (C) and PYY (D) in healthy younger (n = 10 for ghrelin and PYY; n = 9 for 
GIP and GLP-1) and older (n = 10) men during intraduodenal infusions of saline (control; 
solid line with closed circles) and whey protein loads of 30 kcal (7.5 g protein; dashed line 
with closed circles), 90 kcal (22.5 g protein; dashed line with open circles) or 180 kcal (45 
g protein; dotted line with open circles). Effect of protein load, age and interaction effect of 
protein load by age were determined using a mixed-effect model with baseline 
concentrations as a covariate and post-hoc Bonferroni correction; statistical significance was 
accepted at P < 0.05. 
+ P < 0.05 Effect of protein load. Post-hoc tests: higher GIP (AUC 0-60 min) during 30-
kcal protein infusion compared to control (P < 0.001); higher GIP during 30-kcal protein 
infusion compared to control (P < 0.001); lower ghrelin and higher GIP and GLP-1 during 
90-kcal and 180-kcal protein infusions compared to control (ghrelin: P = 0.006, P = 0.002, 









# P < 0.05 Effect of age. 
& P < 0.05 Interaction effect of protein load by age. Post-hoc tests: higher GIP in older than 
young at 60 min during 90- and 180-kcal protein infusions (P < 0.001, P = 0.013).  
concentrations were higher during the 180-kcal protein infusions compared to control (P = 
0.014) and 60-min and AUC GLP-1 concentrations were higher during the 90-kcal (60-min, 




Fasting plasma total (P = 0.97) and essential amino acid (P = 0.54) concentrations were 
similar in older and younger men. Concentrations of cysteine (P < 0.001) and tryptophan (P 
= 0.005) were higher and of aspartic acid (P < 0.001), glutamic acid (P = 0.001) and serine 
(P = 0.033) lower in older than younger men. 
15-min, 60-min and AUC plasma concentrations of total amino acids protein-load 
dependently increased during the infusions in younger and older men (15 min, 60 min, AUC: 
effect of protein load: all P < 0.001, effect of age: P = 0.13, P = 0.37, P = 0.27, interaction 
effect of protein load by age: P = 0.024, P = 0.007, P = 0.016). Essential amino acid  
concentrations at 15 min were lower in older than younger men (mean essential amino acid 
concentrations: younger: 1.0 ± 0.04, older: 0.8 ± 0.02; effect of protein load: both P < 0.001, 
effect of age: P = 0.049, interaction effect of protein load by age: P = 0.024). Post-hoc tests 
revealed that AUC concentrations of total (P = 0.022) and essential (P = 0.014) amino acids 
were lower during the 180-kcal protein infusion in older than younger men (Figure 6.4). 
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Figure 6.4: Mean ( SEM) and area under the curve concentrations of plasma total amino 
acids, essential amino acids (histidine, isoleucine, leucine, lysine, methionine, 
phenylalanine, threonine, tryptophan and valine), branched chain amino acids (isoleucine, 
leucine and valine) and individual amino acids ranked in order of highest to lowest 
prevalence of amino acids in the whey protein hydrolysate, in healthy younger (n = 10; n = 
9 for histidine) and older (n = 10) men during intraduodenal infusions of saline (control; 
solid line with closed circles) and whey protein loads of 30 kcal (dashed line with closed 





















































Main effect of protein load, age and interaction effects were determined using a mixed-effect 
model with baseline concentrations as a covariate and post-hoc Bonferroni correction; 
statistical significance was accepted at P < 0.05.  
+ P < 0.05 Effect of protein load. 
# P < 0.05 Effect of age. 
& P < 0.05 Interaction effect of protein load by age.  
* P < 0.05 Interaction effect post-hoc tests: older compared to younger men (AUC 0-60 
min); a,b,c,d P < 0.05 a different letter indicates a difference between protein loads (AUC 0-
60 min); at 15 min during 180-kcal protein infusion, older compared to younger men: lower 
total (P = 0.022), essential (P = 0.014), branched chain amino acids (P = 0.017), leucine (P 
= 0.018), asparagine (P = 0.019), lysine (P = 0.011), isoleucine (P =0.019), valine (P = 
0.018), threonine (P = 0.023), tyrosine (P = 0.026), phenylalanine (P = 0.028), asparagine 
(P =0.019), serine (P = 0.018) and methionine (P = 0.028); at 60 min: lower glutamine (P = 
0.013), lysine (P = 0.038), arginine (P = 0.029), and higher phenylalanine (P = 0.014) and 
aspartic acid (P = 0.011) during 90-kcal protein infusion, and cysteine during 30-kcal protein 
(P = 0.010) and control (P = 0.003) infusion. 
 
Relationships of energy intake, gut hormones and amino acids 
Energy intake (published previously (194); younger men: control: 1270 ± 150 kcal, 30 kcal: 
1123 ± 151 kcal, 90 kcal: 1028 ± 163 kcal, and 180 kcal: 851 ± 161 kcal; older men: control: 
1068 ± 93 kcal, 30 kcal: 1129 ± 91 kcal, 90 kcal: 1123 ± 98 kcal and 180 kcal: 899 ± 103 
kcal) was positively related to plasma concentrations of ghrelin, and negatively related to 
insulin, glucagon, GIP, GLP-1, PYY (Figure 6.5) and amino acids (Figure 6.6). AUC 
concentrations of amino acids correlated positively with AUC concentrations of insulin, 
glucagon, ghrelin, GIP, GLP-1 and PYY, and negatively with ghrelin (Table 6.1).  
GIP was, within subjects, related to GLP-1 (r = 0.68 P < 0.001); i.e. the greater the increase 
in plasma GIP concentrations the greater the increase in GLP-1. Ghrelin was, within subjects, 
inversely related to insulin (r = -0.33, P = 0.010); i.e. the greater the increase in plasma 
insulin concentrations the greater the inhibition of ghrelin production. 
  






Figure 6.5: Within-subject relationships between energy intake [results of suppression of ad 
libitum energy intake after the intraduodenally infused whey protein loads have been 
published previously (194)] and area under the curve (AUC 0-60 min) of glucose, insulin, 
glucagon, ghrelin, GIP, GLP-1 and PYY concentrations in healthy older and younger men 
combined (n = 20; n = 19 for GIP and GLP-1), younger men (n = 10; n = 9 for GIP and GLP-
1) and older men (n = 10). Within subject correlations were determined using a general linear 
model with fixed slope and random intercept. Statistical significance was accepted at P < 
0.05.  
* P < 0.05, ** P < 0.005, *** P < 0.001. 
 
  







Figure 6.6: Within-subject relationships between energy intake [results of suppression of ad 
libitum energy intake after the intraduodenally infused whey protein loads have been 
published previously (194)] and area under the curve (AUC 0-60 min) of total, essential 
amino acids (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, 
tryptophan and valine), branched chain amino acids (isoleucine, leucine and valine) and 
individual amino acids in healthy older and younger men combined (n = 20; n = 19 for 
histidine), younger men (n = 10; n = 9 for histidine) and older men (n = 10), ranked in order 
of the strongest to weakest R square in the combined group. Within subject correlations were 
determined using a general linear model with fixed slope and random intercept. Statistical 
significance was accepted at P < 0.05.  
* P < 0.05, ** P < 0.005, *** P < 0.001 
  




Table 6.1: Within-subject correlations between concentrations of total amino acids and 
glucose, insulin, glucagon, ghrelin, GIP, GLP-1 and PYY  
     r     P 
Glucose (mmol/L) -0.12   0.35 
Insulin (mU/L)  0.80 <0.001 
Glucagon (pg/mL)  0.84 <0.001 
Ghrelin (pg/mL) -0.32   0.013 
GIP (pmol/L)  0.82 <0.001 
GLP-1 (pmol/L)  0.62 <0.001 
PYY (pmol/L)  0.45 <0.001 
r and P values of within-subject correlations between plasma concentrations of total amino 
acids (mmol/L; AUC) and concentrations (AUC) of blood glucose and plasma insulin, 
glucagon, ghrelin, GIP, GLP-1 and PYY in younger and older men. Within-subject 
correlations were determined by using a general linear model with fixed slope and random 
intercept. n = 20 (n = 19 for plasma concentrations of GIP and GLP-1). 
 
DISCUSSION 
The intraduodenal whey protein infusion, at rates lower than (0.5 kcal/min), comparable to 
(1.5 kcal/min), and at the upper end (3.0 kcal/min), of normal gastric energy emptying (273), 
dose-dependently suppressed plasma concentrations of ghrelin and stimulated 
concentrations of insulin, glucagon, GIP, GLP-1, PYY and amino acids in younger, as well 
as older, men. Plasma concentrations of the hormones insulin, glucagon, GLP-1 and PYY, 
which are secreted by the small intestine in response to the presence of nutrients, and largely 
act to suppress appetite and food intake, were increased to a comparable degree by protein 
infusions in younger and older men. GIP responses were greater in older than younger men. 
Consistent with their effects on appetite, these gut hormone concentrations were negatively 
correlated with energy intake at the subsequent ad libitum meal. Briefly, there was a dose-
dependent suppression of energy intake by protein infusion (0, 30, 90, 180 kcal) in the 




younger men and this was greater than the suppression in older men, which was only 
significant after the 180 kcal protein infusion (194). In contrast, plasma concentrations of 
ghrelin, which is mainly secreted by the stomach and acts to stimulate appetite and food 
intake (238) were suppressed by the protein infusions to a comparable degree in both age 
groups and were positively correlated to subsequent energy intake. Plasma concentrations of 
amino acids correlated negatively with energy intake at the ad libitum meal [published 
previously (194)], with tryptophan and tyrosine having the highest R square in younger men 
and lower R squares in older (range: 0.0 – 0.24) than younger men (range: 0.01 – 0.38). 
While the younger and older men had comparable glucose, insulin and glucagon 
concentrations during the 60 min protein infusions, as assessed by the area under the curve 
method, insulin and glucagon concentrations increased more slowly in older than younger 
men (e.g., significantly lower concentrations at 15 min) and glucose concentrations 
immediately before the buffet meal (60 min) were lower during the ‘higher’ protein-load 
infusions (90 and 180 kcal) compared to control in young, but not older, men. We have 
reported that blood glucose and insulin concentrations were higher during intraduodenal 
glucose infusions in healthy older than younger men (44), which is likely related to reduced 
insulin sensitivity with aging. The slightly different responses in healthy older compared to 
younger men after whey protein administered directly into the small intestine confirms the 
effects of ageing on postprandial glycaemia in absence of insulin resistance or known 
glucose intolerance; both age groups had comparable HOMA-IR. 
Healthy older and younger men had comparable AUC ghrelin concentrations during the 
protein infusions, consistent with responses to mixed-nutrient intake in some (88, 89) but 
not all previous studies (48, 52, 91). It has been suggested that aging-related changes in body 
composition (i.e., a decrease in lean mass and increase in fat mass) may act to decrease 
fasting (92) and postprandial (48) ghrelin concentrations, as body fat is negatively correlated 
to ghrelin concentrations (295) and tends to increase with aging. Other studies however have 




found higher postprandial and fasting ghrelin concentrations in older than younger adults 
and impaired suppression of ghrelin after consumption of a mixed-nutrient meal in older 
than younger subjects (52, 91). The results of this study, where protein was infused directly 
into the small intestine, thereby bypassing and eliminating variations in the rate of gastric 
emptying, support the latter findings; plasma ghrelin levels were higher at the end of the 
protein infusions, immediately before the buffet meal, in older than younger men. 
Plasma GIP concentrations increased rapidly during the protein infusions and these were 
higher in older than younger men, which may be related to differences in small intestinal 
transit of the whey protein. Previously, orally ingested (132, 135), but not intraduodenally 
infused (133), glucose evoked greater GIP responses in older than younger adults. 
GLP-1 and PYY are mainly expressed more distally in the gastrointestinal tract (i.e., ileum 
and colon) and, when compared to GIP (expressed mainly in the duodenum and jejunum), 
had slower increases in plasma concentrations during the protein infusions. PYY 
concentrations particularly increased during the 180-kcal protein load, largely from 30 min 
onwards and more convincingly in the older men. Nevertheless older and younger men had 
comparable plasma AUC GLP-1 and PYY concentrations during the protein infusions, 
which is consistent with responses during intraduodenal infusions of lipid and glucose (53). 
Oral glucose (132) and mixed macronutrient (231) ingestion however are reported to 
increase GLP-1 concentrations more in older than younger women, again highlighting the 
age-related differences in hormone responses to nutrients depending on their route of 
delivery - older compared to younger adults have slightly slower gastric emptying (263). 
The older compared to younger men had a slower increase in essential amino acids (lower 
concentrations at 15 min after starting the whey-protein infusions), particularly leucine, 
isoleucine and lysine, and lower AUC concentrations of total and essential amino acids were 
during the highest 180-kcal protein infusion. Our findings are consistent with previous 
reports that plasma amino acid concentrations peak later and remain elevated longer after 




amino acid ingestion in older than younger adults, with AUC concentrations similar between 
age groups (17). The infused whey protein contained 12% leucine and 2.4% glycine, 
essential amino acids which are thought to play an important role in the modulation of 
skeletal muscle metabolism (296-298). The maximum increase in plasma amino acid 
concentration at the end of the protein infusion, compared to baseline, was comparable in 
younger and older men for most amino acids (with the exception that older men had higher 
maximum increase in aspartic acid and lower increases in alanine and glutamine than 
younger men). This is an important finding as elevated amino acid concentrations are a major 
determinant of muscle protein synthesis (23) and, due to suboptimal protein intake, may not 
always be high enough to have an optimal effect in older people. Studies utilizing stable 
isotope-labelled amino acids have shown that older adults have a reduced sensitivity of 
muscle protein synthesis to the ingestion of relatively small amounts (≤ 20 g) of whey protein 
compared to younger adults (23). These postprandial differences between the younger and 
old were however not evident after consumption of ample amounts of dietary protein (> 
20g).  
Plasma amino acids concentrations correlated positively with plasma concentrations of 
insulin, glucagon, GIP, GLP-1 and PYY and negatively with those of ghrelin. Interaction of 
dietary amino acids, oligopeptides and proteins in the gut induce the so-called ileal brake 
mechanism, including inhibition of proximal gastrointestinal motility, which stimulate the 
vagus nerve afferents to convey information to the nucleus of the solitary tract in the 
brainstem and thereby restrict food intake in the short term (299).  
This study has several limitations, including the relatively small subject numbers. We 
studied only men, as they appear to have the greatest ability to respond to energy 
manipulation (46), so the findings warrant confirmation in women. Although the total loads 
of hydrolysed whey protein delivered (i.e., 8, 24 and 48 g) are representative of a snack or 
main meal, the observed findings may be different for other protein sources. 




In summary, intraduodenal whey protein infusions resulted in load-dependent changes in gut 
hormones and amino acids in younger and older men, and these responses were related to 
subsequent ad libitum energy intake. Plasma concentrations of insulin, glucagon, GLP-1 and 
PYY were increased and ghrelin decreased to a comparable degree by the infusions in both 
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Background: Protein-rich supplements are used widely for the management of malnutrition 
in young and older people. Protein is the most satiating of the macronutrients in young. It is 
not known how the effects of oral protein ingestion on energy intake, appetite and gastric 
emptying are modified by age.  
Objective: The aim of the study was to determine the suppression of energy intake by 
protein compared with control and underlying gastric-emptying and appetite responses of 
oral whey protein drinks in 8 healthy older men (69-80 years) compared to 8 young male 
controls (18-34 years).  
Design: Subjects were studied on 3 occasions to determine the effects of protein loads of 30 
g/120 kcal and 70 g/280 kcal compared to a flavoured water control-drink (0 g whey-protein) 
on energy intake (ad libitum buffet-meal), and gastric emptying (3D-ultrasonography) and 
appetite (0-180 min) in a randomised, double-blind, cross-over design.  
Results: Energy intake was suppressed by the protein compared with control (P = 0.034). 
Suppression of energy intake by protein was less in older men (1 ± 5%) than young controls 
(15 ± 2%; P = 0.008). Cumulative energy intake (meal + drink) during the protein days 
compared with the control day increased more in older (18 ± 6%) men than young (1 ± 3%) 
controls (P = 0.008). Gastric emptying of all three drinks was slower in older men (50% 
gastric-emptying time: 68  5 min) than young controls (36  5 min; P = 0.007). Appetite 
decreased in young, whilst it increased in older (P < 0.05).  
Conclusions: In summary, despite having slower gastric emptying, elderly men exhibited 
blunted protein-induced suppression of energy intake by whey protein compared with young 
controls, so that in the elderly protein ingestion increased overall energy intake more. 
 





The prevalence of malnutrition, both underweight/undernutrition and overweight/ 
overnutrition, has increased over recent decades in older adults (285). Both forms of 
malnutrition are associated with, and lead to, reduced functional capacity and decreased 
quality of life in the ageing population (6, 180, 190, 285). Healthy ageing is associated with 
a reduction of appetite and energy intake, termed ‘the physiological anorexia of ageing’ (6, 
7). Low intake of energy, and protein, predisposes older people to weight loss, particularly 
loss of skeletal muscle (6, 190). A growing awareness of the prevalence and adverse effects 
of the major muscle loss that occurs during ageing, irrespective of body mass index (BMI), 
has led to the development of nutritional strategies designed specifically to preserve and/or 
restore skeletal muscle. Insufficient protein intake in the elderly is likely to exacerbate 
muscle loss by limiting muscle anabolism (300). When severe, muscle loss leads to 
sarcopenia in underweight and obese older individuals, which is strongly associated with 
adverse outcomes (184). Strategies designed to achieve an increase in muscle mass and 
function include exercise programs, especially resistance exercise. However, many older 
adults have co-morbidities and physical limitations that hamper their capacity to fully 
achieve the levels of exercise sufficient to fully protect the loss of muscle mass (301). As 
such, a ‘common’ strategy to (i) increase energy intake and body weight/lean mass in 
undernourished elderly (26, 27, 286), as well as to (ii) limit energy intake and preserve lean 
mass and promote fat loss during energy restriction in overweight and obese older adults 
(35), is the use of protein-enriched supplements. These supplements are usually high-energy 
drinks rich in protein. In particular whey protein, a major dairy protein source, which is rich 
in essential amino acids is often used. Despite the widespread use of such supplements by 
older people, information about their effects on energy intake is limited, and their ‘optimal’ 
composition unknown. 




The rationale for using protein supplements in undernourished or obese sarcopenic older 
people is strengthened by evidence that ageing has only minimal inhibitory effects on the 
capacity to synthesise muscle protein acutely after protein ingestion (17, 21, 271). A recent 
consensus recommendation by the PROT-AGE study group (25) stated that dietary protein 
intake needs to be increased from 0.8-1.0 g/kg body weight per day to 1.2-1.5g/kg in older 
people (e.g., 90-112.5 g for 75 kg body weight) including a minimum of 25-30 g protein 
intake per meal. Older people however may have a significant protein portion waste of their 
meals (~23-68%) resulting in low protein intakes (~40-64 g/day) and, therefore, may require 
supplementation of up to 70 g protein/day (25, 302, 303). In young adults a protein intake of 
up to ~70 g is representative of intakes during a single meal (~ 250 g serving of lean steak). 
Accordingly, if older people can ingest sufficient protein throughout the day, it is likely to 
have positive anabolic effects. Protein, however, is also the most satiating of the 
macronutrients in young people, and high-protein energy restricted diets are used to promote 
weight loss in obese young adults (280). 
In older, undernourished adults, the aim is, of course, to increase, rather than reduce, overall 
energy intake. The effects of dietary protein on energy intake and underlying gastrointestinal 
mechanisms in older people are largely unknown. We have recently demonstrated that 
administration of 30-kcal (7.5 g), 90-kcal (22.5 g) and 180-kcal (45 g) whey-protein loads 
directly into the small intestine suppressed subsequent energy intake less in older men than 
young controls (194). In addition, whereas cumulative energy intake (protein load plus ad 
libitum intake at subsequent buffet meal) was reduced by the intraduodenal protein infusions 
in young subjects, in the older subjects there was an increase in cumulative energy intake. 
Variations in the rate of gastric emptying and gastric distension are important in the 
regulation of appetite and energy intake, particularly in the short-term after nutrient ingestion 
(42, 50, 70, 74). Gastric emptying is regulated primarily as a result of nutrient-mediated 
inhibitory feedback arising from the small intestine. Compared to young adults, in healthy 




older people the perception of proximal gastric distension is reduced, and distension of the 
distal stomach, i.e., antral area, greater. Gastric emptying is probably slightly slower in older 
than young, particularly that of meals rich in carbohydrate and fat (42, 50, 74, 84). These 
differences would favour reductions in energy intake. 
Older adults are less hungry and eat less than younger adults (41, 42, 44-46, 88, 190) and, 
due to lower body weights with disproportionally lower lean mass, require less energy to 
maintain their body weight (189). Therefore, a control condition containing no protein or 
energy is required to determine if young and older subjects differ in their susceptibility to 
further suppression of energy intake by ingestion of nutrients. 
In this study we aimed to characterise the impact of ageing on feeding and gastric responses 
to orally ingested whey protein loads similar to (30 g), and higher than (70 g) the suggested 
protein intake per meal (25, 303) within a period of time (180 min) where these loads were 
expected to empty ‘completely’ from the stomach (50), compared with a control drink (0 g 
whey protein). We hypothesised that orally administered whey protein would slow gastric 
emptying and reduce voluntary energy intake and perceptions of appetite, in a load-related 
fashion, and these suppressive effects would be less in healthy older men than young 
controls. 
 
SUBJECTS AND METHODS 
Subjects 
The study included 8 healthy young men [age (mean ± SEM): 25 ± 2 years (range: 18–34 
years); body weight: 72 ± 3 kg (62–86 kg); height: 1.79 ± 0.02 m, BMI (in kg/m2): 23 ± 1] 
and 8 healthy older men [age: 73 ± 1 years (69–80 years); body weight: 77 ± 4 kg (59–92 
kg); height: 1.73 ± 0.02 m; BMI: 26 ± 1] who were recruited by advertisement. The body 
weight of the 2 groups did not differ significantly (P = 0.29). Height was less and, 




accordingly, BMI higher in older men than young controls (P = 0.045). On the basis of our 
previous work (194), we calculated that 8 subjects per group would allow us to detect a 
difference in the suppression of energy intake by protein of 395 kcal with SD’s of 316 kcal 
(young subjects) and 180 kcal (older subjects) (194) and in the 50% gastric emptying time 
of 80 min with SD’s of 38 min (young subjects) and 63 min (older subjects) (50, 74, 82), 
between young and older subjects, with α = 0.05 and power of 80%. Exclusion criteria were 
smoking, alcohol abuse, diabetes, gastrointestinal surgery (apart from uncomplicated 
appendectomy), significant gastrointestinal symptoms (pain, reflux, diarrhoea, or 
constipation) and use of medications known to potentially affect energy intake, appetite or 
gastrointestinal motor function. For older people, additional exclusion criteria were impaired 
cognitive function [score < 25 on Mini Mental State (274)], depression [score ≥ 11 on the 
Geriatric Depression Questionnaire (275)] and undernutrition [score < 24 on the Mini 
Nutritional Assessment (276)]. The Royal Adelaide Hospital Human Research Ethics 
Committee approved the study protocol. The study was registered as a clinical trial with the 
Australian New Zealand Clinical Trial Registry (www.anzctr.org.au, registration number 
ACTRN12612000941864). All subjects provided written informed consent prior to their 
inclusion in the study. 
 
Protocol 
Subjects were studied on 3 occasions, separated by ≥ 3 days, to determine the effects of 2 
oral whey protein loads (30 g / 120 kcal and 70 g / 280 kcal) and a flavoured water control-
drink (~0 g whey protein / ~2 kcal) on energy intake, gastric emptying, perceptions of 
appetite and gastrointestinal symptoms in a randomised (using the method of randomly 
permuted blocks; www.randomization.com), double-blind, cross-over design. 




Protein drinks (~450 mL) were prepared by dissolving whey protein isolate (Fonterra Co-
Operative Group Ltd., Palmerston North, New Zealand) in varying volumes of 
demineralised water and diet lime cordial (Bickford’s Australia Pty Ltd, South Australia) to 
achieve the desired loads. Drinks were prepared on the morning of each study by a research 
officer (PF) who was not involved in the data analysis. The drinks were served in a covered 
cup, so both the investigator and the subject were blinded to the treatment. 
Subjects were provided with a standardised evening meal [beef lasagne (McCain Foods Pty 
Ltd, Wendouree, VIC, Australia), ~591 kcal] to consume on the night before each study day 
at ~19.00 h. They were instructed to fast overnight from solids and liquids and to refrain 
from strenuous physical activity until they attended the laboratory at the Discipline of 
Medicine, the University of Adelaide, Royal Adelaide Hospital, at ~08.30 h. 
On arrival, subjects were seated in an upright position on a wooden chair, where they 
remained for the duration of the study. In each subject measurements of total gastric volume 
and perceptions of appetite and gastrointestinal symptoms were performed immediately 
before (during fasting; -5 min), and immediately after ingestion of the drink, and at 15-min 
intervals until 180 min, Subjects were instructed to consume the drink within 2 min. Gastric 
volume was acquired by 3-dimensional (3D) ultrasound images. Perceptions of appetite and 
gastrointestinal symptoms were assessed using validated visual analogue scales (VAS). At 
180 min, subjects were presented with a standard, cold, buffet-style meal in excess of what 
they were expected to consume and instructed to eat freely for up to 30 min until comfortably 
full (180–210 min) (250, 251). The composition of the buffet-style meal is provided in Table 
4.1. 
 






The amount eaten (g) was quantified by weighing the buffet meal before and after 
consumption. Energy intake (kcal) at the buffet meal and proportions of intake of protein, 
carbohydrate and fat were calculated using commercially available software (Foodworks; 
Xyris Software Pty Ltd, Spring Hill, QLD, Australia). Energy intake was calculated both as 
the intake at the buffet meal and as the cumulative energy intake, defined as the sum of 
energy intake at the buffet meal and the energy content of the preload drink. Absolute (kcal) 
and percentage suppression/change (expressed as % of energy intake of the control day) of 
energy intake at the buffet meal by a given protein load compared to control was calculated. 
 
Gastric emptying 
Total gastric volume was assessed by 3D ultrasonography, a method that has been validated 
against the ‘gold standard’ scintigraphy for measurement of the emptying of liquids from the 
stomach (68). A Logiq™ 9 ultrasound system (GE Healthcare Technologies, Australia) with 
TruScan Architecture [built-in magnetically sensored 3D positioning and orientation 
measurement (POM)] including a 3D sensor, attached to a 3.5C broad spectrum 2.5-4 MHz 
convex transducer, and a transmitter, placed at the level of the stomach immediately behind 
the subject were used. As the transmitter produces a spatially varying magnetic field that is 
distorted by conductive metals, all metal objects were removed from the patient to minimise 
interference during image acquisition. The stomach was scanned by a continuous 
translational movement along its long axis (~10 s). During each scan subjects were instructed 
to sit still and hold their breath at the end of inspiration. If gastric contractions were observed, 
the acquisition was paused until the contraction wave had passed. The raw data (original 
scan planes) were transferred for 3D reconstructions and volume estimation using EchoPAC 




- 3D software (GE Vingmed Sound, Horten, Norway). Gastric retentions were calculated as 
total gastric volumes minus baseline ‘empty’ gastric volume at each time point expressed as 
percentage of the maximal gastric volume (100%), ie, ~450 mL volume of the ingested drink. 
When ultrasound images lacked sufficient clarity to determine the volume of the stomach, 
data were imputed by linear interpolation. The quality of ultrasound stomach images was 
insufficient to determine gastric emptying in all three conditions in one older subject, and 
this subject was, therefore, excluded from the analysis. The time at which 50% of the preload 
drink had emptied from the stomach (50% gastric emptying time; T50; min) and ‘complete’ 
emptying time (T100; min) of the drink, defined as the time when the residual volume of the 
drink in the stomach was ≤ 5%, was calculated for all conditions. Complete emptying time 
was set to 180 min when the residual volume at 180 min was ≤ 5%. Rate of gastric emptying 
was calculated as mean of rates of emptying during each 15-min interval respectively of the 
early (0-45 min) and late (45-180 min) phase and total (0-180 min) time period. 
 
Perceptions of appetite and gastrointestinal symptoms 
Perceptions of hunger, desire to eat, prospective consumption, fullness, nausea and bloating 
were rated using a visual analogue scale (VAS) questionnaire (47). The questionnaire 
consisted of 100-mm horizontal lines, where 0 represented that the sensation was ‘not felt at 
all’ and 100 represented that the sensation was ‘felt the greatest’. Subjects placed a vertical 
mark on each horizontal line to indicate the strength of each sensation at the specified time 
points. Baseline fasting ratings were calculated as mean of the three study days. One young 
and one older subject did not comply with the guidelines of the VAS questionnaires on one 
or more study days and were excluded from the analyses. 
 





Statistical analyses were performed using SPSS software (version 21; IBM, Armonk, NY, 
USA). Main age and protein-load effects and interaction effects were determined by using 
repeated-measures ANOVA. Relations of energy intake with the rate of gastric emptying 
(kcal/min) and appetite were evaluated by between- and within-subject correlations (277, 




The study protocol was well tolerated by all subjects. 
Energy intake 
Energy intake at the buffet meal was suppressed by whey protein compared with control 
(mean of young and older: there was a decrease in energy intake of 134  38 kcal after the 
30 g (120 kcal) and 105  49 kcal after the 70 g (280 kcal) protein load; main effect of 
protein-load P = 0.034; Figure 7.1). The main effect of age (P = 0.27) and the interaction 
effect of age x protein-load (P = 0.06) were not significant. 
Suppression of energy intake by whey protein compared to control was less in older men 
than young controls (young compared with older: 15  2% compared with 1  5%; main 
effect of age; P = 0.008; in young men 17 ± 3% by the 120-kcal and 12 ± 3% by the 280-
kcal protein load compared to control [P < 0.05] and in older men 2 ± 5% and 0 ± 8% [P > 
0.05]; Figure 7.2). The main effect of protein-load (P = 0.61) and the interaction effect of 
age x protein-load (P = 0.68) were not significant. 
Cumulative energy intake during the protein days compared with the control day increased 
more in older men than young controls (young compared with older: 1  3% compared with 
18  6%; main effect of age P = 0.008) and increased more during the 70 g than the 30 g 




protein day (30 compared with 70 g protein load: 1  4% compared with 19  6%; main 
effect of protein-load P = 0.011). The interaction age x protein-load was not significant (P 
= 0.68). 
Macronutrient proportions at the buffet meal did not differ between the age groups at 
baseline, nor on any of the other study days, and were not affected by either of the protein 
treatments (P > 0.05). 
Cumulative energy intake (i.e. energy intake at the buffet meal plus energy content of the 
drink) during the protein day compared with the control day was age and protein-load 
dependent. The main effects of age (P = 0.008) and protein-load (P = 0.011) for cumulative 
energy intake during the protein days compared with the control day were significant; the 
interaction age x protein-load was not significant (P = 0.68). 
 
 
Figure 7.1: Mean ( SEM) energy intake (kcal) in young (grey shading; n = 8) and older 
(black shading; n = 8) subjects after drinks (open bars) containing water (control) and whey 
protein loads of 30 g and 70 g. Main age and protein-load effects and interaction effects were 
determined by using repeated-measures ANOVA. 
The protein-drinks suppressed subsequent energy intake at the buffet meal compared with 
control. The main effect of protein-load for energy intake was significant (P = 0.034); the 
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Figure 7.2: Mean ( SEM) suppression of energy intake at the buffet meal (kcal) in young 
(grey shading; n = 8) and older (black shading; n = 8) subjects after whey protein loads of 
30 g and 70 g compared to after control (0 g whey protein). Main age and protein-load effects 
and interaction effects were determined by using repeated-measures ANOVA. 
Suppression of energy intake by protein was less in older than young subjects. The main 
effect of age for suppression of energy intake was significant (P = 0.008); the main effect of 




Gastric emptying parameters are detailed in Table 7.1. Baseline gastric volumes were not 
different between young and older men (31  6 mL compared with 39  3 mL; P = 0.28). 
The control drink (water) emptied in a non-linear pattern, whereas the pattern of the 280-
kcal protein drink was more linear, particularly in the older men - age appears to affect the 
initial rate of gastric emptying (Figure 7.3). After ingestion of all 3 study drinks gastric 
emptying was slower in older men than young controls, with T50 times (mean of 3 study 
days young compared with older of 36  5 min compared with 68  5 min; main effect of 
age P = 0.007), equating to an emptying rate of energy of (1.0  0.0 kcal/min in the young 
subjects compared to 0.8  0.0 kcal/min in the older subjects on the two protein days (effect 
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Figure 7.3: Mean ( SEM) gastric retention (%) in young (n = 8) and older (n = 7) subjects 
after drinks containing water (control) and whey protein loads of 30 g or 70 g. Main age and 
protein-load effects and interaction effects were determined by using repeated-measures 
ANOVA. 
Gastric emptying of the water and protein drinks was slower in older than young men. The 
main effects of age and protein-load for the 50% gastric emptying time (T50; min; P = 0.007; 
P < 0.001) and gastric retention (%; area under the curve; P = 0.003; P < 0.001) were 
significant; the age x protein-load interactions for T50 (P = 0.08) and gastric retention (P = 
0.22) were not significant. 
 
Ingestion of the protein drinks resulted in a dose-dependent slowing of gastric emptying, of 
comparable magnitude in both age groups, with T50 more than a doubling from the control 
to the 120-kcal day (mean of all men; 17  2 to 41  5 min), with a further similar increase 
from the 120-kcal to the 180-kcal day (mean of all men; 41  5 to 96  11 min; main effect 
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between the 120-kcal and 280-kcal days. The age x protein-load interactions for T50 (P = 
0.08) and gastric retention (P = 0.22) were not significant. 
 
Table 7.1: Gastric emptying rate, T50, T100 and gastric retention (area under the curve; 0-
180 min) of water (control) and protein drinks in young and older men1 
 Young men (n = 8) Older men (n = 7) 
 0 g 30 g 70 g 0 g 30 g 70 g 
T50 (min)2,3   1214,5    2544,5 72134,5   2334,5    5954,5 123134
,5 
T100 (min)2,6   6074,5 126144,5 17165 109134,5 17464,5 1746 
Amount emptied at 180 min 
(%)7 
1000 981 865 990 892  705 
       
Gastric retention (%)3 17310 33731  59145  27124 54432  80739  
       
Rate of gastric emptying (0-180 
min; kcal/min)7 
  0.70.0 1.30.1   0.60.0  1.10.1 
Early phase of rate of gastric 
emptying (0-45 min; 
kcal/min)6,7 
  1.80.34,5 2.60.24,5  1.20.04  
1.40.14 
Late phase of rate of gastric 
emptying (45-180 min; 
kcal/min)7,8 
  0.30.0  0.90.1   0.40.0  1.00.1 
1All values are means  SEMs. Main age and protein-load effects and interaction effects 
were determined by using repeated-measures ANOVA. 




250% emptying time (T50; min). Complete emptying time (T100; min) of the drink was 
defined as the time when the residual volume of the drink in the stomach was ≤ 5% and T100 
was set to 180 min when the residual volume at 180 min was ≥ 5%. 
3The main effects of age and protein-load for gastric retention (AUC from baseline to 180 
min; P = 0.003; P < 0.001) and T50 (P = 0.007; P < 0.001) were significant. The age (young, 
older) x protein-load (0, 120, 280 kcal) interaction for gastric retention (AUC from baseline 
to 180 min; P = 0.22) and T50 (P = 0.08) was not significant. 
4P < 0.05; between age groups 
5P < 0.05; between protein conditions 
6The age x protein-load interaction and main effects of age and protein-load for T100 (P = 
0.048, P = 0.027; P < 0.001) and early phase rate of gastric emptying (0-45 min; P = 0.003, 
P = 0.001; P = 0.001) were significant. 
7Rate of gastric emptying was calculated as mean of rates of emptying during each 15-min 
interval respectively of the early (0-45 min) and late (45-180 min) phase and total (0-180 
min) time period. 
8The main effect of protein-load for the amount emptied at 180 min (%; P < 0.001), rate of 
gastric emptying (0-180min; P < 0.001) and late phase of rate of gastric emptying (45-180 
min; P < 0.001) were significant. The age x protein-load interaction and main effect of age 
for the amount emptied at 180 min (%; P = 0.17; P = 0.06), rate of gastric emptying (0-180 
min; P = 0.14; P = 0.08) and late phase of rate of gastric emptying (45-180 min; P = 0.87; P 
= 0.23) were not significant. 
 
Perceptions of appetite and gastrointestinal symptoms 
Appetite 
Baseline ratings of desire to eat (young compared with older; 49  8 compared with 32  6 
mm; P = 0.11), prospective food consumption (54  8 compared with 43  5 mm; P = 0.25), 
hunger (43  8 compared with 34  6 mm; P = 0.37) and fullness (17  4 compared with 7 
 3 mm; P = 0.09) were not statistically different between young and older men. Ratings of 
desire to eat, prospective food consumption, and hunger differed from baseline over time (0-
180 min) during all study days in both age groups (P < 0.05); fullness increased from 
baseline in young (P < 0.05), but not in older (P > 0.05), subjects (Figure 7.4). 
The main effect of age for AUC ratings of desire to eat (mean of 3 study days; young: a 
decrease of 647  910 mm from baseline; older: an increase of 1027  458 mm from baseline; 
P = 0.024) and prospective food consumption (mean of 3 study days; young: a decrease of 
1616  706 mmm from baseline; older: an increase of 119  370 mm from baseline; P = 




0.021) was significant, while the main effect of age for ratings of hunger (P = 0.48) and 
fullness (P = 0. 59) was not. The main effect of protein-load and the age x protein-load 
interaction for ratings of desire to eat, prospective food consumption, hunger and fullness 
were not significant (Table 7.2). 
 
Figure 7.4: Mean ( SEM) visual analogue scores (mm; 0-180 min) of desire to eat (A and 
B) and fullness (C and D) in young (n = 7) and older (n = 7) subjects after whey protein 
loads of 30 g and 70 g and a control drink (water), and after the ad libitum buffet meal (210 
min). Time (0-180 min) effects were determined by using repeated-measures ANOVA. 
Ratings of desire to eat changed from baseline during all study days in both age groups (P < 
0.05); fullness was increased from baseline in young (P < 0.05), but not in older (P > 0.05), 
subjects. 
 
Nausea and bloating 
Baseline ratings of nausea (young compared with older; 13  4 compared with 3  1 mm, P 
= 0.040) were lower in older men than young controls, while ratings of bloating were not (8 
 4 compared with 3  1 mm, P = 0.29). Ratings of bloating increased in young (P < 0.05), 
but not in older (P > 0.05), subjects (Figure 7.5). The main effects of age and protein-load 
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Figure 7.5: Mean ( SEM) visual analogue scores (0-180 min; mm) of nausea (A and B) 
and bloating (C and D) in young (n = 7) and older (n = 7) subjects after whey protein loads 
of 30 g and 70 g and a control drink (water), and after the ad libitum buffet meal (210 min). 
Time effects (0-180 min) were determined by using repeated-measures ANOVA. 
Ratings of nausea were not different from baseline in either age group (P > 0.05); ratings of 
bloating were increased from baseline in young (P < 0.05), but not in older (P > 0.05), 
subjects. 
 
Relations between energy intake with gastric emptying and perceptions of 
appetite 
Energy intake (kcal) at the buffet meal was, within subjects, inversely related to gastric 
retention (AUC from baseline to 180 min; %) in young (r = -0.54, P = 0.026), but not older 
(r = -0.16, P = 0.57), men (all men; r = -0.35, P = 0.05); i.e., the slower the study drink 
emptied from the stomach (0-180 min) within a young subject - 70 g < 30 g < 0 g - the lower 
the subsequent energy intake (180-210 min).
 
Figure 5 
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Table 7.2: Hunger, desire to eat, prospective food consumption, fullness, nausea and bloating (area under the curve) after water (control) and protein 
drinks (0-180 min) in young and older men1 
 Young men 
(n = 7) 
   Older men 
(n = 7) 
    
 0 g 30 g 70 g Mean change by 
protein compared 
with control 




Desire to eat (mm)3 -86485 186835 -15341181 -588860 933678 -4001311 2454690 94421 0.490 
Prospective food 
consumption (mm)3 
231876 -14221082 -18111228 -1848643 257638 -793846 10301095 -138921 0.154 
Hunger (mm) 1376945 28582 -5531168 -16381065 167719 -1731804 20301405 761862 0.105 
Fullness (mm) 14531756 1521602 23661086 4901502 1670697 2751525 1655790 -7051007 0.521 
Nausea (mm) 10211093 2741717 20591160 1451210 334308 175181 204126 -145209 0.817 
Bloating (mm) 21861328 13112023 15811331 -739913 342376 618475 595366 265166 0.301 
1All values are means  SEMs. Main age and protein-load effects and interaction effects were determined by using repeated-measures ANOVA. 
2 Age effect of mean change by protein (30 g and 70 g) compared with control (0 g) (ANOVA). 
 
 
3 The main effect of age for ratings of desire to eat (P = 0.024) and prospective food consumption (P = 0.021) was significant. The age (young, older) x 
protein-load (0, 120, 280 kcal) interaction for ratings of desire to eat (P = 0.10), prospective food consumption (P = 0.60), hunger (P = 0.33), fullness (P 
= 0.83), nausea (P = 0.47) and bloating (P = 0.34) was not significant. The main effect of age for ratings of hunger (P = 0.48), fullness (P = 0. 59), nausea 
(P = 0.19) and bloating (P = 0.34) was not significant. The main effect of protein-load for ratings of desire to eat (P = 0.46), prospective food consumption 
(P = 0.42), hunger (P = 0.74), fullness (P = 0. 64), nausea (P = 0.67) and bloating (P = 0.54) was not significant. 
 




Suppression of energy intake at the buffet meal by protein compared to control was, between 
subjects, directly related to suppression of prospective food consumption by protein 
compared to control (r = 0.60, P = 0.024) in all men. There was no association between 
fullness ratings at 180 min (i.e., just before the buffet meal) and energy intake, in the young 
(r = 0.04, P = 0.92), older (r = 0.35, P = 0.40) or combined subjects (r = 0.18, P = 0.50). 
Suppression of energy intake by protein was, irrespective of age, directly related to energy 
intake during the control day (young: r = 0.88, P = 0.004; older: r = 0.71, P = 0.048; 
combined subjects: r = 0.82, P < 0.001). The age effect on the suppression of energy intake 
at the buffet meal by protein was still significant (P = 0.001) taking energy intake during the 
control day into account as a covariate. 
 
DISCUSSION 
This study examined the influence of ageing on the acute effects of oral whey protein 
consumption on suppression of energy intake, appetite and gastric emptying. The major 
finding was that suppression of energy by protein was less in healthy older men (1%) than 
young controls (15%), so that the cumulative energy intake (buffet meal plus preload drink) 
was increased more by the protein ingestion in older men (18%) than young controls (1%). 
These observations are consistent with our recent finding that the suppression of subsequent 
energy intake by intraduodenal infusions of whey protein was less in healthy older men 
(~1%) than young controls (~19%) (194). They are also consistent with reports of reduced 
responsiveness in older people to the suppressive effects of oral mixed macronutrient meals 
on energy intake (46, 63), and extend these to show that these age differences also apply 
when protein is ingested on its own. 
The oral whey protein consumptions decreased the ratings of desire to eat and prospective 
food consumption when compared to the baseline, after overnight fasting, ratings in young, 




whilst they were increased in the healthy older males. The ratings of prospective food 
consumption reflected subsequent energy intake in both age groups. The greater the 
reduction in these ratings after protein consumption the greater the reduction in subsequent 
energy intake. Thus, while older people are less hungry and eat less than younger adults (41, 
42, 44-46, 88, 190), they appear to also be less susceptible to further suppression of appetite 
and eating behaviour by ingestion of energy and nutrients, including protein. 
The finding of an age-related reduction in the satiating effects of protein is potentially 
important. In young adults protein is the most satiating macronutrient when ingested orally 
(280), and there is evidence that high protein diets promote satiety and facilitate deliberate 
weight loss during energy restriction diets in overweight, younger adults (281). While 
beneficial in those circumstances, protein-enriched nutritional supplements given to older 
people for management of undernutrition, could have unintended adverse effects, if the 
satiating effects of protein are undiminished, or increased, by age. The use of high-protein 
supplements by older people for this purpose is widespread and increasing. This is partly in 
response to greater awareness of the prevalence of undernutrition and sarcopenia in older 
people, and evidence that protein supplementation may increase both muscle mass and 
function (20, 271). The age-related reduction in suppression of appetite and feeding 
responses to oral protein, and to protein directly infused into the small intestine (194), 
suggest that if timing and preparation are optimised, it may be possible to give sufficient 
protein to older people to preserve, or increase muscle mass and function, without 
suppressing energy intake. The optimum composition for nutritional supplements for 
management of undernutrition in older people is not known. The nutritional supplements are 
probably best given in liquid form between meals (60) as suppression of energy intake by 
energy-containing beverages are less when compared to iso-energetic solid loads (304). 
In the young men, suppression of energy intake by the 70 g whey protein was comparable 
with the 30 g, suggesting that there may be a threshold of maximum suppression in energy 




intake. This observation is consistent with comparable suppression of energy intake by 
protein rich meals 3 hours after whey protein ingestion of 15 and 30 g (305) and 4 hours 
after oral protein intakes of 24, 44 and 80 g (306). 
Cumulative energy intake was increased most by the highest protein dose (70 g); a 
substantial increase of 19% or 175 kcal. Although only a limited number of studies have 
examined the effects of state of nutrition in older people on the regulation of appetite, there 
is persuasive evidence of substantial differences between undernourished and healthy older 
people, which may potentially be an outcome of and/or contribute to the undernourished 
state. In particular, suppression of energy intake by a mixed nutrient preload was less in 
undernourished older women when compared to healthy older women (48). These findings 
raises the possibility that appropriately designed protein supplements might even act to 
increase overall energy intake in undernourished people by meaningful amounts. 
The regulation of appetite and energy intake is dependent on the precise co-ordination of 
interrelated ‘intragastric’ and ‘small intestinal’ sensory and motor mechanisms, including 
variations in gastric emptying (on average 1-4 kcal/min) (261) and gastric distension (70). 
Gastric emptying of ingested nutrients results in a relatively constant rate of energy delivery 
of the ingested nutrient load from the stomach to the duodenum. Slower gastric emptying 
results in greater distension of the stomach at a given time after food ingestion. This can, in 
turn, lead to greater fullness and a consequent reduction in subsequent energy intake. The 
suppressive effect of gastric distension on energy intake has led to successful attempts to 
reduce energy intake and induce weight loss in obese people by implanting gastric balloons 
(307). While slower gastric emptying prolongs retention of food in the stomach favouring 
satiation, it also delays the onset of powerful satiety signals initiated by the interaction of 
nutrients with the small intestine (295). 
In the present study, gastric emptying of the water and both protein drinks was slower in 
older men than young controls, consistent with results of previous studies (74, 78, 82). The 




water drink emptied slower in older men than young controls, which implies an intragastric 
etiology. There was dose-dependent slowing of gastric emptying by protein to a similar 
degree in both age groups, with 50% gastric emptying time more than doubling from the 
control to the 30 g protein day, and from the 30 g to the 70 g day. The older subjects had a 
slower gastric emptying of the protein drinks than the young subjects (0.8 kcal compared 
with 1.0 kcal/min on average over 180 min), especially during the initial phase of emptying. 
Therefore the older men had greater intragastric volumes at all time points between protein 
ingestion and the buffet meal than the young men, despite the latter, fullness increased from 
baseline in young but not in older and the protein-induced suppression of subsequent energy 
intake was less in the older men compared with the young controls. This finding, and the 
lack of an association between fullness ratings at the start of the buffet meal and energy 
intake at that meal, suggests that age-related slowing of gastric emptying rate is not a major 
mediator of the age-related differences in protein-induced satiety at three hours after 
ingestion. It should, however, be recognised that to evaluate intragastric factors, the buffet 
meal has to be given much earlier. At the start of the meal, more than 85% of all drinks had 
emptied from the stomach, except the 70 g protein drink in the older subjects. Also all drinks, 
except the 70 g protein drink in the older subjects, emptied in a non-linear pattern, so once 
gastric emptying has started both intragastric volume and small-intestinal feedback were 
relevant. In older people, however, the perception of proximal gastric distension is 
diminished (84), which may explain why their slower gastric emptying had little if any 
suppressive effect on subsequent energy intake in this study. More likely, age-related 
differences in the satiating effects of orally ingested protein are mediated predominantly by 
mechanisms activated after the protein passes into the small intestine, e.g., gut hormone 
secretion (cholecystokinin, glucagon-like peptide-1, peptide tyrosine tyrosine and gastric 
inhibitory peptide) (114) and gut motility (269), rather than intragastric mechanisms, or by 
central mechanisms of amino acids, e.g., leucine, which is abundant in whey acts directly in 




the central nervous system, to reduce intake. This is consistent with our previous finding of 
greater suppression of energy intake by protein in young than older men when protein is 
infused directly into the small intestine, thus removing any influence of differences in gastric 
emptying (194), implying that both intragastric and small intestinal mechanisms act to 
suppress energy intake are attenuated in healthy elderly. Further studies are needed to 
determine the nature of these mechanisms. 
This study has several limitations. The subject numbers were relatively small. We studied 
only men, as they appear to have the greatest ability to regulate energy intake in response to 
energy manipulation (46). The results do not, therefore, necessarily apply to the effects of 
ageing in women. Further studies are needed to determine this, and also the effects of protein 
when administered as part of a mixed macronutrient supplement in both undernourished and 
obese older people. Nevertheless, our findings support the use of protein supplements to 
increase energy intake in older people. 
The significant finding was that despite having slower gastric emptying, older men exhibited 
blunted protein-induced suppression of energy intake by oral whey protein compared with 
young controls, so that in the older men compared with the young controls protein ingestion 
increased overall energy intake more. The observations support the use of protein 
supplements in undernourished older people, but suggest that their use as a strategy to 
decrease energy intake in older obese individuals may not be effective. Future studies are 
needed to characterise the effects of protein and carbohydrate and fat in isolation and as a 
mixture, both in a liquid and solid form, in malnourished, i.e., underweight and obese, elderly 
and, thereby, provide comprehensive insights into the underlying mechanisms, and lead to 
improved, evidence-based, strategies for the use of supplements to increase energy intake in 
older undernourished individuals or to decrease energy intake as part of a weight-loss diet 
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Background: Protein-rich supplements are used widely to prevent and manage malnutrition 
in older adults. We previously showed that 30 g whey-protein ingestion, three hours before 
a buffet meal, suppressed energy intake in young, but not in older, men. Information about 
the impact of the timing of ingestion of protein drinks on the suppression of energy intake 
in older adults is lacking. 
Objective: The aim of the study was to determine the effect of the timing of whey-protein 
ingestion on appetite and subsequent ad libitum energy intake in healthy older men. 
Design: In a single blind, randomised design, sixteen older men were studied on five 
occasions, on which they consumed a whey-protein drink (30 g/ 120 kcal, 140 mL) three, 
two, one hour(s), or immediately before a buffet meal, from which ad libitum energy intake 
was quantified, and iso-palatable non-caloric drinks (~1 kcal) at the remaining time-points. 
On the control day, non-caloric drinks were ingested at all time points. Perceptions of 
appetite and gastrointestinal symptoms were determined, by visual analogue scales, 
throughout the study days. 
Results: There was no effect of the timing of protein ingestion on perceptions of appetite 
and gastrointestinal symptoms (P > 0.05) or energy intake at the buffet meal (3 h: 888 ± 49 
kcal, 2 h: 879 ± 56 kcal, 1 h: 909 ± 47 kcal, 0 h: 892 ± 51 kcal, control: 930 ± 49 kcal, P = 
0.94). Total energy intake (i.e., preload + test meal) was higher on the protein days compared 
to control (82 ± 24 kcal increase, P = 0.003). 
Conclusions: In older men ingestion of 30 g protein increased total energy intake, 
irrespective of the time of intake in relation to the meal. These observations support the use 
of ‘pure’ whey-protein drinks to increase overall protein and energy intake in older adults at 
risk of undernutrition. 
 





The prevalence of undernutrition in the ageing population, which is associated with reduced 
functional capacity and decreased quality of life, has increased over recent decades (6, 180, 
190, 285). A growing awareness of the prevalence, and substantial adverse effects, of the 
major muscle loss that occurs during ageing has stimulated the development of nutritional 
strategies designed specifically to preserve and/or restore skeletal muscle mass and function. 
A ‘common’ strategy is the use of supplements, which are usually high-energy drinks rich 
in whey protein (26, 27, 35, 286). Older people ingest protein in the range of ~40-66 g/day, 
less than the recommended minimum of 30 g protein intake per meal (i.e., ≥ 90 g/day)(25, 
308). Despite the widespread use of protein-rich drinks, information about their effects on 
energy intake in older adults is largely lacking. 
In young adults protein is the most satiating of the macronutrients(280) and the timing of 
intake affects the suppression of subsequent energy intake. For example, in young women 
less food is consumed during an ad libitum meal when a preload is administered 30 min, 
compared to intakes at 60 or 120 min, before a meal(309). Also a recent systematic review 
indicated that, in young and middle-aged adults (18-65 years), i) ad libitum energy intake at 
a meal is suppressed most when a mixed-macronutrient preload is given no more than 30 
min before the meal, ii) whereas an inter-meal interval of 30-120 min suppresses energy 
intake modestly and, iii) an inter-meal interval of 120 min or more is likely to increase total 
energy intake (i.e., preload + test meal), compared to a control day(310). 
To our knowledge only one study has evaluated the effect of the timing of supplements on 
appetite (i.e., inter-meal interval) and subsequent ad libitum energy intake in older 
individuals. Wilson et al. reported that total energy intake was higher when a mixed 
macronutrient preload (300 kcal) was consumed 60 min or more before a meal, compared to 
when the preload was given directly before, the meal in a group of younger (23-35 years, 




BMI: 20-25 kg/m2) and older adults (70-85 years, BMI: 21-24 kg/m2) combined(60). A 
limitation of this study was that the potential effect of the timing of supplement intake could 
only be analysed as main time-effect (younger and older adults combined) due to the 
specificity of the study design [i.e., three-factor interaction between age, preload-type 
(water, high-protein, high-fat, high-carbohydrate) and time (≥ 60 min compared to directly 
before the meal)](60). Accordingly, whether the timing of ingestion of a protein supplement 
influences energy intake in older subjects is not known. Despite this; based on the above 
findings, recommendations have been made that supplements are best given between meals 
with a substantial time gap between the supplement and the next meal, to maximise overall 
protein and energy intake (60, 311-314). We recently reported that administration of both a 
30 g- and 70 g-protein drink (~450 mL) three hours before a subsequent buffet meal, 
suppressed ad libitum energy intake substantially in younger (25 ± 2 years; suppression of 
energy intake after a protein load of 30 g compared to control: 17 ± 3%; 70 g: 12 ± 3%), but 
not in older (73 ± 1 years; 30 g: 2 ± 5%; 70 g: 0 ± 8%), men (263). These marked differences 
in suppression of energy intake by protein is not surprising in view of the ‘anorexia of 
ageing’ (6) - healthy ageing is associated with a reduction in appetite and food intake (315). 
The aim of this study was to determine the effects of the timing of whey-protein intake on 
appetite and energy intake in healthy older men. Given the lesser suppression of energy 
intake by protein in older than younger people, we hypothesised that the timing of protein-
supplement administration can be much more liberal in older adults so that they can be given 
closer to meals without a substantial suppressive effect on subsequent ad libitum energy 
intake. 
 




SUBJECTS AND METHODS 
Subjects 
The study included 16 Caucasian older men [age: Mean ± SEM: 76 ± 1 years (range: 66 – 
85 years); body weight: 81 ± 2 kg (67 – 94 kg); height: 1.75 ± 0.01 m (1.65 – 1.85 m); body 
mass index (BMI): 27 ± 1 kg/m2 (22 – 31 kg/m2)] who were recruited by advertisement. 
Exclusion criteria were smoking, consuming > 10 alcoholic drinks per week, diabetes, 
gastrointestinal surgery (apart from uncomplicated appendectomy), significant 
gastrointestinal symptoms (abdominal pain, gastro-oesophageal reflux, diarrhoea, or 
constipation), use of medications known to potentially affect appetite, food intake, or 
gastrointestinal motor function, impaired cognitive function [score < 25 on Mini Mental 
State(274)], depression [score ≥ 11 on the Geriatric Depression Questionnaire(275)] and 
undernutrition [score < 24 on the Mini Nutritional Assessment(276)]. 
The Royal Adelaide Hospital Human Research Ethics Committee approved the study 
protocol and the study was conducted in accordance with the Declaration of Helsinki. The 
study was registered as a clinical trial with the Australian New Zealand Clinical Trial 
Registry (www.anzctr.org.au, registration number ACTRN12615000070538). All subjects 
provided written informed consent prior to their inclusion. 
 
Protocol 
In randomised order (using the method of randomly permuted blocks; 
www.randomization.com), each subject was studied on five occasions, each separated by 3-
14 days. On the protein study days an oral whey-protein load (30 g/ 120 kcal) was ingested 
at either three (P3), two (P2), one (P1) hour(s), or immediately before (P0) a buffet meal, 
and iso-palatable, non-caloric drinks (~1 kcal) were consumed at the remaining time points. 
On the remaining control day, non-caloric drinks were ingested at all time points; i.e., at 




three, two, one hour(s), and immediately before the meal. Subjects were blinded to the 
treatment order. Drinks were served in a covered cup and matched for taste by using diet 
lime cordial, as per our previous protocol (263). Protein drinks (30 g/ 120 kcal, 140 mL) 
were prepared by dissolving whey-protein isolate (Fonterra Co-Operative Group Ltd., 
Palmerston North, New Zealand) in 70 mL of water and 50 mL of diet lime cordial 
(Bickford’s Australia Pty Ltd, Salisbury South, SA, Australia). Control drinks were made up 
of 90 mL of water and 50 mL of diet lime cordial. 
Subjects were provided with a standardised evening meal [beef lasagne (McCain Foods Pty 
Ltd, Wendouree, VIC, Australia), ~591 kcal] to consume on the night before each study day 
at 07.00 pm. They were instructed to fast overnight from solids and liquids and to refrain 
from strenuous physical activity and alcohol for the 24 hours before they attended the 
laboratory at the Discipline of Medicine, the University of Adelaide, Royal Adelaide 
Hospital, at 08.30 am. 
Perceptions of appetite and gastrointestinal symptoms were determined immediately before 
(during fasting; 0 min), after ingestion of each drink (+5 min), and at 30-min intervals until 
180 min by validated visual analogue scales (VAS), i.e., 0, 5, 30, 60, 65, 90, 120, 125, 150, 
180, 185 min (47). Subjects were instructed to consume each drink within ~2 min. At 185 
min, subjects were presented with a standard, cold, buffet meal, in excess of what they were 
expected to consume, and instructed to eat freely for up to 30 min until comfortably full 
(185-215 min; ~12.00-12.30 pm)(263). The composition of the buffet meal is presented in 
Table 4.1. 
 






The amount eaten (g) was quantified by weighing the buffet meal before and after 
consumption. Energy intake (kcal) at the buffet meal and proportions of protein, 
carbohydrate and fat (energy-percent) were calculated using commercially available 
software (Foodworks; Xyris Software Pty Ltd, Spring Hill, QLD, Australia). Energy intake 
was calculated both as intake at the buffet meal and as the total energy intake; defined as the 
sum of energy intake at the buffet meal and the energy content of the whey-protein preload 
drink (263). Absolute (kcal) and percentage suppression of energy intake at the buffet meal 
(expressed as % of energy intake of the control day) for a given time of protein consumption 
compared to control were calculated. 
Habitual energy intake was assessed after the initial screening visit by a food diary 
maintained for three successive days, either three weekdays or two weekdays and a weekend 
day, and was calculated using commercially available software (Foodworks; Xyris Software 
Pty Ltd, Spring Hill, QLD, Australia). 
 
Perceptions of appetite and gastrointestinal symptoms 
Perceptions of hunger, desire to eat, prospective consumption, fullness, nausea and bloating 
were rated using a visual analogue scale (47). The questionnaire consisted of 100-mm 
horizontal lines, where 0 represented that the sensation was ‘not felt at all’ and 100 
represented that the sensation was ‘felt the greatest’. Subjects placed a vertical mark on each 
horizontal line to indicate the strength of each sensation at the specified time points. 
 





Statistical analyses were performed using SPSS software (version 21; IBM, Armonk, NY, 
USA). On the basis of our previous work (194, 263) we calculated that 16 subjects would 
allow for a detectable difference of 169 kcal of suppression of energy intake compared with 
control between the timing conditions of the whey-protein ingestions, i.e., at three, two, one 
hour(s) or immediately before the buffet-style meal. Main time effects were determined by 
using repeated-measures ANOVA and post-hoc Bonferroni corrections. Time effects of 
perceptions of appetite and gastrointestinal symptoms were determined with repeated 
measures ANOVA. Comparisons of perceptions of appetite and gastrointestinal function 
between baseline and 185 min, and before and after drink consumption, were determined 
with paired two-tailed student t-tests. Relations of energy intake with perceptions of appetite 
were evaluated by within-subject correlations(277). Statistical significance was accepted at 
P < 0.05. Area under the curves (AUCs) were calculated by using the trapezoidal rule. All 
data are presented as means ± SEMs. 
 
RESULTS 
The study protocol was well tolerated by all subjects. Habitual energy intake, assessed by 3-
day food diaries, was 2,406 ± 177 kcal, with proportions of protein, carbohydrate and fat of 
18 ± 1, 41 ± 2 and 35 ± 1 energy-percent. Habitual energy intake correlated positively with 
energy intake during the control day (r = 0.608; P = 0.012). 
 
Energy intake 
Energy intake at the buffet meal (Figure 8.1) did not differ between study days (protein load 
at three, two, one hour(s), or just before the meal and control day; P3: 888 ± 49 kcal, P2: 879 
± 56 kcal, P1: 909 ± 47 kcal, P0: 892 ± 51 kcal, control: 930 ± 49 kcal; P = 0.73). Total 




energy intake during the four protein days was greater compared with the control day 
(average increase of 82 ± 24 kcal ad libitum energy intake after protein drink compared to 
control, 10 ± 3%; P = 0.004). 
 
Figure 8.1: Mean ( SEM) ad libitum energy intake (kcal) in older men (n = 16) after drinks 
(open bars) during a control study day (no protein) and on protein study days with 
administration of a 30 g whey-protein drink three (P3), two (P2), one (P1) hour(s), or 
immediately before (P0) a buffet meal. 
The time effect was determined by repeated-measures ANOVA (P > 0.05, energy intake). 
* P = 0.004 Mean total (preload plus test meal) energy intake protein days compared to 
control day (ANOVA). 
 
Perceptions of appetite and gastrointestinal symptoms 
Baseline and AUC perceptions of hunger (48 ± 8 mm; 8546 ± 1336 mm), desire to eat (41 ± 
7 mm; 8083 ± 1149 mm), prospective food consumption (47 ± 6 mm; 9048 ± 1046 mm), 
fullness (6 ± 2 mm; 2458 ± 630 mm), nausea (6 ± 2 mm; 1252 ± 319 mm) and bloating (5 ± 
2 mm; 1520 ± 335 mm) were not different between study days (P > 0.05). 
Perceptions of hunger (P = 0.035), desire to eat (P = 0.002), prospective food consumption 
(P = 0.040), fullness (P = 0.001) and bloating (P = 0.010), but not nausea (all P = 0.22), 
changed over time from baseline (Figure 8.2). Perceptions of desire to eat (10 ± 5 mm; P = 
0.047), fullness (14 ± 4 mm; P = 0.005) and bloating (7 ± 2 mm; P = 0.009), but not hunger 
(4 ± 5 mm; P = 0.43), prospective food consumption (7 ± 4 mm; P = 0.13) and nausea (2 ±  







Figure 8.2: Mean ( SEM) visual analogue score (VAS) rating of hunger, desire to eat, 
prospective food consumption, fullness, nausea and bloating in older men (n = 16) during 
the control study day (black line) and during the protein study days with consumption of a 
30 g whey-protein drink three (P3), two (P2), one (P1) hour(s), or just before (P0) a buffet 
meal. The time points of protein administration are indicated with a larger round open marker 
(). The time effect was determined by repeated-measures ANOVA (P > 0.05, area under 
the curve for hunger, desire to eat, prospective food consumption, fullness, nausea and 
bloating). 
 
2 mm; P = 0.16), were higher after the final drink immediately before the meal (185 min) 
compared to baseline. Both drinks; the 30 g whey-protein and the iso-palatable control drink, 
induced comparable reductions, 5 min post compared to pre drink ingestion, in hunger 




























protein drink compared to control drink P = 0.60), and increases in fullness (protein: 5 ± 2 
mm increase, P = 0.015; control: 5 ± 1 mm increase, P = 0.001; protein compared to control 
P = 0.99) and bloating (protein: 2 ± 1 mm increase, P = 0.024; control: 2 ± 1 mm increase, 
P = 0.029; protein compared to control P = 0.99). There were no changes, in desire to eat 
(protein: 2 ± 2 mm reduction, P = 0.23; control: 2 ± 1 mm reduction, P = 0.17; protein 
compared to control P = 0.46), prospective food consumption (protein: 1 ± 1 mm reduction, 
P = 0.26; control: 1 ± 1 mm reduction, P = 0.20; protein compared to control P = 0.97) or 
nausea (protein 1 ± 1 mm increase, P = 0.63; control 0 ± 0 mm, P = 0.84; protein compared 
to control P = 0.61). 
 
DISCUSSION 
This study evaluated the acute effects of the timing of consumption of a 30 g whey-protein 
preload on energy intake, appetite and gastrointestinal symptoms in healthy older men. The 
protein drink did not suppress ad libitum energy intake when administered three, two, one 
hour(s), or just before a meal. However, there was a comparable effect of the whey-protein 
preload to increase total (i.e., preload plus test meal) energy intake by ~10% compared to 
the control study day in the older men, irrespective of the timing of its ingestion. These 
observations support the use of ‘pure’ whey protein to increase overall protein and energy 
intake in older adults at risk of undernutrition. 
We have previously shown that an identical 30 g whey-protein drink suppresses energy 
intake in young people when it is given 180 min before a meal (263). The lack of suppression 
of energy intake in older adults is likely to be associated with a reduced responsiveness to 
the suppressive effects of nutrients on appetite and energy intake (46, 63, 194, 263). 
The 30 g protein dose used in this study has the capacity to increase body weight, particularly 
when ingested several times per day. It is also, in the range reported to have favourable 




effects on muscle mass (23) and, therefore, often recommended as an appropriate dose for 
supplementation in older people (25, 316). Lower amounts of protein may not reach the 
threshold for postprandial muscle protein accretion (23, 25). Our observations support the 
use of protein supplements in older people to preserve or increase skeletal muscle mass and 
function without suppressing energy intake at the following meal. Accordingly the timing of 
ingestion of protein or protein-rich supplements by older people relative to usual meals may 
not be important, as previously proposed (60, 311, 312), so that they can even be taken just 
before the usual meal without suppressing subsequent food intake. 
Studies have shown that frail, older people who performed resistance exercise and consumed 
supplemental dietary protein for 24 weeks had significant muscle gain, together with 
increased muscle strength and performance (317). In older people, administration of protein 
immediately after (resistance) exercise results in increased muscle hypertrophy compared to 
administration of protein two hours after completion of the training bout (318). Given the 
outcomes of this study it is likely that timing of protein supplements related to physical 
exercise is much more important than the timing related to food intake. 
This study has limitations which should be appreciated. The subject numbers were relatively 
small, although the results seem to be clear-cut. Only one dose (30 g/ 120 kcal) of whey 
protein was used, and the effect may not apply to other macronutrients (i.e., fat and 
carbohydrate). The timing of the whey-protein drink varied in relation to the buffet meal 
(three, two, one hour(s), or immediately before the meal), but timing of assessment of ad 
libitum energy intake from ingestion of the first drink was identical in all study days, i.e., 
three hours thereafter. Also a consequence of the study design, the protein study days (i.e., 
30 g whey-protein drinks of 140 mL administered three, two, one hour(s), or just before the 
meal) contained three control study drinks for blinding the timing of protein ingestion (total 
volume of 560 mL in both control and protein study days), therefore, the volume effect of 
the drinks should be appreciated. In older people, however, the perception of proximal 




gastric distension is diminished (84). Also we did not determine gastrointestinal mechanisms 
(e.g., gastric emptying and gut hormones). 
In conclusion, in healthy older subjects, a 30 g whey-protein supplement has no suppressive 
effect on ad libitum energy intake within three hours of administration, and increases total 
energy intake (preload plus test meal), irrespective of the time of intake before the meal. This 
supports the use of ‘pure’ whey supplements to increase overall protein and energy intake in 
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Background: Protein- and energy-rich supplements are used widely for the management of 
malnutrition in the elderly. Information about the effects of protein on energy intake and 
related gastrointestinal mechanisms and whether these differ between men and women is 
limited. 
Objective: The aim of the study was to determine the effects of whey protein on energy 
intake, appetite, gastric emptying and gut hormones in healthy older men and women. 
Design: Eight older women and eight older men (mean ± SEM; age 72 ± 1years and BMI 
25 ± 1 kg/m2) were studied on three occasions in which they received protein loads of 30 g 
(120 kcal) or 70 g (280 kcal), or a flavoured-water control-drink (0 kcal). At regular intervals 
over 180 min, appetite (visual analogue scales), gastric emptying (3D-ultrasonography), 
blood glucose and plasma gut hormone concentrations (insulin, glucagon, ghrelin, CCK, 
GIP, GLP-1 and PYY) were measured and ad libitum energy intake was quantified from a 
buffet meal (180-210 min - energy intake, appetite and gastric emptying in the men have 
been published previously). 
Results: Energy intake at the buffet meal was ~80% higher in older men than older women 
(P < 0.001). Energy intake was not suppressed by protein compared to control in men or 
women (P > 0.05). There was no effect of gender on gastric emptying, appetite and 
gastrointestinal symptoms, glucose or gut hormones (P > 0.05). There was a protein load-
dependent slowing of gastric emptying, increase in concentrations of insulin, glucagon, 
CCK, GIP, GLP-1 and PYY, and increase in total energy intake (drink + meal, 12% increase 
with 30 g, 32% increase with 70 g, P < 0.001). Energy intake at the buffet meal was inversely 
related to stomach volume and the area under the curve of hormone concentrations (P < 
0.05). 




Conclusions: In older men and women whey protein drinks, compared to control, load-
dependently slowed gastric emptying, and altered gut hormone secretion, but had no 
suppressive effect on subsequent ad libitum energy intake. 
 
  





Over recent decades, the prevalence of malnutrition, both under-nutrition and obesity, has 
increased in older men and women (285, 319). A growing awareness of the prevalence and 
adverse effects of the major muscle loss that occurs during ageing, irrespective of body mass 
index (BMI, kg/m2), e.g. reduced functional capacity and decreased quality of life (6, 190, 
285), has led to the development of nutritional strategies designed specifically to preserve 
and/or restore skeletal muscle mass and function. A ‘common’ strategy is the use of 
supplements which are usually high-energy drinks rich in whey protein (26, 27, 35, 286, 
320). 
Despite this increasing use of protein-rich drinks, information about their effects on energy 
intake and underlying gastrointestinal mechanisms in older men and, particularly, older 
women, is lacking. In young adults protein is the most satiating of the three macronutrients 
(280). After a mixed macronutrient preload young women, when compared to young men, 
appear to compensate less in the subsequent meal resulting in a higher total (i.e. meal plus 
preload) energy intake (321, 322). Variations in gut hormone secretion and/or action [e.g., 
ghrelin, cholecystokinin (CCK), glucose-dependent insulinotropic polypeptide/ gastric 
inhibiting polypeptide (GIP), glucagon-like polypeptide-1 (GLP-1) and peptide tyrosine 
tyrosine (PYY)], as well as the rate of gastric emptying and gastric distension are likely to 
play a role in the regulation of appetite and energy intake in younger adults, particularly in 
the short-term after nutrient ingestion (70, 112-114, 234, 237, 288). 
Compared to young adults healthy older people exhibit decreased taste and food palatability, 
are less hungry and more full during fasting and postprandial states, and consume less food 
and energy, including protein (315). This has been termed ‘the physiological anorexia of 
ageing’ (6, 190). Healthy ageing is associated with a reduced responsiveness to the 
suppressive effects of nutrients on appetite and energy intake (46, 63, 194, 263). We have 




recently demonstrated that acute administration of 30 g (120 kcal), and 70 g (280 kcal) oral 
whey protein loads suppressed subsequent energy intake by 12-17% in young, without 
suppression in healthy older, men (263). Accordingly, protein ingestion increased total 
energy intake (protein plus subsequent ad libitum energy intake) compared to control in older 
men more than in the young men. 
In this study we aimed to further characterise the feeding and gut (hormone) responses to 
orally ingested whey protein loads in older people, by studying older women as well as men. 
We hypothesised that orally administered whey protein would have a load-related effects on 
gastric emptying and plasma gut hormone concentrations (insulin, glucagon, ghrelin, CCK, 
GIP, GLP-1, PYY) in healthy older men and women, suppress of subsequent ad libitum 
energy intake less and, therefore, result in a greater increase in overall energy intake (protein 
drink plus meal intake) compared to control in older women than older men (previously 
published data of energy intake, appetite and gastric emptying). 
 
SUBJECTS AND METHODS 
Subjects 
The study included 8 older men [age: Mean ± SEM: 73 ± 1 years; body weight: 77 ± 4 kg; 
height: 1.73 ± 0.02 m; BMI: 26 ± 1 kg/m2; the men were included in our previous study 
comparing energy intake, appetite and gastric emptying between young and older men (263)] 
and 8 older women (70 ± 1 years; 63 ± 2 kg; 1.58 ± 0.02 m; 25 ± 1 kg/m2) who were recruited 
by advertisement. There were no differences in either age (P = 0.14) or BMI (P = 0.70) 
between the males and females. On the basis of our previous work (194), with an observed 
within-subjects SD of 181 kcal and upper 60% confidence limit of 234 kcal, we calculated 
that 8 subjects per group would allow detection of a within-groups difference between 
treatments of 271 kcal (n = 8 older women), and a between genders difference of 353 kcal 




(n = 8 older women compared with n = 8 older men), with power equal to 0.8 and alpha 
equal to 0.05.  
Exclusion criteria were smoking, alcohol abuse, use of illicit substances, diabetes, 
gallbladder or pancreatic disease, gastrointestinal surgery (apart from uncomplicated 
appendectomy), gastrointestinal symptoms (abdominal pain, gastro-oesophageal reflux, 
diarrhoea, or constipation), use of medications known to potentially affect energy intake, 
appetite or gastrointestinal motor function, impaired cognitive function [score < 25 on Mini 
Mental State (274)], depression [score ≥ 11 on the Geriatric Depression Questionnaire (275)] 
and undernutrition [score < 24 on the Mini Nutritional Assessment (276)], being lactose 
intolerant or having food allergies, low ferritin levels or blood donation in the 12 weeks prior 
to the study days, and failing to comprehend the study protocol. The Royal Adelaide Hospital 
Human Research Ethics Committee approved the study protocol and the study was 
conducted in accordance with the Declaration of Helsinki. The study was registered as a 
clinical trial with the Australian New Zealand Clinical Trial Registry (www.anzctr.org.au, 
registration number ACTRN12612000941864). All subjects provided written informed 
consent prior to their inclusion. 
 
Protocol 
The protocol was identical to that of our previous study comparing young and older men and 
the results (i.e. energy intake, appetite and gastric emptying) in the older men have been 
published previously (263). Each subject was studied on 3 occasions, separated by 3-14 days, 
to determine the effects of two oral whey protein loads (30 g/ 120 kcal and 70 g/ 280 kcal) 
and a flavoured water control-drink (~0 g protein) on energy intake, gastric emptying, 
perceptions of appetite and gastrointestinal symptoms, in a randomised [using the method of 




randomly permuted blocks; www.randomization.com (16 subjects randomised in 1 block 
with random permutations)], double-blind, cross-over design. 
Protein drinks were served in a covered cup and prepared by dissolving whey protein isolate 
(Fonterra Co-Operative Group Ltd., Palmerston North, New Zealand) in varying volumes of 
demineralised water and diet lime cordial (Bickford’s Australia Pty Ltd, Salisbury South, 
SA, Australia) to achieve the desired loads [i.e. 30 g whey protein (volume of the powder: 
19 mL) in 335 mL distilled water and 85 mL cordial (2.5 kcal/100mL), 70 g whey protein 
(volume of the powder: 45 mL) in 280 mL water and 100 mL cordial, the control drink 
consisted of 359 mL distilled water and 90 mL cordial]. Sodium chloride in the amount of 
0.3 g and 1.2 g was added to the 30 g and control drinks, respectively, to match the osmolality 
(88 mOsm/L) with the 70 g drink. To ensure that all ingredients were dissolved evenly 
throughout and to minimise the layer of foam on top of the solution, the drinks were stirred 
continuously at low speed on a stirring plate. The volume of each drink was measured before 
serving and the recorded volumes differed modestly (i.e. control: 450 mL; 30 g protein: 439 
mL; and 70 g protein: 425 mL). All drinks were provided to participants in a covered cup, 
so that both the investigator conducting the data collection and the participants were blinded 
to the test drinks. The drinks were prepared by a research assistant who was not involved in 
data analysis of the study results. 
Subjects were provided with a standardised evening meal [beef lasagne (McCain Foods Pty 
Ltd, Wendouree, VIC, Australia), ~591 kcal] to consume on the night before each study day 
at ~19.00 h. They were instructed to fast overnight from solids and liquids and to refrain 
from strenuous physical activity until they attended the laboratory at the Discipline of 
Medicine, The University of Adelaide, Royal Adelaide Hospital, at ~08.30 h. 
On arrival, subjects were seated in an upright position on a wooden chair, where they 
remained for the duration of the study, and an intravenous cannula for blood taking was 
inserted. In each subject, measurements of total gastric volume and perceptions of appetite 




and gastrointestinal symptoms were performed immediately before (during fasting; 0 min), 
and immediately after, ingestion of the drink, and at 15-min intervals until 180 min. Subjects 
were instructed to consume the drink within 2 min. Gastric volume was measured by 3-
dimensional (3D) ultrasonography (263). Perceptions of appetite and gastrointestinal 
symptoms were assessed using validated visual analogue scales (VAS) and blood samples 
were collected for the measurements of gut hormones. At 180 min, each subject was 
presented with a standard, cold, buffet-style meal in excess of what they were expected to 
consume (total energy content of 2,457 kcal; 19% protein, 50% carbohydrates, 31% fat) for 
30 min (180-210 min) until comfortably full, in a room by themselves to limit external 
distractions (257). The buffet-style meal consisted of palatable food items including sliced 
bread, cheese, ham and chicken, fruits, yoghurt, custard, margarine, mayonnaise, iced coffee, 





The amount eaten at the buffet meal (g) was quantified by weighing the food before and after 
consumption. Energy intake (kcal) at the buffet meal and proportions of protein, 
carbohydrate and fat were calculated using commercially available software (Foodworks 
version 8; Xyris Software Pty Ltd, Spring Hill, QLD, Australia). Energy intake was 
calculated both as intake at the buffet meal and as the cumulative energy intake, defined as 
the sum of energy intake at the buffet meal and the energy content of the preload drink. 
Absolute (kcal) and percentage suppression/ change energy intake at the buffet meal 
(expressed as % of energy intake of the control day) by a given protein load compared to 
control were calculated. 




Perceptions of appetite and gastrointestinal symptoms 
Perceptions of hunger, desire to eat, prospective consumption, fullness, nausea and bloating 
were rated using a visual analogue scale (VAS) questionnaire at 0, 5, 15, 30, 45, 60, 75, 90, 
105, 120, 135, 150, 165, 180, 210 min (47). The questionnaire consisted of 100-mm 
horizontal lines, where 0 represented that the sensation was ‘not felt at all’ and 100 
represented that the sensation was ‘felt the greatest’. Subjects placed a vertical mark on each 
horizontal line to indicate the strength of each sensation at the specified time points.  
 
Gastric emptying 
Total gastric volume was measured by a Logiq™ 9 ultrasound system (GE Healthcare 
Technologies, Australia) with TruScan Architecture [built-in magnetically sensored 3D 
positioning and orientation measurement (POM)] including a 3D sensor, attached to a 3.5C 
broad spectrum 2.5-4 MHz convex transducer, and a transmitter, placed at the level of the 
stomach immediately behind the subject at 0, 5, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 
165, 180 min (68). As the transmitter produces a spatially varying magnetic field that is 
distorted by conductive metals, all metal objects were removed from the subject to minimise 
interference during image acquisition. The stomach was scanned by a continuous 
translational movement along its long axis (~10 s). During each scan the subject was 
instructed to sit still and hold their breath at the end of inspiration. If gastric contractions 
were observed, the acquisition was paused until the contraction wave had passed. The raw 
data (original scan planes) were transferred for 3D reconstructions and volume estimation 
using EchoPAC - 3D software (GE Vingmed Sound, Horten, Norway). Gastric retention was 
calculated as total gastric volume minus baseline ‘fasting’ gastric volume at each time point 
expressed as percentage of the maximal gastric volume (100%), i.e. volume of the ingested 
drink. When ultrasound images lacked sufficient clarity to determine the volume of the 
stomach, data were imputed by linear interpolation. In one male subject the quality of 




ultrasound stomach images was insufficient to determine gastric emptying in all three 
conditions, and data of gastric emptying data of this subject were, therefore, excluded from 
the analysis. The time at which 50% of the preload drink had emptied from the stomach 
(50% gastric emptying time; T50; min) was calculated for all conditions. Rate of gastric 
emptying was calculated as the mean of rates of emptying (kcal/min) during each 15-min 
interval respectively of the early (0-60 min) and late (60-180 min) phase and total (0-180 
min) time period. 
 
Blood glucose and plasma insulin, glucagon, ghrelin, CCK, GIP, GLP-1 and PYY 
Blood samples were collected, at 0, 5, 15, 30, 45, 60, 90, 120, 150, 180 min, into ice-chilled, 
EDTA-coated tubes. No inhibitors were added (264). Plasma was obtained by centrifugation 
for 15 min at 3200 rpm at 4°C and samples were stored at -80°C for further analysis of 
hormone concentrations. 
Blood glucose (millimoles per liter) was determined immediately after collection by the 
glucose oxidase method using a portable glucometer (Optium Xceed, Abbott Laboratories, 
Australia). Intra- and inter-assay coefficients of variation were 3.2% and 10.8%, 
respectively. 
Total plasma insulin (milliunits per liter) was measured by enzyme-linked immunosorbent 
assay (ELISA) immunoassay (10-1113; Mercodia, Uppsala, Sweden). The minimum 
detectable limit was 1.0 mU/L. Intra- and inter-assay coefficients of variation were 3.0% and 
8.7%, respectively.  
Total plasma glucagon (picograms per milliliter) was measured by radioimmunoassay (RIA) 
(GL-32K; Millipore, Billerica, MA, USA). The minimum detectable limit was 20 pg/mL. 
The intra- and inter-assay coefficients of variance were 4.3 and 7.1%. The ratio of insulin to 
glucagon was calculated for each time point in each subject. Homeostatic model assessment 
(HOMA) index at baseline was calculated according to the following formula: insulin 




concentration (microunits per liter) x glucose concentration (nanomoles per liter) / 22.5 
(290). 
Total plasma ghrelin (picograms per milliliter) was measured using a RIA with some 
modifications to a published method (323). The radiolabel was supplied by Perkin Elmer 
(Boston, MA, USA; NEX388). The standard and samples were incubated with the antibody 
and radiolabel for 3-4 days at 4oC. The detection limit was 40 pg/mL. Intra- and inter-assay 
coefficients of variation were 6.7 and 12.1%, respectively. 
Plasma CCK-8 (picomoles per liter) was measured by RIA using an adaption of a previous 
method (324). Samples were extracted in 66% ethanol; extracts were dried down and re-
suspended in assay buffer (50 mmol phosphate/L phosphate, 10 mmol EDTA/L, 2 g 
gelatin/L, pH = 7.4). Standards were prepared using synthetic sulphated CCK-8 (Sigma 
Chemical, St Louis, MO, USA), antibody (C2581, Lot 105H4852, Sigma Chemical) was 
added at a working dilution of 1/17,500 and sulphated CCK-8 125I-labeled with Bolton and 
Hunter reagent (Perkin Elmer, Boston, MA, USA) was used as tracer. Incubation was for 7 
days at 4˚C. The antibody bound fraction was separated by the addition of dextran-coated 
charcoal containing gelatin (0.015 g gelatin, 0.09 g dextran, 0.15 g charcoal in 30 mL assay 
buffer) and the radioactivity determined in the supernatants following centrifugation. The 
detection limit was 1 pmol/L. The intra- and inter-assay coefficients of variation were 5.4% 
and 13.9%, respectively. 
Total plasma GIP (picomoles per liter) was measured by RIA (293). The standard curve was 
prepared in buffer, rather than extracted charcoal stripped serum and the radio-iodinated 
label was supplied by Perkin Elmer (Boston, MA, USA). The minimum detectable limit was 
2 pmol/L. The intra- and inter-assay coefficients of variation were 3.9% and 9%, 
respectively. 




Total plasma GLP-1 (picomoles per liter) was measured by RIA (GLPIT-36HK; Millipore, 
Billerica, MA, USA). The detection limit was 3 pmol/L. Intra - and inter -assay coefficients 
of variation were 6.3% and 10.3%, respectively. 
Total plasma PYY (picomoles per liter) was measured using RIA using antisera (kindly 
donated by Dr. B Otto, Medizinische Klinik, Klinikum Innenstadt, University of Munich, 
Munich, Germany) against human peptide YY (1-36) (Sigma-Aldrich, St Lois, MO, USA) 
and raised in rabbits. This antisera showed < 0.001% cross reactivity with human pancreatic 
polypeptide or sulphated CCK-8 and 0.0025% cross reactivity with human neuropeptide Y. 
Standards (1.6-50 fmol/tube) or samples (200 µL plasma) were incubated in 200 µL assay 
buffer (50 mM NaPO4, 10 mM EDTA, 2 g/L gelatin, 0.1 g/L Na-Azide, pH = 7.4) and a 
1/12000 dilution of antisera for 24 hours. The standards and samples were further incubated 
with 10000 counts/min tracer [Perkin Elmer (Boston, MA, USA; NEX3410)] for 24 hours. 
Separation of the antibody bound tracer from free tracer was by second antibody 
precipitation (i.e. 500 µL of 1/100 dilution of sheep anti-rabbit immunoglobulin in wash 
buffer comprising 50 mM Tris-base, 150 mM NaCl, 8% polyethylene glycol 6000 pH = 8.0 
and 50 µL of normal rabbit serum diluted 1/50 in wash buffer), incubated 2 hours at room 
temperature centrifuged at 4000 x g for at least 20 min at 4˚C, supernatants poured off and 
pellets counted in a gamma counter. The detection limit was 1.5 pmol/L. Intra- and inter-
assay coefficients of variations were 8.7% and 18.2%, respectively. 
 
Data analysis 
Statistical analyses were performed using SPSS software (version 21; IBM, Armonk, NY, 
USA). Main effects of gender and protein load, and their interaction effects on energy intake 
and gastric emptying were determined using repeated measures ANOVA, with protein load 
as the within-subject factor, and gender as the between-subject factor. Main effects of gender 




and protein load and their interaction effects on perceptions of appetite and gastrointestinal 
symptoms, blood glucose and plasma hormone concentrations, were determined using a 
repeated measures mixed-effect model, with protein load as the within-subject factor and 
gender as the between-subject factor, including baseline values at each treatment visit as a 
covariate. Post-hoc comparisons, adjusted for multiple comparisons using Bonferroni's 
correction, were performed when there were significant main or interaction effects. 
Within-subject correlations were determined by using a general linear model with fixed slope 
and random intercept (277). Areas under the curve (AUC) were calculated from baseline to 
180 min, using the trapezoidal rule. Assumptions of normality were verified for all outcomes 
before statistical analysis. Statistical significance was accepted at P < 0.05. All data are 
presented as means ± SEMs. 
 
RESULTS 
The study protocol was well tolerated by all subjects. 
 
Energy intake 
Energy intake at the buffet meal (Figure 9.1) was approximately 80% higher in older men 
than older women (mean energy intake of 3 study days in men: 1042 ± 69 kcal and women: 
584 ± 61 kcal; main effect of gender P < 0.001, main effect of protein load P = 0.34, 
interaction effect of gender by protein load P = 0.81). Energy intake at the buffet meal did 
not differ between study days [preload drink containing 0 g (control), 30 g or 70 g protein], 
with no significant suppression of energy intake compared to that on the control day by either 
protein load [mean suppression of 45 ± 23 kcal or 5 ± 3% after the 30 g (120 kcal) or 70 g 
(280 kcal) protein drinks compared to control; main effect of gender P = 0.62, main effect 
of protein load P = 0.83, interaction effect of gender by protein load P = 0.67]. There was a 




dose-dependent effect of the protein load on total (preload drink + meal) energy intake [mean 
total energy intake of men and women control: 843 ± 77 kcal, 30 g protein: 923 ± 75 kcal 
(12% increase), 70 g protein: 1073 ± 78 kcal (32% increase), mean total energy intake of 3 
study days in men: 1175 ± 69 kcal and women: 717 ± 61 kcal; main effect of gender P < 
0.001, main effect of protein load P < 0.001, interaction effect of gender by protein load P 
= 0.81]. Macronutrient preferences during the buffet meal did not differ between either men 
or women, or study visits (mean macronutrient composition of the buffet meal; protein: 20 








Figure 9.1: Mean ( SEM) energy intake at the buffet meal (kcal) in older men (energy 
intake at the buffet meal in grey shading; n = 8) and women (energy intake at the buffet meal 
in black shading; n = 8) after drinks (energy intake of the drink as the white part of each bar) 
containing flavoured water (control) and whey protein loads of 30 g (120 kcal) and 70 g (280 
kcal). Main gender and protein load effects and interaction effects were determined by using 
repeated-measures ANOVA and post-hoc Bonferroni correction. 
# P < 0.001 Main effect of gender: energy intake at the buffet meal was higher in older men 
than older women (main effect of protein load P = 0.34, interaction effect of gender by 
protein load P = 0.81). 
* P < 0.001 Main effects of gender and protein load: total energy intake (preload drink + 
meal) was higher in older men than older women, and total energy intake was higher after 
the 30 g (9.5% increase) and 70 g (27% increase) protein load compared to control 
(interaction effect of gender by protein load P = 0.81). 
Suppression of energy intake by protein (30 g and 70 g) compared to control (main effect of 
gender P = 0.62, main effect of protein load P = 0.83, interaction effect of gender by protein 
load P = 0.67). 
    * 
    * 
    * 
    * 
    # 




Perceptions of appetite and gastrointestinal symptoms 
Baseline perceptions of hunger, desire to eat, prospective food consumption, fullness, nausea 
and bloating were not different between men and women or study days (P > 0.05, Figure 
9.2). There was an interaction effect of gender by protein load for prospective food 
consumption (effect of gender P = 0.50, effect of protein load P = 0.10, interaction effect of 
gender by protein load P = 0.015) - the post-hoc analysis revealed that women have higher 
perceptions of prospective food consumption during control compared to the 70 g protein 
condition (P = 0.018). The main effects of gender and protein load and the interaction effect 
of gender by protein load for hunger, desire to eat, fullness, nausea and bloating (AUC 0-
180 min), as well as the gender and treatment effect of prospective food consumption were 
not significant (P > 0.05). 
 
Gastric emptying 
Gastric emptying parameters are detailed in Table 9.1. Baseline gastric volumes were not 
different between men and women (39  3 mL and 34  5 mL, P = 0.45) or study days (P = 
0.76). The control drink (water), as well as the 30 g protein drink, emptied in an overall non-
linear pattern, whereas the pattern of emptying of the 70 g protein drink was linear (Figure 
9.3). 
There was a dose-dependent effect of the whey protein load to slow gastric emptying [T50 
for mean of men and women control: 23  2 min, 30 g: 65  7 min, 70 g: 130  10 min; 
effect of gender T50 P = 0.41, effect of protein load T50 P < 0.001, interaction effect of 
gender by protein load T50 P = 0.77; effect of gender AUC 0-180 min P = 0.22 AUC 0-60 
min (early phase) P = 0.27 AUC 60-180 min (late phase) P = 0.24, effect of protein load 
AUC 0-180 min P < 0.001 AUC 0-60 min P < 0.001 AUC 60-180 min P < 0.001, interaction 
effect of gender by protein load AUC 0-180 min P = 0.58 AUC 0-60 min P = 0.43 AUC 60- 










Figure 9.2: Mean ( SEM) visual analogue score (VAS) of hunger, desire to eat, prospective 
food consumption, fullness, nausea and bloating in older men (n = 8) and women (n = 8) 
after drinks containing flavoured water (control; dotted line with open circles) and whey 
protein loads of 30 g (dashed line with closed circles) or 70 g (solid line with closed circles). 














mixed-effect model with baseline concentrations as a covariate and post-hoc Bonferroni 
correction.  
P > 0.05 main effect of gender and protein load and interaction effect of gender by protein 
load for visual analogue scales of hunger, desire to eat, prospective food consumption, 
fullness, nausea and bloating (AUC 0-180 min). 
& P < 0.05 Interaction effect of gender by protein load  
* P < 0.05 70 g protein compared with the control (in women, perceptions of prospective 
food consumption were higher after the 70 g protein drink compared to control). 
 
  
Figure 9.3: Mean ( SEM) gastric retention (%) in older men (n = 7; closed circles) and 
women (n = 8; open circles) after drinks containing flavoured water (control; dotted line) 
and whey protein loads of 30 g (dashed line) or 70 g (solid line). Main gender and protein 
load effects and interaction effects were determined by using repeated-measures ANOVA. 
* P < 0.001 main effect of protein load for 50% gastric-emptying time (main effect of gender 
P = 0.41; interaction effect of gender by protein load P = 0.77). 
# P < 0.001 main effect of protein load AUC 0-180 min, 0-60 min (early phase) and 60-180 
min (late phase) (main effect of gender AUC 0-180 min P = 0.22 AUC 0-60 min P = 0.27 
AUC 60-180 min P = 0.24, interaction effect of gender by protein load AUC 0-180 min P = 
0.58 AUC 0-60 min P = 0.43 AUC 60-180 min P = 0.46). 
 
180 min P = 0.46], with no difference in rate of gastric emptying between men and women 
[mean rate of gastric emptying of men and women total phase 0-180 min: 30 g: 0.6 ± 0.02 
kcal/min, (range: 0.4 - 0.7 kcal/min); 70 g: 1.0 ± 0.07 kcal/min (range: 0.5 - 1.4 kcal/min); 
early phase 0-60 min (when drinks were still emptying): 30 g: 1.0 ± 0.09 kcal/min, (range: 
0.2 - 1.5 kcal/min); 70 g: 1.2 ± 0.1 kcal/min (range: 0.2 - 2.2 kcal/min); late phase 60-180 
min: 30 g: 0.4 ± 0.03 kcal/min (range: 0.3 - 0.8kcal/min); 70 g: 0.9 ± 0.07 kcal/min (range: 


































Table 9.1: Gastric emptying of water (control) and protein drinks in older men and women. 
 Older men (n = 7) Older women (n = 8) P value 
    0 g    30 g    70 g    0 g    30 g    70 g protein load gender interaction 
50% emptying time (T50; min)   233      595   12313   233      7013 13616 < 0.001 0.41 0.77 
Rate of gastric emptying (kcal/min) 1   0.60.0  1.10.1   0.60.0  0.90.1 < 0.001 0.29 0.25 
Early phase rate of gastric emptying   1.10.1. 1.30.1   0.90.2  1.10.2     0.08 0.25 0.86 
                           (0-60 min; kcal/min) 1          
Late phase rate of gastric emptying   0.40.0  1.00.1   0.50.1  0.80.1 < 0.001 0.67 0.12 
                       (60-180 min; kcal/min) 1          
Amount emptied at 60 min (%)   842   543   283   825   438   235 < 0.001 0.19 0.67 
Amount emptied at 180 min (%)   990   892   705   991   874   596 < 0.001 0.29 0.29 
All values are mean  SEM. Main gender and protein load effects and interaction effects were determined by using repeated-measures ANOVA. 
1Rate of gastric emptying was calculated as mean of rates of emptying during each 15-min interval respectively of the early (0-60 min) and late (60-180 
min) phase and total (0-180 min) time period




effect of gender by protein load P = 0.25]. By 180 min, the 30 g protein drink had ‘complete’ 
gastric emptying (90% or more) in seven subjects, a further seven subjects showed emptying 
of ~85% and one subject of ~60%; whilst the 70 g protein was emptied from the stomach by 
~85% or more in only three subjects. 
 
Glucose and gut hormones 
Baseline concentrations of blood glucose and plasma insulin, glucagon, ghrelin, CCK, GIP, 
GLP-1, PYY, as well as HOMA-IR and the ratio of insulin to glucagon were not significantly 
different between men and women or study visits (P > 0.05, Figures 9.4 and 9.5).  
The main effect of gender was not significant for concentrations (AUC 0-180 min) of 
glucose (P = 0.70) glucagon (P = 0.94), ghrelin (P = 0.35), CCK (P = 0.16), GIP (P = 0.18), 
or GLP-1 (P = 0.55). Older women showed higher plasma concentrations of insulin (main 
effect of gender; P = 0.040) and PYY (P = 0.037) and an increased ratio of insulin to 
glucagon (P = 0.008) compared to older men. 
The main effect of protein load was significant for concentrations (AUC 0-180 min) of 
insulin, glucagon, ghrelin, CCK, GIP, GLP-1, PYY, and ratio of insulin to glucagon (all P < 
0.001), but not significant for glucose (P = 0.36). 
The interaction effect of gender by protein load was significant for concentrations (AUC 0-
180 min) of ratio of insulin to glucagon (P = 0.018), but not significant for glucose (P = 
0.44), insulin (P = 0.081), glucagon (P = 0.45), ghrelin (P = 0.26), CCK (P = 0.18), GLP-1 
(P = 0.60) and PYY (P = 0.45). Post-hoc analyses revealed that the ratio of insulin to 
glucagon was higher in women than men after the 30 g (P = 0.034) and 70 g (P = 0.006) 
protein drink. 
















Figure 9.4: Mean ( SEM) concentrations (AUC 0-180 min) of blood glucose and plasma 
insulin and glucagon and ratio of insulin to glucagon in older men (n = 8) and women (n = 
8) after drinks containing flavoured water (control; dotted line with open circles) and whey 
protein loads of 30 g (dashed line with closed circles) or 70 g (solid line with closed circles). 
Main effect of gender and protein load and interaction effects were determined using a 
mixed-effect model with baseline concentrations as a covariate and post-hoc Bonferroni 
correction.  
# P = 0.034 Main effect of gender (plasma insulin and the ratio of insulin to glucagon 
concentrations were higher in older women than older men). 
+ P < 0.001 Main effect of protein load (plasma insulin, glucagon and the ratio of insulin to 
glucagon concentrations were protein load dependent). 
& P < 0.05 Interaction effect of gender by protein load (Post-hoc tests: $ P < 0.05 plasma 
insulin and the ratio of insulin to glucagon concentrations were higher in women than men 
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was higher after both the 30 g and 70 g protein load compared control, in men the ratio of 
insulin to glucagon was higher after the 30 g protein drink compared to control). 
 
In women, the ratio of insulin to glucagon was higher after both the 70 g and 30 g protein 
drink compared to control (all P < 0.001). In men, the ratio of insulin to glucagon was higher 
after the 70 g protein drink compared to control (P = 0.002). 
In many cases the protein load-effects were time dependent. The difference (earlier return to 
baseline after 30 g vs. 70 g protein intake) in late phase responses (> ~90-120 min) of ghrelin 
in men, CCK in women, and glucagon and GIP in men and women between both protein 
loads (Figures 9.4 and 9.5) may be related to gastric emptying being completed earlier after 
the 30 g than 70 g protein load (Figure 9.3 and Table 9.1). 
 
Relationships between energy intake, appetite, gastric emptying and gut 
hormones 
Energy intake (kcal) at the buffet meal was, within subjects, inversely related to gastric 
emptying (T50 and gastric retention AUC 0-180 min, early phase AUC 0-60 min and late 
phase AUC 60-180 min) and gastric volume at 180 min in women (Table 9.2); i.e. the slower 
the drink emptied from the stomach within a subject – 70 g < 30 g < 0 g – the lower the 
subsequent energy intake (180-210 min). 
Energy intake (kcal) at the buffet meal was, within subjects, positively related to plasma 
concentrations (AUC 0-180 min) of ghrelin and inversely related to plasma concentrations 
of PYY in older men and women combined and to insulin, glucagon, CCK, GIP and PYY in 
older women (e.g. the greater the increase in plasma concentrations of insulin, glucagon, 
CCK GIP and PYY within a subject – 70 g > 30 g > 0 g – the lower the subsequent energy  

















































Figure 9.5: Mean ( SEM) plasma concentrations (AUC 0-180 min) of ghrelin, CCK, GIP, 
GLP-1 and PYY in older men (n = 8) and women (n = 8) after drinks containing flavoured 
water (control; dotted line with open circles) and whey protein loads of 30 g (dashed line 
with closed circles) or 70 g (solid line with closed circles). Main effects of gender and protein 





































































































concentrations as a covariate. Main effects of gender and interaction effects of gender by 
protein load of the gut hormones were not significant. 
+ P < 0.001 Main effect of protein load. 
 
intake. Energy intake was also, within subjects, related to plasma hormone concentrations 
before the meal (180 min) in older women (insulin r = -0.50 P = 0.041, ghrelin r = 0.65 P = 
0.005, CCK r = -0.54 P = 0.025, GIP r = -0.49 P = 0.048, PYY r = -0.73 P = 0.001). 
Gastric emptying (gastric retention AUC 0-180 min) was, within subjects, related to plasma 
insulin, glucagon, CCK, GIP, GLP-1 and PPY concentrations (AUC 0-180 min) and 
inversely related to ghrelin concentrations as well as perceptions of appetite and 
gastrointestinal symptoms (Table 9.3); i.e. the higher the plasma hormone concentrations of 
insulin, glucagon, CCK, GIP, GLP-1 and PPY the slower the rate of gastric emptying within 
a subject and the lower the concentrations of ghrelin and feelings of hunger. 
Hunger and prospective food consumption were, within subjects, inversely related to CCK 
concentrations and desire to eat was inversely related with CCK and GIP concentrations. 
Fullness correlated positively to CCK concentrations and nausea correlated positively with 
glucose and negatively to ghrelin concentrations (Table 9.4). 
GIP was, within subjects, related to GLP-1 (r = 0.52 P = 0.002); i.e. the greater the increase 
in plasma GIP concentrations the greater the increase in GLP-1. Ghrelin was, within subjects, 
inversely related to insulin (r = -0.59, P < 0.001); i.e. the greater the increase in plasma 
insulin concentrations the greater the inhibition of ghrelin production. 
 
DISCUSSION 
This study examined the acute effects of oral whey protein consumption on energy intake, 
appetite, gastric emptying and plasma gut hormone concentrations in older women, as well 
as men. The protein drinks did not suppress subsequent ad libitum food intake in either 
gender. Consequently, there was a dose-dependent effect of the whey protein drinks (30, 70 




Table 9.2: Within-subject correlations between energy intake at the buffet meal and 
perceptions of appetite and gastrointestinal symptoms, gastric emptying and concentrations 
of blood glucose and plasma gut hormones in older men and women. 
 Within-subject correlations 
 Older men (n = 
8)1 
Older women (n 
= 8) 
  Combined 
     r     P     r       P     r     P 
Hunger  0.43  0.11  0.29  0.30  0.35  0.06 
Desire to eat  0.23  0.42 -0.43  0.11 -0.07  0.71 
Prospective food consumption  0.11  0.70  0.22  0.43  0.14  0.47 
Fullness  0.10  0.72  0.29  0.29  0.16  0.42 
Nausea  0.14  0.62 -0.40  0.14 -0.09  0.66 
Bloating -0.05  0.85  0.00  1.00 -0.01  0.94 
       
50% emptying time (T50) -0.10  0.71 -0.66  0.004 -0.29  0.11 
Gastric retention AUC 0-180 -0.15  0.59 -0.61  0.01 -0.30  0.10 
Gastric retention AUC 0-60 -0.16  0.57 -0.59  0.01 -0.30  0.10 
Gastric retention AUC 60-180 -0.15  0.60 -0.59  0.01 -0.29  0.11 
Gastric retention at 180 min  -0.36  0.19 -0.62  0.008 -0.41  0.021 
(before buffet meal)       
       
Glucose -0.10  0.71  0.26  0.31  0.04  0.84 
Insulin -0.10  0.70 -0.64  0.006 -0.29  0.10 
Glucagon -0.10  0.70 -0.57  0.016 -0.24  0.17 
Ghrelin  0.33  0.19  0.43  0.08  0.35  0.045 




CCK -0.11  0.66 -0.52  0.031 -0.25  0.16 
GIP -0.18  0.49 -0.54  0.027 -0.28  0.11 
GLP-1 -0.42  0.10  0.13  0.63 -0.05  0.77 
PYY -0.43  0.08 -0.69  0.002 -0.45  0.009 
r and P values of within-subject correlations between energy intake at the buffet meal (kcal) 
and visual analogue scale (mm; AUC 0-180 min) perceptions of hunger, desire to eat, 
prospective consumption, fullness, nausea and bloating (mm; AUC 0-180 min), gastric 
emptying half time (T50), gastric retention (%; AUC 0-180 min), gastric retention at 180 
min and concentrations (AUC 0-180 min) of blood glucose (mmol/L) and plasma insulin 
(mU/L), glucagon (pg/mL), ghrelin (pg/mL), CCK (pmol/L), GIP (pmol/L), GLP-1 (pmol/L) 
and PYY (pmol/L) in older men and women. Within-subject correlations were determined 
by using a general linear model with fixed slope and random intercept. 1n = 7 for gastric 
retention in the older men. 
 
g protein) to increase total energy intake (preload drink + meal) compared to the control 
drink in both men and women. In both genders, protein caused a load-dependent slowing of 
gastric emptying, and increase in plasma concentrations of insulin, glucagon, ghrelin, CCK, 
GIP, GLP-1 and PYY. As the protein doses used are in the range reported to have favourable 
effects on muscle mass (13), our observations of comparable effects of protein on appetite 
and underlying gastrointestinal mechanisms in men and women, support the use of protein 
supplements in older people to preserve, or increase skeletal muscle mass and function 
without suppressing energy intake. 
Total energy intake was increased most by the highest protein dose [70 g (280 kcal)] 
compared to the control day; a substantial increase of 32% or 230 kcal, compared with an 
increase of 12% or 80 kcal after the 30 g (120 kcal) protein load. These observations are 
consistent with evidence of reduced suppression of energy intake by nutrient ingestion in 
older, compared with young, men (46, 63, 194, 263), and extend these findings to older 
women. Importantly, these observations indicate that doses of protein that have been shown 
to be sufficient to cause dietary protein muscle deposition, can be ingested by both older 
women and men, without suppressing appetite or overall energy intake. In older, when 




compared to younger adults, the sensitivity of muscle protein synthesis to the ingestion of 
small amounts (≤ 20 g) of whey protein may be reduced (23). However, these postprandial 
differences between the young and old are, not evident after consumption of ample amounts 
of dietary protein (> ~35 g). Moreover, administration of protein supplements in older people 
may increase total energy intake (supplement plus subsequent meal), as was observed in this 
study. This contrasts to the effects of protein in younger adults - identical whey drinks given 
according to the same study protocol produced a significant ~15% suppression of ad libitum 
food intake compared to control in our previous study (263). It should be appreciated that 
the long-term effects of protein supplements on energy intake in older adults are unknown 
and reported effects on muscle mass and function are inconsistent (325-328). 
Appetite and energy intake are dependent on the precise co-ordination of interrelated 
‘gastric’ and ‘small intestinal’ mechanisms triggered by the interaction with the nutrients 
ingested. We, and others, have shown that healthy ageing is associated with modest slowing 
of gastric emptying of both solids and liquids, although the rate of emptying generally 
remains within the normal range for young subjects (i.e. ~1 – 4 kcal/min) (50, 74, 82, 263). 
Slower gastric emptying results in greater distension of the stomach at any given time after 
ingestion of a meal. This can, in turn, lead to greater fullness and, at least in young adults, a 
consequent reduction in subsequent energy intake. In the present study there was a marked, 
dose-dependent, slowing of gastric emptying by the protein drinks, with the 50% gastric 
emptying time more than doubling from control to 30 g protein day, and again from the 30 
g to 70 g protein day. The rate of gastric emptying of the protein drinks in both men and 
women (~1 kcal/min) was apparently at the lower end of the normal range. Gastric emptying 
of the 30 g protein drink slowed further after the early phase (~0.5 kcal/min) when on average 
~48% of the drink was emptied after 60 min; whereas the 70 g protein drink continued being 
emptied at ~1 kcal/min after ~25% had emptied on average after 60 min.  




There was no significant difference between emptying rates in older men and women. 
Controversy exists regarding the gender-related difference in gastric emptying. Previously 
gastric emptying, determined by scintigraphy, has been found to be modestly slower in 
young and middle aged lean, but not obese (329), women than men (83, 330, 331), but not 
in all studies (80). Bennink et al. also observed slower gastric emptying of a solid, but not 
liquid, test meal in lean healthy young women compared to men (332). We have reported 
that energy intake at a buffet meal is associated negatively (r = -0.90, P < 0.001) with antral 
area (distal stomach) immediately before the meal in young and older subjects who received 
mixed macronutrient drinks (0, 250, and 750 kcal) (42). Although the negative association 
between gastric retention and energy intake in the female (but not male) subjects in this study 
is consistent with some suppression of energy intake by gastric distension, the finding that 
the marked protein-induced slowing of gastric emptying after ingestion of the protein drinks 
was not associated with suppression of subsequent energy intake, suggests that this effect, if 
present, is probably minor in elderly people. This would be consistent with the finding of 
Rayner et al. that the perception of gastric distension is diminished in healthy older people 
(84). 
Gastric emptying was, within subjects, related to plasma gut hormone concentrations –higher 
plasma concentrations of insulin, glucagon, CCK, GIP, GLP-1 and PYY correlated with 
lower plasma ghrelin concentrations and perceptions of hunger, and slower gastric emptying 
of the protein drink (70 g < 30 g < 0 g). There was an immediate load-dependent increase in 
the plasma hormone concentrations of CCK and GIP (both mainly produced in the 
duodenum and proximal jejunum) reaching a plateau from 15-30 min onwards, whereas the 
hormones that are produced more distally in the gut; GLP-1 and PYY (GLP-1 mainly 
produced in the ileum and PYY in the ileum and colon) showed a more constant increase. 
Gastric emptying was completed earlier after the 30 g than the 70 g protein load, which 
resulted in a time-dependent response (earlier return to baseline after 30 g vs. 70 g protein 




intake) in plasma concentrations of CCK in women, and glucagon and GIP in men and 
women after 30 g vs. 70 g protein load. Healthy older, when compared to young people, 
have higher postprandial concentrations of CCK, GIP, GLP-1 and PYY, which may 
contribute to slowing of gastric emptying (42, 48, 52, 132). The latter may in part be related 
to impairment of clearance, including GIP and GLP-1 inactivation by dipeptidyl peptidase 
IV (DPP-IV) and renal processes (132). 
Healthy ageing is characterised by impaired glucose tolerance or insulin resistance (132, 
239). The latter may reflect increased adiposity and reduction in the secretion of, or 
pancreatic beta cell sensitivity to (176), the incretins GLP-1 and GIP (132, 134). Insulin 
peaked between 30 and 60 min and returned to baseline after 180 min, and this effect was 
greater in older women than older men. Glucagon increased almost concurrently in older 
men and women, before decreasing again after 90 min after the 30 g, whereas it stayed 
elevated after the 70 g protein load. 
Our study has several limitations which should be recognised. The number of subjects was 
relatively small and, therefore, the study may be underpowered for secondary outcomes, 
including perceptions of appetite and gastrointestinal symptoms and the change in gastric 
emptying after the 70 g whey protein load in older women than older men. Energy intake 
was assessed three hours after protein intakes at a buffet meal, and not during the remainder 
of the day - accordingly, potential compensating changes in energy intake after lunch were 
not evaluated. While the drinks were matched for taste and osmolality, we did not assess the 
subject’s perceptions of taste, pleasantness and/or palatability of the drinks. As a 
consequence of the study design the protein preload drinks were iso-caloric for both older 
men and women. Older women are expected to have lower energy requirements when 
compared to the older men, and the drinks given to female group in this study could therefore 
be judged to be ‘larger’ than those given to the male group when considered in relation to 
energy requirements. Blood glucose was measured by a glucometer, and blood samples of 




glucagon and GLP-1 were collected without protease inhibitors, which could be considered 
to be less than optimal, however, the results appeared clear-cut with significant changes in 
both glucagon and GLP-1 in response to the protein loads in the direction expected.  
In summary, ingestion of protein drinks at doses previously shown to suppress energy intake 
in young men, had no effect on ad libitum energy intake in either older women or men, three 
hours after consumption. Consequently, consumption of protein drinks lead to an increase 
in the total energy intake. 
  




Table 9.3: Within-subject correlations between gastric retention and perceptions of appetite 
and gastrointestinal symptoms and concentrations of blood glucose and plasma gut 
hormones in older men and women.  
 Older men (n = 7) Older women (n = 8)    Combined 
     r     P     r       P     r     P 
Hunger  0.00   0.99 -0.44   0.08 -0.63   0.12 
Desire to eat -0.09   0.76 -0.52   0.031 -0.36   0.044 
Prospective food consumption  0.14   0.62 -0.65   0.005 -0.34   0.06 
Fullness -0.45   0.09  0.51   0.004  0.20   0.29 
Nausea  0.11   0.70  0.14   0.58  0.12   0.54 
Bloating  0.21   0.46  0.07   0.79  0.09   0.63 
       
Glucose -0.55   0.033 -0.23   0.38 -0.35   0.053 
Insulin  0.90 <0.001  0.89 <0.001  0.87 <0.001 
Glucagon  0.94 <0.001  0.96 <0.001  0.94 <0.001 
Ghrelin -0.73   0.020 -0.57   0.017 -0.64 <0.001 
CCK  0.78   0.001  0.92 <0.001  0.87 <0.001 
GIP  0.92 <0.001  0.85 <0.001  0.87 <0.001 
GLP-1  0.76   0.001  0.75   0.001  0.75 <0.001 
PYY  0.72   0.002  0.85 <0.001  0.80 <0.001 
r and P values of within-subject correlations between gastric retention (%; AUC 0-180 min) 
and visual analogue scale (mm, AUC 0-180 min) perceptions of hunger, desire to eat, 
prospective consumption, fullness, nausea and bloating, and concentrations (AUC 0-180) of 
blood glucose (mmol/L) and plasma insulin (mU/L), glucagon (pg/mL) ghrelin (pg/mL), 
CCK (pmol/L), GIP (pmol/L), GLP-1 (pmol/L) and PYY (pmol/L) in older men and women. 




Table 9.4: Within-subject correlations between perceptions of hunger, desire to eat, prospective food consumption, fullness, nausea and bloating, and 
concentrations of blood glucose and plasma gut hormones in older men and women (n = 16).  
 Hunger Desire to eat Prospective food 
consumption 
Fullness Nausea Bloating 
     r     P     r     P     r     P     r     P     r     P     r     P 
Glucose  0.09 0.63  0.01 0.97 -0.09 0.63  0.14 0.44  0.37 0.047 -0.22 0.23 
Insulin -0.31 0.09 -0.35  0.06 -0.36 0.05  0.29 0.12  0.09 0.63  0.09 0.63 
Glucagon -0.27 0.14 -0.32  0.09 -0.30 0.10 -0.06 0.75  0.10 0.58  0.10 0.59 
Ghrelin  0.18 0.33  0.12  0.50  0.10 0.57 -0.14 0.44 -0.37 0.048 -0.02 0.90 
CCK -0.41 0.029 -0.50  0.009 -0.56 0.004  0.38 0.043  0.18 0.32  0.11 0.56 
GIP -0.35 0.06 -0.37  0.047 -0.34 0.07  0.21 0.25  0.13 0.46  0.08 0.68 
GLP-1 -0.22 0.23 -0.27  0.149 -0.25 0.17  0.04 0.83  0.05 0.77  0.06 0.75 
PYY -0.12 0.53 -0.19  0.30 -0.30 0.10  0.15 0.40  0.04 0.83  0.16 0.39 
r and P values of within-subject correlations between perceptions of appetite and gastrointestinal symptoms (AUC 0-180 min) and concentrations (AUC 
0-180 min) of blood glucose (mmol/L) and plasma insulin (mU/L), glucagon (pg/mL), ghrelin (pg/mL), CCK (pmol/L), GIP (pmol/L), GLP-1 (pmol/L) 
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Background: Protein supplements, usually drinks rich in whey protein, are used widely for 
weight loss purposes in overweight adults. Information comparing the effects of whey 
protein on appetite and energy intake in men and women is limited. 
Objective: To compare the acute effects of whey-protein intake on energy intake, appetite, 
gastric emptying and gut hormones in healthy young men and women. 
Design: Gastric emptying (3D-ultrasonography), blood glucose and plasma insulin, 
glucagon, ghrelin, cholecystokinin (CCK), gastric inhibitory polypeptide (GIP) and 
glucagon-like peptide-1 (GLP-1) concentrations (0-180min), appetite (visual analogue 
scales), and ad libitum energy intake from a buffet meal (180-210min) were determined after 
ingestion of 30 g (120 kcal) or 70 g (280 kcal) whey protein, or a flavoured-water control 
drink (~2 kcal) in 8 healthy young men (25 ± 2y, 72 ± 3kg, 23 ± 1 kg/m2) and 8 women (23 
± 1y, 64 ± 2kg, 24 ± 0.4 kg/m2). 
Results: There was a protein-load effect on gastric emptying, blood glucose, plasma insulin, 
glucagon, ghrelin, CCK, GIP and GLP-1 concentrations, and perceptions of hunger, desire 
to eat and prospective food consumption (P < 0.05). Ad libitum energy intake (average 
decrease of 206 ± 39kcal [15 + 2%] for men and of 46 ± 54kcal [0 + 26%] for women for 
the mean of the intakes after the 30 g and 70 g whey-protein loads) and hunger were 
suppressed more by the whey-protein ingestion compared to control in men than women (P 
< 0.05). Consequently, total energy intake (from protein drink plus buffet meal) was greater 
in women than men (P < 0.05). The drinks emptied more slowly, and plasma glucagon, CCK 
and GLP-1 responses were less, in women than men (P < 0.05). 
Conclusion: The acute effects of whey protein ingestion on appetite, energy intake, gastric 
emptying and gut hormone responses are influenced by gender in healthy young adults. 
  





Supplements and diets high in protein content, particularly whey protein, are used frequently 
for weight loss purposes, in both men and women, based on the rationale that ingestion of 
protein has a  muscle sparing effect and greater satiating effects than dietary carbohydrate 
and fat (287, 333). As such, many high protein diets have been developed and recommended 
to aid weight loss; well-known versions include the Atkins Diet, South Beach Diet, Zone 
Diet and Stillman Diet. Our recent studies in healthy young men have shown that whey 
protein, ingested either orally, or infused intraduodenally, suppresses ad libitum energy 
intake at a subsequent meal, in excess of the caloric content of the protein load, so that total 
energy intake (protein plus meal) is less after intake of protein than after a non-caloric control 
(114, 334). When infused intraduodenally, whey protein increases pyloric and decreases 
antral and duodenal motility, factors important in the regulation of gastric emptying (114, 
334). Oral whey protein ingestion load-dependently slows gastric emptying and increases 
plasma insulin, glucagon, ghrelin, cholecystokinin (CCK), gastric inhibitory polypeptide 
(GIP) and glucagon-like peptide-1 (GLP-1) concentrations in healthy young men (334). 
These effects on gastrointestinal mechanisms are associated with the suppression of appetite 
and energy intake (114, 334). 
It has been reported that women, when compared to men, exhibit lower compensation of 
energy intake, but comparable perceptions of appetite, after ingestion of liquid and semi-
liquid caloric preloads (321, 322). For example, after a milk or fruit drink preload, women 
compared to men compensate less in subsequent energy intake i.e. on average 50% in women 
versus 107% in men when compared to a control day, resulting in an increase in total energy 
intake (drink plus meal) in women (322). It has also been reported that after mixed-nutrient 
meals women compared to men have slower gastric emptying (83, 330-332) and lower 
plasma glucagon (335), CCK (336) and GLP-1 concentrations (335). It is not known whether 




gender modulates the acute effects of whey protein, administered in loads representative of 
a small to large meal (30–70 g, e.g. ~100–250 g serving of lean steak), to suppress energy 
intake and, if so, what the underlying gastrointestinal mechanisms are. 
The aim of the study was to determine the comparative load-dependent effects of 30 g and 
70 g whey protein intake on ad libitum energy intake at a buffet meal, as well as perceptions 
of appetite and gastrointestinal symptoms, gastric emptying, blood glucose and plasma 
insulin, glucagon, ghrelin, CCK, GIP and GLP-1 concentrations in healthy young men and 
women. We hypothesised that women compared to men would have less suppression of 
energy intake, slower gastric emptying and lower gut hormone responses after whey protein 
ingestion. 
 
SUBJECTS AND METHODS 
Subjects 
Participants were recruited by advertisement. The study included 8 young men [mean ± 
SEM: age: 25 ± 2 years; body weight: 72 ± 3 kg; height: 1.79 ± 0.02 m; body mass index 
(BMI): 23 ± 1 kg/m2 - the men were included in our previous study relating to energy intake, 
gastric emptying and perceptions of appetite and gastrointestinal symptoms in healthy older 
compared to younger men (263)] and 8 young age- (P = 0.60) and BMI-matched (P = 0.24) 
women [23 ± 1 years; 64 ± 2 kg; 1.64 ± 0.02 m; 24 ± 0.4 kg/m2]. 
All participants were non-smokers, unrestrained eaters [score ≤ 12 on the eating restraint 
component of the Three-Factor Eating Questionnaire (337)]. Further exclusion criteria were 
gastrointestinal surgery (apart from uncomplicated appendectomy), gastrointestinal 
symptoms (abdominal pain, gastro-esophageal reflux, diarrhea, or constipation), use of 
medications known to potentially affect energy intake, appetite or gastrointestinal motor 
function, diabetes, gallbladder or pancreatic disease, lactose intolerance or food allergies, 




consumption of a vegetarian diet, alcohol abuse, use of illicit substances, low ferritin levels 
or blood donation in the 12 weeks prior to the study, failure to comprehend the study protocol 
and, in women, lactation, pregnancy or the use of hormonal contraceptives. The Royal 
Adelaide Hospital Human Research Ethics Committee approved the study protocol. The 
study was conducted in accordance with the Declaration of Helsinki and registered as a 
clinical trial with the Australian New Zealand Clinical Trial Registry (www.anzctr.org.au, 
registration number ACTRN12611000706976). All participants provided written informed 
consent prior to their inclusion. 
 
Protocol 
Subjects were studied on 3 occasions, separated by 3-14 days, to determine the 
comparative effects of two oral whey protein loads; 30 g (120 kcal) and 70 g (280 kcal), 
and a flavoured water control-drink (~2 kcal) on energy intake, perceptions of appetite and 
gastrointestinal symptoms, gastric emptying, blood glucose and plasma gut hormone 
concentrations in a randomised [www.randomization.com (16 subjects with random 
permutations)], double-blind, cross-over design. In women, study days were scheduled 
during the follicular phase of their menstrual cycle (i.e. the first 13 days of the cycle) to 
minimise the potential effect of fluctuations in hormones on gastric emptying and energy 
intake at the buffet meal (338). 
Protein drinks were prepared by dissolving whey protein isolate (Fonterra Co-Operative 
Group Ltd., Palmerston North, New Zealand) in varying volumes of demineralised water 
and diet lime cordial (Bickford’s Australia Pty Ltd, Salisbury South, SA, Australia) to 
achieve the desired loads [i.e. 30 g whey protein (volume of the powder: 19 mL) in 335 
mL distilled water and 85 mL cordial (2.5 kcal/100 mL), 70 g whey protein (volume of the 
powder: 45 mL) in 280 mL water and 100 mL cordial, the control drink consisted of 359 




mL distilled water and 90 mL cordial]. Sodium chloride in the amount of 0.3 g and 1.2 g 
was added to the 30 g and control drinks, respectively, to match the osmolarity (88 
mOsm/L) with the 70 g drink. To ensure that all ingredients were dissolved evenly 
throughout and to minimise the layer of foam on top of the solution, the drinks were all 
stirred continuously at low speed on a stirring plate. The volume of each drink was 
measured before serving and the recorded volumes differed modestly (i.e. control: 450 mL; 
30 g protein: 439 mL; and 70 g protein: 425 mL). All drinks were provided to subjects in a 
covered cup, so that both the investigator conducting the data collection and the subject 
were blinded to the test drinks. The drinks were prepared by a research assistant who was 
not involved in analysis of the study results. 
Subjects were provided with a standardised evening meal [beef lasagna (McCain Foods Pty 
Ltd, Wendouree, VIC, Australia), ~591 kcal] to consume on the night before each study 
day at ~19.00 h. They were instructed to fast overnight from solids and liquids and refrain 
from strenuous physical activity until they attended the laboratory at ~08.30h. 
On arrival, subjects were seated in an upright position on a wooden chair, where they 
remained for the duration of the study, and an intravenous cannula for blood sampling was 
inserted. In each subject, measurements of total gastric volume and perceptions of appetite 
and gastrointestinal symptoms were performed before (during fasting; 0 min) and 
immediately after ingestion of the drink, and at 15-min intervals until 180 min (47). 
Subjects were instructed to consume the drink within 2 minutes. Gastric volume was 
measured by 3-dimensional (3D) ultrasonography (263). Perceptions of appetite and 
gastrointestinal symptoms were assessed using validated visual analogue scales (VAS) and 
blood samples were collected for the measurement of blood glucose and plasma gut 
hormone concentrations. At 180 min, subjects were presented, in a room by themselves to 
limit external distractions, with a standard, cold, buffet meal in excess of what they are 
expected to consume (total energy content of 2,457 kcal; 19% protein, 50% carbohydrates, 




31% fat) over 30 min (257). The buffet meal consisted of palatable food items including 
sliced bread, cheese, ham and chicken, fruits, yoghurt, custard, margarine, mayonnaise, 




The amount eaten at the buffet meal (g) was quantified by weighing the food before and after 
consumption. Energy intake (kcal) at the buffet meal and proportions of protein, 
carbohydrate and fat were calculated using commercially available software (Foodworks 
version 8; Xyris Software Pty Ltd, Spring Hill, QLD, Australia). Energy intake was 
calculated both as intake at the buffet meal and as total energy intake, defined as the sum of 
energy intake at the buffet meal and the energy content of the drink. Absolute change (kcal) 
and percentage suppression (expressed as % of energy intake of the control day) of energy 
intake at the buffet meal by a given protein load compared to control were calculated (263). 
 
Perceptions of appetite and gastrointestinal symptoms 
Perceptions of hunger, desire to eat, prospective consumption, fullness, nausea and bloating 
were rated using a visual analogue scale (VAS) questionnaire at 0, 5, 15, 30, 45, 60, 75, 90, 
105, 120, 135, 150, 165, 180, 210 min (47). The questionnaire consisted of 100-mm 
horizontal lines, where 0 represented that the sensation was ‘not felt at all’ and 100 
represented that the sensation was ‘felt the greatest’. Subjects placed a vertical mark on each 
horizontal line to indicate the strength of each sensation. 
 





Total gastric volume was measured by a Logiq™ 9 ultrasound system (GE Healthcare 
Technologies, Sydney, NSW, Australia) with TruScan Architecture [built-in magnetically 
sensored 3D positioning and orientation measurement (POM)] including a 3D sensor, 
attached to a 3.5C broad spectrum 2.5-4 MHz convex transducer, and a transmitter, placed 
at the level of the stomach immediately behind the subject at 0, 5, 15, 30, 45, 60, 75, 90, 105, 
120, 135, 150, 165, 180 min (263). As the transmitter produces a spatially varying magnetic 
field that is distorted by conductive metals, all metal objects were removed from the subject 
to minimise interference during image acquisition. The stomach was scanned by a 
continuous translational movement along its long axis (~10 s). During each scan the subject 
was instructed to sit still and hold their breath at the end of inspiration. If gastric contractions 
were observed, the acquisition was paused until the contraction wave had passed. The raw 
data (original scan planes) were transferred for 3D reconstructions and volume estimation 
using EchoPAC - 3D software (GE Vingmed Sound, Horten, Norway). Gastric retention 
(early phase: 0-60 min and late phase: 60-180 min; %) was calculated as total gastric volume 
minus baseline ‘fasting’ gastric volume at each time point expressed as percentage of the 
maximal gastric volume (100%), i.e. volume of the ingested drink. When ultrasound images 
lacked sufficient clarity to determine the volume of the stomach, data were imputed by linear 
interpolation. The time at which 50% of the preload drink had emptied from the stomach 
(50% gastric emptying time; T50; min) and ‘complete’ gastric emptying time (100% gastric 
emptying time; T100; min), defined as the time when the residual volume of the drink in the 
stomach was ≤5%, was calculated for all conditions. Complete emptying time was set to 180 
min when the residual volume at 180 min was >5% (263). The overall rate of gastric 
emptying was calculated as the mean of rates of emptying (kcal/min) during each 15-min 
interval respectively of the early phase (0-60 min), late phase (60 min until complete 




emptying time per individual) and total time period (0 min until complete emptying time per 
individual). 
 
Blood glucose and plasma insulin, glucagon, ghrelin, CCK, GIP, GLP-1 and PYY 
Blood samples were collected, at 0, 5, 15, 30, 45, 60, 90, 120, 150, 180 min, into ice-chilled, 
ethylenediaminetetraacetic acid (EDTA) coated tubes. No inhibitors were added (264). 
Blood glucose concentrations (millimoles per liter) were determined immediately after 
collection by the glucose oxidase method using a portable glucometer (Optium Xceed, 
Abbott Laboratories, Doncaster, VIC, Australia). Plasma was obtained by centrifugation for 
15 min at 3200 rpm at 4°C and samples were stored at -80°C for further analysis of hormone 
concentrations (339). 
Plasma total insulin concentrations (milliunits per liter) were determined by enzyme-linked 
immunosorbent assay (ELISA) immunoassay (10-1113; Mercodia, Uppsala, Sweden). The 
detection limit was 1.0 milliunits per liter. Intra- and inter-assay coefficients of variation 
were 3.0 and 8.7%. Homeostatic model assessment (HOMA) index was calculated according 
to the following formula: insulin concentration at baseline (microunits per liter) x glucose 
concentration at baseline (nanomoles per liter) / 22.5 (290). 
Plasma total glucagon concentrations (picograms per milliliter) were determined by 
radioimmunoassay (RIA; GL-32K; Millipore, Billerica, MA, USA). The detection limit was 
20 picograms per milliliter. Intra- and inter-assay coefficients of variance were 4.3% and 
7.1%.  
Plasma total ghrelin concentrations (picograms per milliliter) were determined by RIA 
(Perkin Elmer, Boston, MA, USA; NEX388) (292, 340, 341). The standard and samples 
were incubated with the antibody and radiolabel for 3-4 days at 4oC. The detection limit was 
40 pg/mL. Intra- and inter-assay coefficients of variation were 6.7% and 12.1%. 




Plasma CCK-8 (picomoles per liter) were determined by RIA (324, 341). Samples were 
extracted in 66% ethanol, extracts were dried down and re-suspended in assay buffer (50 
mM phosphate, 10 mM EDTA, 2 g/L gelatin, pH = 7.4). Standards were prepared using 
synthetic sulphated CCK-8 (Sigma Chemical, St Louis, MO, USA) and an antibody (C2581, 
Lot 105H4852, Sigma Chemical) was added at a working dilution of 1/17,500 and sulphated 
CCK-8 125I-labeled with Bolton and Hunter reagent (Perkin Elmer, Boston, MA, USA). 
Incubation was for 7 days at 4˚C. The antibody bound fraction was separated by the addition 
of dextran-coated charcoal containing gelatin (0.015 g gelatin, 0.09 g dextran, 0.15 g 
charcoal in 30 mL assay buffer). The radioactivity was determined in the supernatants 
following centrifugation with a detection limit of 1 picomoles per liter. Intra- and inter-assay 
coefficients of variation were 5.4% and 13.9%. 
Plasma total GIP concentrations (picomoles per liter) were measured by RIA (Perkin Elmer, 
Boston, MA, USA) (293). The standard curve was prepared in buffer, rather than extracted 
charcoal stripped serum. The detection limit was 2 picomoles per liter. Intra- and inter-assay 
coefficients of variance were 3.9% and 9%. 
Plasma total GLP-1 concentrations (picomoles per liter) were measured by RIA (GLPIT-
36HK; Millipore, Billerica, MA, USA). The detection limit was 3 pmol/L. Intra - and inter 
-assay coefficients of variance were 6.3% and 10.3%. 
 
Data analysis 
On the basis of our previous work (194), with an observed within-subjects standard deviation 
(SD) of 181 kcal, we estimated an SD using the upper 60% confidence limit of 234 kcal and 
calculated that 8 subjects per group would allow detection of a within-groups (n = 8) 
difference between treatments of 271 kcal and a between groups difference of 353 kcal (n = 
8 women compared with n = 8 men), with power equal to 0.8 and alpha equal to 0.05. 




Statistical analyses were performed using SPSS Statistics software (version 21, IBM, 
Armonk, NY, USA). Effects of gender, protein load and their interaction effect on energy 
intake and gastric emptying were determined using repeated measures ANOVA, with protein 
load as the within-subject factor, and gender as the between-subject factor. To adjust for 
baseline values at each visit as a covariate, a repeated measures mixed effect model, with 
protein load as the within-subject factor and gender as the between-subject factor was used 
to test for effects of gender and protein load and their interaction effect on perceptions of 
appetite and gastrointestinal symptoms, blood glucose and plasma hormone concentrations. 
Post-hoc comparisons, adjusted for multiple comparisons using Bonferroni's correction, 
were performed when there were significant main or interaction effects. Within-subject 
correlations were determined by using a general linear model with fixed slope and random 
intercept (277). Areas under the curve (AUC) were calculated using the trapezoidal rule. 
Assumptions of normality were verified for all outcomes before statistical analysis. 




The study protocol was well tolerated by all subjects and there were no untoward effects. 
 
Energy intake 
Energy intake at the buffet meal was less in women than men (gender effect P = 0.010). On 
the control day energy intake was 34% lower in women than men (791 ± 87 kcal vs. 1205 ± 
109 kcal, P = 0.010). 
Energy intake at the buffet meal was suppressed by protein compared to control in men, but 
not women (protein-load effect P = 0.008, interaction-effect of gender by protein-load P = 




0.046; Figure 10.1). The mean suppression of the 30 g and 70 g protein loads compared to 
control was 206 ± 39 kcal or 15 ± 2% for men, while it was 46 ± 54 kcal or 0 ± 26% for 
women (gender-effect P = 0.032, protein-load effect P = 0.75, interaction-effect P = 0.19). 
There was a protein-load effect (P = 0.002) on total energy intake (drink plus buffet meal), 
which was higher in women than men (gender-effect P = 0.010, interaction-effect P = 0.046). 
Compared to the total energy intake on the control day, total energy intake on the 30 g and 
70 g protein days increased 22 ± 13% and 35 ± 15% respectively in women, and decreased 
8 ± 3% and increase 10 ± 5%, respectively, in men. Total energy intake was higher after the 
70 g compared to the 30 g protein load in men (P = 0.021), and after the 70 g protein drink 
compared to control in women (P = 0.033). 
 
Macronutrient intakes at the buffet meal 
At the buffet meal women consumed a higher percentage of their energy intake as protein 
than men (average of all three study days: women: 24 ± 1%, men: 20 ± 1%; gender-effect P 
= 0.023, protein-load effect P = 0.31, interaction-effect, P = 0.60) and fat (women: 36 ± 1%, 
men: 28 ± 1%; gender-effect P = 0.006, protein-load effect P = 0.09, interaction-effect P = 
0.85), and less as carbohydrate (women: 41 ± 3%, men: 52 ± 2%; gender-effect P = 0.001, 












Figure 10.1: Mean ( SEM) energy intake at the buffet meal (kcal; energy intake in closed 
bars) in healthy young men (gray shading; n = 8) and women (black shading; n = 8) after 
intake of drinks (energy content in open bars) containing flavored water (control) and 
whey protein loads of 30 g (120 kcal) and 70 g (280 kcal). Effects of gender and protein-
load and interaction effects were determined by using repeated-measures ANOVA. 
Interaction effect of gender by protein-load energy intake at the buffet meal P = 0.046 and 
total energy intake (drink + buffet meal) P = 0.046. 
# Effect of gender: energy intake P = 0.010 and total energy intake P = 0.010 were higher 
in men than women. 
Effect of protein load: energy intake P = 0.008 and total energy intake P = 0.002. * Post 
hoc effects: energy intake was lower after the 30 g (P = 0.001) and 70 g (P = 0.049) 
protein drink compared to control in men. ^ Post hoc effects: total energy intake was higher 
after the 70 g compared to the 30 g protein drink in men (P = 0.021); $ Post hoc effects: 
total energy was higher after the 70 g protein drink compared to control in women (P = 
0.033). 
 
Perceptions of appetite and gastrointestinal symptoms 
Baseline hunger, desire to eat, prospective food consumption, fullness, nausea and bloating 
were comparable in men and women (all P > 0.05). Protein drink ingestion was associated 
with a load-dependent decrease in perceptions (AUC and ratings immediately before the 
buffet meal at 180 min) of hunger (P = 0.002 and P = 0.002), desire to eat (P = 0.001 and P 
< 0.001) and prospective food consumption (P = 0.001 and P = 0.005). 
Hunger ratings were lower in women than men during the control day, and decreased in men, 
but not women, after both 30 g (P = 0.004) and 70 g (P < 0.001) protein loads compared to 
control day values (gender-effect P = 0.08, interaction-effect of gender by protein-load P = 



































Figure 10.2: Mean ( SEM) Visual analogue score (VAS, mm) of hunger, desire to eat, 
prospective food consumption, fullness, nausea and bloating in healthy young men (n = 8) 
and women (n = 8) after drinks containing flavoured water (control; dotted line with open 
circles) and whey protein loads of 30 g (dashed line with closed circles) or 70 g (solid line 
with closed circles). Effects of gender and protein-load and interaction effects were 
determined by using repeated-measures ANOVA including baseline values at each treatment 
visit as a covariate. 
+ P < 0.005 Effect of protein load: perceptions (area under the curve; AUC) of hunger (P = 
0.002), desire to eat (P = 0.001) and prospective food consumption (P = 0.001) protein-load 
dependently increased after drink ingestion. 
$ P = 0.0016 Interaction effect of gender by protein-load: perceptions of hunger were lower 
in women than men after the control drink. 
* P < 0.005 Interaction effect of gender by protein-load: in men hunger was suppressed after 




Gastric emptying parameters are detailed in Table 10.1. Baseline gastric volumes were 
comparable in men (31  6 mL) and women (34  4 mL, P = 0.69) and between study days 
(P = 0.41). The control (water) and the 30 g protein drinks emptied in an overall non-linear 
pattern, whereas the pattern of the 70 g protein drink was linear (Figure 10.3). Gastric 
retention (AUC % decrease in stomach volume compared to directly after drink ingestion, P 
< 0.001), gastric emptying halftime (T50, P < 0.001), complete emptying time (T100, P < 
0.001) and the rate of gastric emptying (kcal/min, P < 0.001) protein-load dependently 
increased after drink ingestion. The drinks emptied slower in women than men; gastric 
retentions were higher in women compared to men (gender-effect P = 0.021, interaction-
effect of gender by protein-load P = 0.34). 
 
Glucose and gut hormones 
Baseline concentrations of blood glucose (5.4 ± 0.1 mmol/L) and plasma insulin (5.3 ± 0.6 
mU/L), glucagon (68 ± 4 pg/mL), ghrelin (1507 ± 207 pg/mL), CCK (3.3 ± 0.4 pmol/L) and 
GIP (16 ± 2 pmol/L), and HOMA index (1.3 ± 0.1) were comparable in men and women (P 




> 0.05) while plasma GLP-1 concentrations were marginally lower in women (16.5  0.9 
pmol/L) than men (20.6  2.0 pmol/L, P < 0.001). 
AUC blood glucose and plasma ghrelin decreased, and plasma insulin, glucagon, CCK, 
GIP, GLP-1 concentrations increased in a protein-load dependent fashion (all P < 0.01; 
Figure 10.4). 60 min and 180 min plasma ghrelin decreased and plasma insulin, glucagon, 
CCK, GIP and GLP-1 concentrations increased in a protein-load dependent fashion (all P < 
0.05; Table 10.2). AUC blood glucose concentrations were lower after the 30 g protein drink 
compared to control. 60-min plasma ghrelin concentrations were lower after both protein 
drinks compared to control (all P < 0.05). AUC plasma ghrelin concentrations were lower 
after the 70 g protein drink compared to the 30 g protein and control drinks. 60-min and 
AUC plasma insulin, glucagon, CCK, GIP and GLP-1 concentrations were higher after both 
protein drinks compared to control, and 180-min and AUC concentrations after the 70 g 
compared to the 30 g protein drink (all P < 0.05). 60-min plasma GLP-1 concentrations were 
higher after 70 g compared to 30 g protein (P = 0.036). 
Women compared to men had higher 60-min and AUC blood glucose concentrations (P 
< 0.05), and lower 60-min, 180-min and AUC plasma glucagon, CCK and GLP-1 
concentrations (all P < 0.05). Women compared to men had higher 60-min and AUC plasma 
glucagon concentrations, lower 60-min and AUC plasma GLP-1 and 180-min and AUC GIP 
concentrations (gender by protein-load interactions all P < 0.05). 





Figure 10.3: Mean ( SEM) gastric retention (%) in healthy young men (n = 8; closed 
circles) and women (n = 8; open circles) after drinks containing flavoured water (control; 
dotted line) and whey protein loads of 30 g (dashed line) or 70 g (solid line). Effects of 
gender and protein-load and interaction effects were determined by using repeated-measures 
ANOVA. 
* P < 0.05 50% gastric emptying time (T50): effect of gender and protein-load (interaction 
effect of gender by protein-load P = 0.17) 
# P < 0.05 area under the curve (AUC): effect of gender and protein-load (interaction effect 
of gender by protein-load P = 0.34). 
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Figure 10.4: Mean ( SEM) blood glucose and plasma insulin, glucagon, ghrelin, CCK, GIP 
and GLP-1 concentrations in healthy young men (n = 8, n = 7 for GIP and GLP-1) and 
women (n = 8) after drinks containing flavoured water (control; dotted line with open circles) 
and whey protein loads of 30 g (dashed line with closed circles) or 70 g (solid line with 
closed circles). Effects of gender and protein-load and interaction effects were determined 
by using repeated-measures ANOVA including baseline values at each treatment visit as a 
covariate and post-hoc Bonferroni corrections. 
# P < 0.05 Effect of gender; $ P < 0.05 Post-hoc: plasma glucagon and GLP-1 concentrations 
were lower in women than men after all drinks 
+ P < 0.001 Effect of protein load; * P < 0.05 Post-hoc: plasma glucagon, GIP and GLP-1 
concentrations were higher after both protein drinks compared control in men and women 
& P < 0.05 Interaction effect of gender by protein-load; ^ P < 0.05 Post-hoc: plasma glucagon 
and GLP-1 - and GIP only in men - concentrations were higher after the 70 g protein drink 
compared to the 30 g protein drink in men and women. 
 
Relationships between energy intake, appetite, gastric emptying and gut 
hormones 
Energy intake at the buffet meal was, within subjects, related to 180-min plasma insulin, 
(r = -0.37, P = 0.032), CCK (r = -0.36, P = 0.041), GIP (r = -0.37, P = 0.033) and GLP-1 (r 
= -0.37, P = 0.001) concentrations, and perceptions of hunger (r = 0.37, P = 0.032), desire 
to eat (r = -0.53, P = 0.002) and prospective food consumption (r = 0.40, P = 0.022). GIP 
was related to GLP-1 (r = 0.78 P < 0.001) while ghrelin was inversely related to insulin (r = 
-0.63 P < 0.001).
 
 
Table 10.1: Gastric emptying parameters of whey protein (30 g and 70 g) and control drinks in healthy young men and women 
 Men (n = 8) Women (n = 8) 
    0 g    30 g 
(120kcal) 
   70 g  
(280kcal) 
   0 g    30 g 
(120kcal) 
   70 g 
(280kcal) 
50% emptying time (T50; min) +   121     254    7213  191     395  9814 
100% emptying time (100, min) +   607 12614 1716  8115 1764 1800 
Rate of gastric emptying (kcal/min) 1, +   1.00.1  1.50.1   0.90.0  1.20.0 
Early phase rate of gastric emptying 1 +   1.40.1.  2.30.1   1.30.1  1.70.3 
Late phase rate of gastric emptying 1 +   0.30.1  1.00.2   0.50.1  1.00.1 
Amount emptied at 60 min (%) +  951  724  493  933  656  376 
Amount emptied at 180 min (%) +, *  1000a  981a  865b  991a 1000a  753b 
All values are mean  SEM. Effects of gender and protein-load and interaction effects were determined by repeated-measures ANOVA. 
1 Rate of gastric emptying was calculated as mean of rates of emptying during each 15-min interval respectively of the early phase (i.e. 0-60 min), the 
late phase (i.e. 60 min until 100% emptying time per individual) and total time period (i.e. 0 min until 100% emptying time per individual). + P < 0.001 
Effect of protein load. P ≤ 0.1. * P < 0.005 Interaction effect of gender by protein-load: amount emptied at 180 min 




Table 10.2: Concentrations of glucose, insulin, glucagon, ghrelin, cholecystokinin (CCK), gastric inhibitory polypeptide (GIP) and glucagon-like 
peptide-1 (GLP-1) 
A Gender effect  B Protein-load effect 
 Men Women Average  Control 30g protein 70g protein Average 
60 min         
   Glucose 4.9 ± 0.1 5.3 ± 0.1   5.5 ± 0.1a 4.8 ± 0.2b 5.0 ± 0.1b  
   Insulin   14.4 ± 1.5  4.0 ± 0.5a 18.3 ± 2.3b 20.9 ± 2.3b  
   Glucagon  132 ± 12 96 ± 6   62 ± 3a 134± 11b 145 ± 12b  
   Ghrelin   1319 ± 180  1563 ± 236a 1230 ± 179b 1165 ± 130b  
   CCK 6.3 ± 0.7 3.8 ± 0.3   3.5 ± 0.4a 5.4 ± 0.6b 6.2 ± 0.7b  
   GIP   24.2 ± 1.3  10 ± 1a 31 ± 2b 31 ± 2b  
   GLP-1 32.4 ± 3.1 21.4 ± 1.2   20 ± 2a 29 ± 3b 32 ± 2c  
180 min         
   Glucose 5.0 ± 0.1 5.6 ± 0.2      5.3 ± 0.1 
   Insulin 5.1 ± 1.2 7.6 ± 0.7   3.6 ± 0.4a 3.5 ± 0.4a 11.9 ± 1.6b  
   Glucagon  99 ± 6 84 ± 6   59 ± 3a 71 ± 7b 145 ±10c  
   Ghrelin   1477 ± 253  1713 ± 294a 1633 ±281a 1085 ± 194b  
   CCK 4.8 ± 0.5 3.1 ± 0.2   3.1 ± 0.3a 3.4 ± 0.4a 5.3 ± 0.4b  
   GIP   19.2 ± 1.2  7 ± 1a 19 ± 1b 31 ± 2c  
   GLP-1 35 ± 3 23 ± 1   20 ± 2a 28 ± 2b 38 ± 3c  
         
       
C Interaction effect 
 Men Women 
 Control 30 g protein 70 g protein Control 30 g protein 70 g protein 
60 min       
   Glucagon 65±5*,a 154±18*,b 177±15*,c 58±4a 115±10b 114±11b 
   GLP-1 23.0±2.4a 35.0±4.2b 39.1±3.0*,b 17.2±1.3a 22.5±1.4,b 24.7±1.4b 




   GIP 7.6±1.7*,a 19.6±1.8*,b 31.8±3.7c 5.9±1.9a 21.4±2.2b 32.9±3.9c 
Main gender (A) and protein-load effects (B), and interaction effects (C) of gender by protein-load for mean ( SEM) 60-min and 180-min concentrations 
of blood glucose (mmol/L) and plasma insulin (mU/L), glucagon (pg/mL), ghrelin (pg/mL), cholecystokinin (CCK; pmol/L), gastric inhibitory 
polypeptide (GIP; pmol/L) and glucagon-like peptide-1 (GLP-1; pmol/L) in healthy young men (n = 8, n = 7 for GIP and GLP-1) and women (n = 8) 
after control (~2 kcal) and 30 g (120 kcal) or 70 g (280 kcal) protein loads. Results are presented separately for gender or protein-load if the main effect 
was significant, in case of non-significance the average was presented. Interaction effects of gender by protein-load are given if the effect was significant. 
Effects of gender and protein-load and interaction effects were determined by using repeated-measures ANOVA including baseline values at each 
treatment visit as a covariate and post hoc Bonferroni corrections. Post hoc effects: * P < 0.05: men vs. women; a,b,c P < 0.05: a different letter indicates 
a significant difference between drink-conditions within subject group.





This study examined the acute effects of oral whey protein ingestion on energy intake, 
perceptions of appetite and gastrointestinal symptoms, gastric emptying, blood glucose and 
plasma gut hormone concentrations in women and men. The current study is the first study 
we are aware of to compare the effect of gender on these parameters after pure protein intake. 
There was a load-dependent suppressive effect of protein on perceptions of hunger, desire 
to eat, prospective food consumption, and blood glucose and plasma ghrelin concentrations, 
slowing of gastric emptying, and increase of plasma insulin, glucagon, CCK, GIP and GLP-
1 concentrations. Hunger and energy intake were less in women than men. The major finding 
was that hunger and ad libitum energy intake were suppressed by the whey protein ingestion 
in men, but not women. Men had a 15% reduction in food intake at the buffet meal after the 
protein drinks, whereas there was no suppression in women. The suppression in men 
represented almost 100% compensation for the energy content of the protein drinks (206kcal 
reduction vs 200kcal mean energy content of the two protein drinks), whereas there was no 
compensation in women. Consequently, compared to intake on the control day, total energy 
intake (protein drink plus buffet test meal) was increased by the protein drinks in women 
(150 kcal [30%]), with no effect on total intake in men. The drinks emptied from the 
stomach more slowly and plasma glucagon, CCK and GLP-1 concentrations were less in 
women than men. 
There is evidence that protein has greater satiating effects than the other macronutrients 
(carbohydrate and fat (36-39)) and that enhanced protein diets can facilitate weight loss (40, 
287); protein diets are widely used for this purpose by both men and women trying to lose 
weight. There is also evidence, however, that men lose weight more easily than women on 
energy-restricted diets (342), and that women, when compared to men compensate less for 
energy intake after mixed macronutrient drinks (322) and semi-liquid (yoghurt) preloads 




(321). This may be due, at least in part, to the lower satiating effect of protein in young 
women than men we have demonstrated in the present study. The outcomes of this study 
may therefore have important implications for the types of dietary modifications 
recommended to promote weight loss in those trying to lose weight. Less emphasis on 
protein enrichment in women may be appropriate. 
Appetite and energy intake are dependent on the precise co-ordination of interrelated 
‘gastric’ and ‘small intestinal’ mechanisms triggered by the interaction with the nutrients 
ingested. Gastric emptying has an important role in mediating gut hormone release in 
response to protein, fat and carbohydrates (114, 273, 343, 344), and emptying of food content 
from the stomach itself is slowed by feedback mechanisms in the small intestine including 
the release of CCK and GLP-1 (345, 346). Gastric emptying was markedly and dose-
dependently slowed by the whey protein in this study, with the 50% gastric emptying time 
more than doubling from control to the 30 g protein day, and doubling again from the 30 g 
to 70 g protein day. Gastric emptying was completed earlier after the 30 g than the 70 g whey 
protein load, which resulted in a time-dependent response (earlier return to baseline after 30 
g vs. 70 g protein intake) in plasma concentrations of insulin, glucagon, ghrelin and CCK in 
men and women after 30 g vs. 70 g protein load. There was an immediate increase in plasma 
CCK and GIP concentrations, both mainly produced in the duodenum and proximal jejunum, 
reaching a plateau from 15-30 min onwards, while GLP-1, produced in the ileum more 
distally in the gut, showed a more constant increase. Rates of gastric emptying of the protein 
drinks were at the lower end of the normal range of gastric emptying i.e., 1-4 kcal/min (24, 
41-43), with faster gastric emptying rates during the 70 g compared to the 30 g protein loads. 
Our findings that gastric emptying was slower in women compared to men were similar to 
the results of most (83, 330-332), but not all, previous studies (80, 332). 
The findings of lower glucagon, CCK and GLP-1 concentrations after protein in women 
compared to men are consistent with previous reports that women have lower plasma 




concentrations of glucagon and GLP-1 after a mixed-nutrient liquid meal (335), but not after 
glucose (347), and of CCK after mixed-nutrient drinks (336), but not after corn oil (348), 
than men. Both CCK and GLP-1 suppress appetite and food intake (288), so the reduced 
response of these hormones to protein in women than men provides one possible explanation 
for the observed, reduced satiating effect of whey protein in women than men. In the present 
study  plasma insulin, ghrelin and GIP concentrations were comparable in men and women, 
consistent with most previous reports; for insulin after oral glucose (347, 349), insulin and 
ghrelin after mixed-nutrient ingestion (350), and insulin and GIP during intravenous glucose 
administration (349). Ghrelin concentrations have, however, also been reported to be higher 
in women than men after oral loads of glucose and lipids (351).  
It has been suggested that sex hormones may affect food intake (352). Pre-menopausal 
women are reported to have slower gastric emptying and lower appetite, food intake and 
plasma GLP-1 concentrations during the follicular than luteal phase, without changes in 
CCK concentrations (338). The young adult, pre-menopausal women in the present study 
were investigated during the follicular phase of the menstrual cycle, so it is possible that 
some of the differences between women and men observed (e.g. slower gastric emptying, 
lower GLP-1 concentrations) would have been less marked or absent if the women were 
examined during the luteal phase of their cycles. Similarly, we do not know if the reduced 
suppression of appetite and food intake by protein observed in this study in women compared 
to men persists into the luteal phase.  
Energy intake at the buffet meal was related to perceptions of appetite and plasma gut 
hormone concentrations immediately before the meal. Also energy intake at the buffet meal 
and perceptions of appetite were related to the rate of emptying of the whey protein drink 
from the stomach and plasma gut hormone responses, which were interrelated; the greater 
the increase in plasma insulin, glucagon, CCK, GIP and GLP-1 and decrease in ghrelin 
concentrations, the slower the drink emptied from the stomach within a subject – 70 g < 30 




g < 0 g – the lower the perceptions of appetite, and the lower the subsequent energy intake 
at the buffet meal. GIP was related to GLP-1 (r = 0.78, P < 0.001) while ghrelin (AUC 0-
180 min) was inversely related to insulin (r = -0.63, P < 0.001). 
Although our study has several limitations, including the relatively small number of subjects, 
the results appear clear-cut. The protein preload drinks were selected to be iso-caloric for 
both men and women. Women are expected to have lower energy requirements when 
compared to men, and the drinks given to female group in this study could, therefore, be 
considered to be ‘larger’ than those given to the male group when considered in relation to 
energy requirements. While the drinks were matched for taste, we did not assess the subject’s 
perceptions of taste, pleasantness and/or palatability of the drinks. Women were studied 
during the follicular phase of their menstrual cycle, and it is unsure whether the results can 
be translated to the luteal phase. Blood glucose was measured by a glucometer, which is less 
than optimal, however, the results appear to be clear-cut. 
In summary, in young healthy women, when compared to men, whey protein drinks emptied 
slower from the stomach, and plasma glucagon, CCK and GLP-1 concentrations were lower 
associated with less suppression of energy intake and hunger by whey. These findings have 
potential implications for the efficacy of ingesting whey or other proteins to decrease overall 
food intake and achieve voluntary weight loss in women. Further studies are needed to 
determine how broadly these findings apply to other settings, including the use of other 
proteins, while longer-term studies will be needed to determine the effects of ingesting whey 




Table 10.3: Within-subject correlations between perceptions of appetite and gastrointestinal symptoms, gastric retention and blood glucose and plasma 
gut hormone concentrations after intake of whey protein (30 g and 70 g) and control drinks in healthy young men and women 
 Hunger Desire to eat Prospective food 
consumption 
Fullness Nausea Bloating 
     r     P     r     P     r     P     r     P     r     P     r     P 
Gastric retention -0.39   0.024 -0.57  <0.001 -0.55   0.001 0.27   0.13  0.12   0.51  0.16   0.36 
Glucose -0.07 0.71 -0.17 0.35 -0.06 0.72  0.12 0.51  0.32 0.07  0.17 0.35 
Insulin -0.40 0.022 -0.51  0.003 -0.46 0.006  0.28 0.11  0.12 0.52  0.22 0.21 
Glucagon -0.41 0.017 -0.50  0.003 -0.49 0.003  0.30 0.08  0.12 0.49  0.16 0.39 
Ghrelin  0.44 0.011  0.50 0.003  0.46 0.008 -0.15 0.39 -0.10 0.59  0.00 1.00 
CCK -0.35 0.047 -0.40 0.021  -0.47 0.006  0.23 0.20  0.14 0.43  0.29  0.12 
GIP -0.39 0.025 -0.47 0.006 -0.48 0.004  0.18 0.32  0.01 0.94  0.11 0.55 
GLP-1 -0.51 0.002 -0.55  0.001 -0.51 0.002  0.32 0.07  0.24 0.18  0.23 0.19 
r and P values of within-subject correlations, determined by using a general linear model with fixed slope and random intercept, between perceptions of 
hunger, desire to eat, prospective food consumption, fullness, nausea, bloating [area under the curve (AUC 0-180 min) and blood glucose (mmol/L) and 
plasma insulin (mU/L), glucagon (pg/mL), ghrelin (pg/mL), CCK (pmol/L), GIP (pmol/L) and GLP-1 (pmol/L) concentrations (AUC 0-180 min) in 
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Background: Protein-rich supplements are used widely to prevent and manage undernutrition 
in older people. We have previously shown that healthy older, compared to younger, adults 
have less suppression of energy intake by whey protein—although the effects of age on 
appetite-related gut hormones are largely unknown. 
Objective: To determine and compare the acute effects of whey protein loads on blood 
glucose and plasma gut hormone concentrations in older and younger adults. 
Design: Sixteen healthy older (eight men, eight women; mean ± SEM: age: 72 ± 1 years; body 
mass index: 25 ± 1 kg/m2) and 16 younger (eight men, eight women; 24 ± 1 years; 23 ± 0.4 
kg/m2) adults were studied on three occasions in which they ingested 30 g (120 kcal) or 70 g 
(280 kcal) whey protein, or a flavoured-water control drink (~2 kcal). At regular intervals over 
180 min, blood glucose and plasma insulin, glucagon, ghrelin, cholecystokinin (CCK), gastric 
inhibitory peptide (GIP), and glucagon-like peptide-1 (GLP-1) concentrations were measured. 
Results: Plasma ghrelin was dose-dependently suppressed and insulin, glucagon, CCK, GIP, 
and GLP-1 concentrations were dose-dependently increased by the whey protein ingestion, 
while blood glucose concentrations were comparable during all study days. The stimulation of 
plasma CCK and GIP concentrations was greater in older than younger adults. 
Conclusions: In conclusion, orally ingested whey protein resulted in load-dependent gut 









Despite the well-recognised major adverse impact of nutritional impairment on the health of 
the elderly, including ageing-related muscle loss (190), and related increase in the use of 
high-energy drinks, usually rich in whey protein, few nutritional studies have involved older 
people. We have recently reported that healthy older, compared to younger, adults have less 
suppression of energy intake by whey protein, ether ingested orally (263) or infused directly 
into the proximal small intestine (194). 
Appetite, energy intake, and blood glucose regulation are likely to be dependent on 
gastrointestinal mechanisms triggered by the interaction with the nutrients ingested. 
Mechanisms which reduce energy intake in younger adults include the stimulation of gut 
hormone secretion, e.g., cholecystokinin (CCK) and glucagon-like peptide (GLP-1), and the 
suppression of ghrelin. The incretin hormones gastric inhibitory polypeptide (GIP) and GLP-
1 play major roles in the control of plasma insulin, glucagon, and blood glucose 
concentrations in response to nutrient ingestion (353). We, and others, have reported that age 
affects gut hormone responses; healthy older, compared to younger, adults had higher CCK 
concentrations after overnight fasting, after mixed nutrient intake (42, 48), and during 
intraduodenal glucose and lipid infusions (53), in addition to higher insulin in response to 
intraduodenal glucose infusion (44), higher GIP after glucose ingestion (132, 135), and 
higher GLP-1 after an overnight fast (89, 132, 231) as well as after glucose (132) and mixed 
macronutrient intakes (231), while the reported effects of age on fasting and postprandial 
ghrelin after mixed macronutrient intakes are inconsistent (48, 52, 88, 89, 91). 
The aims of the study were to further determine the effects of oral whey protein loads on 
blood glucose and plasma insulin, glucagon, ghrelin, CCK, GIP, and GLP-1 concentrations 
in older as well as younger adults. We hypothesised that orally administered whey protein 




would result in load-related responses of glucose and gut hormones, and that these responses 
to whey protein would be greater in older than younger subjects. 
 
SUBJECTS AND METHODS 
Subjects 
Sixteen older adults (eight men and eight women, age: mean ± standard error of the mean 
(SEM): 72 ± 1 years; body weight: 70 ± 3 kg; height: 1.66 ± 0.02 m; body mass index (BMI): 
25 ± 1 kg/m2) and 16 younger adults (eight men and eight women, 24 ± 1 years; 68 ± 2 kg; 
1.71 ± 0.02 m; 23 ± 0.4 kg/m2) were included. The study protocol was approved by the Royal 
Adelaide Hospital Research Ethics Committee, and subjects provided written informed 
consent (clinical trial registration: ACTRN12612000941864). 
 
Protocol 
The protocol was identical to that of our previous studies comparing younger and older men 
(263), and older men and women (339) - results of blood glucose and plasma gut hormone 
concentrations in the healthy older women compared to men are published (339). The study 
had a randomised (using the method of randomly permuted blocks; 
www.randomization.com [16 subjects randomised in one block with random permutations)] 
double-blind cross-over design including three study days, separated by three to 14 days. 
Subjects consumed a standardised evening meal (beef lasagna (McCain Foods Pty Ltd., 
Wendouree, VIC, Australia), ~591 kcal) before the study days at ~19.00 h. They were 
instructed to fast overnight from solids and liquids thereafter and to refrain from strenuous 
physical activity. On the study day, subjects attended the laboratory at ~08.30 h and were 
seated in an upright position (263, 339). 




Subjects ingested drinks containing 30 g (120 kcal) or 70 g (280 kcal) whey protein or a 
control drink (~2 kcal) (263, 339). The drinks were prepared by a research assistant who was 
not involved in the data analysis of the study results, flavoured with diet lime cordial 
(Bickford’s Australia Pty Ltd., Salisbury South, SA, Australia), and served in a covered cup. 
 
Measurements 
Blood samples were collected, using an intravenous cannula, at 0, 5, 15, 30, 45, 60, 90, 120, 
150, and 180 min, into ice-chilled ethylenediaminetetraacetic acid (EDTA) coated tubes. No 
inhibitors were added (264). Plasma was obtained by centrifugation for 15 min at 3200 rpm 
at 4 °C and samples were stored at −80 °C. Ad libitum energy intake (kcal) was determined 
from a buffet-style meal (180–210 min) (263). Gastric emptying was determined from total 
gastric volume measurements by three-dimensional (3D) ultrasonography (Logiq™ 9 
ultrasound system, GE Healthcare Technologies, Sydney, NSW, Australia) (263). 
Blood glucose (millimoles per liter) was determined immediately after collection by the glucose 
oxidase method using a portable glucometer (Optium Xceed, Abbott Laboratories, Doncaster, 
VIC Australia). Intra- and inter-assay coefficients of variation were 3.2 and 10.8%. Plasma total 
insulin [milliunits per liter (mU/L)] was measured by enzyme-linked immunosorbent assay 
(ELISA) immunoassay (10-1113; Mercodia, Uppsala, Sweden). The minimum detectable limit 
was 1.0 mU/L. Intra- and inter-assay coefficients of variation were 3.0% and 8.7%. Plasma total 
glucagon [picogram per milliliter (pg/mL)], ghrelin (pg/mL), CCK-8 [picomoles per liter 
(pmol/L)], GIP (pmol/L), and GLP-1 (pmol/L) were measured by radioimmunoassay (RIA) 
(339). Minimum detectable limits were 20 pg/mL, 40 pg/mL, 1 pmol/L, 2 pmol/L, and 3 pmol/L. 
Intra- and inter-assay coefficients of variance were: insulin: 3.0% and 8.7%, glucagon: 4.3% and 
7.1%, ghrelin: 6.7% and 12.1%, CCK: 5.4% and 13.9%, GIP: 3.9% and 9%, GLP-1: 6.3% and 
10.3%. 





Data and Statistical Analysis 
Sixteen subjects per age group would allow detection of differences in the area under the 
curve (AUC) of the primary outcomes of 25,920 pg/mL.min ghrelin, 198 pmol/L.min CCK, 
and 1080 pmol/L.min GLP-1 between groups with power equal to 0.8 and alpha to 0.05. 
Statistical analyses were performed using SPSS software (version 22; IBM, Armonk, NY, 
USA). Effects of age and protein load and their interaction effect were determined using a 
repeated measures mixed-effect model, including baseline values as a covariate and 
Bonferroni’s post hoc correction. AUC was calculated from baseline to 180 min using the 
trapezoidal rule and peak/nadir as the largest change from baseline. Statistical significance 
was accepted at p < 0.05. All data are presented as means ± SEMs. 
 
RESULTS 
Baseline concentrations after an overnight fast of blood glucose (mean ± SEM; older and 
younger: 5.4 ± 0.1 and 5.4 ± 0.1 mmol/L), plasma glucagon (64 ± 4 and 68 ± 4 pg/mL), 
ghrelin (1438 ± 156 and 1507 ± 207 pg/mL), and GIP (13 ± 2 vs. 16 ± 2 pmol/L) were 
comparable between age groups (P > 0.05), while insulin was lower (older vs. younger: 3.3 
± 0.4 vs. 5.3 ± 0.6 mU/L, P = 0.006) and CCK (4.8 ± 0.6 vs. 3.3 ± 0.4 pmol/L, P = 0.033) 
and GLP-1 (32 ± 4 vs. 22 ± 2 pmol/L, P = 0.041) were higher in healthy older compared to 
younger adults. AUC ghrelin dose-dependently decreased and insulin, glucagon, CCK, GIP, 
and GLP-1 dose-dependently increased (Figure 11.1, post hoc effects: 30 g and 70 g vs. control, 
70 g vs. 30 g protein drink, all P < 0.01). Nadir glucose was lower (P = 0.005), and peak 
glucagon (P = 0.001) and GLP-1 (P = 0.001) were higher after 70 g compared to 30 g whey 
protein ingestion. Time to peak of glucagon was higher after 70 g compared to 30 g whey protein 
ingestion (P < 0.001). Plasma gut hormone concentrations were related (ghrelin positively, and 
insulin, glucagon, CCK, GIP, and GLP-1 negatively) to energy intake (energy intake after 0 g, 




30 g, and 70 g whey protein intake: younger: 1082 ± 106 kcal, 963 ± 79 kcal, 948 ± 82 kcal; 
older: 843 ± 77 kcal, 803 ± 75 kcal, 793 ± 78 kcal) and gastric emptying (younger and older men 
(263) and older men and women (339) published previously; Table 11.1). 
Older compared to younger adults had higher AUC and peak concentrations and time to peak 
of CCK (AUC: P = 0.031; older vs. younger: peak: 5.0 ± 0.7 pmol/L vs. 3.3 ± 0.3 pmol/L, 
P = 0.007; time to peak: 95 ± 12 min vs. 65 ± 8 min, P = 0.046) and GIP (AUC: P = 0.036; 
peak: 17.8 ± 2.7 pmol/L vs. 16.6 ± 1.4 pmol/L, P = 0.028; time to peak: 132 ± 11 min vs. 
101 ± 9 min, P = 0.037). AUC interaction effects of age by protein load were not significant. 
 
Table 11.1: Correlations between gut hormones, energy intake and gastric emptying 
 Energy intake Gastric emptying (T50) 
 r P r P 
Insulin -0.41 0.001 0.80 <0.001 
Glucagon -0.34 0.005 0.81 <0.001 
Ghrelin 0.36 0.003 -0.53 <0.001 
CCK -0.33 0.008 0.77 <0.001 
GIP -0.32 0.008 0.75 <0.001 
GLP-1 -0.31 0.011 0.68 <0.001 
r and P values of within-subject correlations between energy intake [control (~2kcal), 30 g 
(120 kcal) and 70 g (280 kcal) whey protein intake: younger n = 16: 1082 ± 106 kcal, 963 ± 
79 kcal, 948 ± 82 kcal; older n = 16: 843 ± 77 kcal, 803 ± 75 kcal, 793 ± 78 kcal), gastric 
empting half time [T50; control, 30 and 70 g whey protein intake: younger n = 16: 16 ± 1 
min, 32 ± 3 min, 85 ± 10 min; older n = 15: 23 ± 2 min, 65 ± 7 min, 130 ± 10 min] and 
concentrations (AUC 0-180 min) of blood glucose (mmol/L) and plasma insulin (mU/L), 
glucagon (pg/mL), ghrelin (pg/mL), CCK (pmol/L), GIP (pmol/L) and GLP-1 (pmol/L) in 
younger and older adults. Within-subject correlations were determined by using a general 
linear model with fixed slope and random intercept. 
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Figure 11.1: Mean and area under the curve ( SEM) values of blood glucose and plasma 
insulin, glucagon, ghrelin, CCK, GIP and GLP-1 concentrations in younger (n = 16) and 
older (n = 16) adults after 30 g (120 kcal; dashed line with closed circles) or 70 g (280 kcal; 
solid line with closed circles) whey-protein ingestion or control (~2 kcal; dashed line with 




open circles). Main effects of age and protein load and the interaction effect of age by protein 
load were determined using a mixed-effect model with baseline concentrations as a 
covariate. 
* P ≤ 0.005, protein load effect: AUC blood glucose and plasma ghrelin dose-dependently 
decreased and plasma insulin, glucagon, CCK, GIP and GLP-1 dose-dependently increased 
after whey protein ingestion. 




This study examined the influence of age on the acute effects of orally ingested whey protein 
on blood glucose and plasma gut hormone concentrations in healthy adults. Plasma ghrelin 
was dose-dependently suppressed, while insulin, glucagon, CCK, GIP and GLP-1 
concentrations were dose-dependently increased by the whey protein ingestion. Our 
observations extend the previously reported data of the acute effects of orally ingested whey 
protein on plasma insulin, glucagon, ghrelin, CCK, GIP, and GLP-1 concentrations in young 
adults (334, 354). The protein load effects were particularly evident after ~60 min, when the 
majority of the dose of 30 g whey protein had emptied from the stomach (339); plasma 
concentrations returned to baseline after 30 g, while they remained at their maximal 
increase/decrease after 70 g whey protein intake. 
Our findings confirmed earlier reports that older, when compared to younger, adults have 
higher plasma CCK (42, 48, 53) and GLP-1 (132, 231) concentrations after an overnight fast, 
while fasting insulin concentrations were reduced in our study in healthy adults. Age also 
affected CCK and GIP, but not insulin, responses following whey protein ingestion; as 
previously reported after mixed macronutrient ingestion for CCK (42, 48) and oral, but not 
intraduodenally infused (133), glucose ingestion for GIP (132, 135), glucose, and insulin 
(44, 133), postprandial concentrations were greater. The higher plasma CCK and GIP 
concentrations in older rather than younger adults may be related to differences in the small 
intestinal transit of the whey protein, and clearance including GIP inactivation by dipeptidyl 




peptidase IV (DPP-IV) and renal processes (132). The higher incretin hormone GIP response 
following whey protein ingestion in older compared to younger adults is likely to be 
beneficial for glycemic control in older people. 
The causes of the age-related reduction in the suppression of energy intake by nutrients 
observed in this and other studies must include altered responses to the presence of nutrients 
in the small intestine, because the reduced suppression is observed after intraduodenal (194) 
as well as oral nutrient administration (46, 48, 263). CCK is a anorexigenic hormone and acts 
to suppress hunger and food intake (355). We have reported previously that older, when 
compared to younger, age in healthy subjects is associated with at least preserved, and possibly 
even increased, sensitivity to the satiating effects of exogenously administered CCK (43). 
Because plasma fasting and post-protein CCK concentrations were higher in older compared 
to young subjects in the present and previous studies, it is perhaps surprising that these higher 
concentrations were associated with reduced, not increased, protein-induced suppression of 
energy intake in the healthy older compared to young adult subjects (194, 263). It is possible 
that the test meal may have been given too late at 3 hours to assess the full effect of CCK 
changes, as plasma concentrations had returned to baseline by then after all but the highest 
whey protein load. Nevertheless, these findings are consistent with our previous finding that 
under-nourished older people have higher fasting and post-nutrient CCK concentrations in 
comparison to well-nourished older people, but reduced nutrient-induced suppression of food 
intake compared to well-nourished older people (48). Together, these findings suggest that 
age-related changes in CCK (circulating concentrations and/or action) are unlikely to 
contribute much, if anything, to the age-related reduction in food intake after the ingestion of 
protein and other nutrients. 
The findings of this study do not exclude a role for GLP-1 or GIP in the lesser suppression 
of food intake by whey protein in healthy older subjects. Baseline circulating concentrations 
of the anorexigenic hormone GLP-1 were significantly higher in older compared to younger 




subjects, with no difference between age groups in the subsequent whey protein-induced 
rise, consistent with responses during intraduodenal infusions of lipid and glucose (53). The 
higher baseline GLP-1 levels may have acted to further inhibit the suppression of appetite 
and thus food intake after whey protein ingestion. GLP-1 is mainly secreted more distally in 
the gastrointestinal tract (i.e., ileum and colon) than CCK and GIP (expressed mainly in the 
duodenum and jejunum), and the GLP-1 concentrations following whey protein ingestion 
increased more slowly than CCK and GIP concentrations. The emptying of food content 
from the stomach is slowed down by feedback mechanisms in the intestines including the 
release of CCK and GLP-1 (345, 346); indeed, gastric emptying of the whey protein was 
slower in the older compared to younger adults (263). Although the effect of GIP on human 
appetite and food intake, if any, is not clear, there is limited animal evidence to suggest it 
may act to stimulate food intake; GIP receptor-deficient mice are resistant to diet-induced 
obesity (356). The greater increase in circulating GIP concentrations after whey protein in 
healthy older compared to younger subjects might therefore act to reduce the protein-induced 
suppression of food intake. More studies will be required to investigate the role of these 
hormones in age-related feeding changes. Also, psychological factors, including increased 
dietary restraint, particularly in women (357), may affect the short-term energy intake 
regulation of older adults. 
Healthy older and younger adults had comparable plasma ghrelin concentrations following 
whey protein ingestion, consistent with responses to mixed-nutrient intake in some (88, 89) 
but not all previous studies (48, 52, 91). It has been suggested that aging-related changes in 
body composition (i.e., a decrease in lean mass and increase in fat mass) may act to decrease 
fasting (92) and postprandial (48) ghrelin concentrations, as body fat is negatively correlated 
to ghrelin concentrations (295) and tends to increase with older age. Other studies, however, 
have found higher postprandial and fasting ghrelin concentrations in older adults than those in 




younger adults and impaired suppression of ghrelin after the consumption of a mixed-nutrient 
meal in older compared to younger subjects (52, 91). 
This study has several limitations, including the relatively small subject numbers. Total 
ghrelin instead of active ghrelin was measured, which could be considered to be less than 
optimal; however, the results appeared to be clear-cut, with significant dose-dependent 
suppressive effects of the protein loads on ghrelin in the direction expected. 
The finding that plasma gut hormone responses to whey protein are not blunted in healthy 
older compared to younger men is likely to have implications to the composition of dietary 
supplements for older people, and warrants further research to their relation to food intake 
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Background Protein-rich supplements are used widely for the management of malnutrition 
in the elderly. We reported previously that the suppression of energy intake by whey protein 
is less in older than younger adults.  
Objective: To determine the effects of substitution, and adding of carbohydrate and fat to 
whey protein, on ad libitum energy intake from a buffet meal (180–210 min), gastric 
emptying (3D-ultrasonography), plasma gut hormone concentrations (0–180 min) and 
appetite (visual analogue scales), in healthy older men. 
Design In a randomised, double-blind order, 13 older men (75 ± 2 years) ingested drinks 
(~450 mL) containing: (i) 70 g whey protein (280 kcal; ‘P280’); (ii) 14 g protein, 28 g 
carbohydrate, 12.4 g fat (280 kcal; ‘M280’); (iii) 70 g protein, 28 g carbohydrate, 12.4 g fat 
(504 kcal; ‘M504’); or (iv) control (~2 kcal).  
Results: The caloric drinks, compared to a control, did not suppress appetite or energy 
intake; there was an increase in total energy intake (drink + meal, p < 0.05), which was 
increased most by the M504-drink. P280- and M504-drink ingestion were associated with 
slower a gastric-emptying time (n = 9), lower ghrelin, and higher cholecystokinin (CCK) 
and glucagon-like peptide-1 (GLP-1) than M280 (P < 0.05). Glucose and insulin were 
increased most by the mixed-macronutrient drinks (P < 0.05).  
Conclusions: In conclusion, energy intake was not suppressed, compared to a control, and 
particularly whey protein, affected gastric emptying and gut hormone responses. 
 
  





Over recent decades, the prevalence of malnutrition, both under-nutrition and obesity, has 
increased in older men and women in Western societies (285, 319). A growing awareness of 
the prevalence and adverse effects of the major muscle loss that occurs during aging, 
irrespective of body mass index (BMI, kg/m2) - e.g., reduced functional capacity and 
decreased quality of life (190, 285, 358)- has led to the development of nutritional strategies 
designed specifically to preserve and/or restore skeletal muscle mass and function. A 
‘common’ strategy is the use of supplements, which are usually high-energy drinks rich in 
whey protein (26, 27, 35, 286, 320). 
Despite this increasing use of protein-rich drinks, information about their effects on energy 
intake and underlying gastrointestinal mechanisms in older people is limited. In younger 
adults, preloads high in protein suppress appetite and energy intake (36, 359-363) more than 
iso-caloric preloads high in fat or carbohydrate. In young adults, variations in gut hormone 
secretion and/or action [e.g., ghrelin, cholecystokinin (CCK) and glucagon-like polypeptide-
1 (GLP-1)], as well as gastric emptying, are likely to regulate energy intake (70, 112-114, 
234, 237, 288). 
Compared to younger adults, healthy older people exhibit decreased taste and food 
palatability, are less hungry and fuller during the fasting and postprandial states, and 
consume less food and energy (315). This has been termed the ‘anorexia of aging’ (190, 
358). Healthy aging is also associated with reduced responsiveness to the suppressive effects 
of nutrients on appetite and energy intake (46, 63, 194, 263). We have recently demonstrated 
that acute administration of 30 g (120 kcal), and 70 g (280 kcal) whey protein drinks, 180 
min before a meal, suppressed subsequent energy intake by 12–17% in young, but without 
suppression in healthy older, men (263) so that in older men protein ingestion increased total 
energy intake (drink plus energy intake) compared to a control (~0 kcal) to a greater extent 




than in the young men. Gastric emptying of the whey protein drink was shown to be slower 
in older than younger men (263). In young adults, gastric emptying of 500 mL of protein 
(375 kcal) has been reported to be comparable to carbohydrate (400 kcal) or fat (375 kcal), 
when expressed as the rate of emptying in mL/min (364), as well as slower when ingested 
as a mixed macronutrient dairy breakfast (high-protein compared to high-carbohydrate; 
~400 kcal) (365). The high-protein dairy breakfast had higher plasma CCK and GLP-1 
responses - gut hormones known to slow gastric emptying (365). 
The aim of this study was to determine the effects of substitution and addition of 
carbohydrate and fat to whey protein on ad libitum energy intake at a buffet meal, gastric 
emptying, gut hormones and perceptions of appetite and gastrointestinal symptoms, in 
healthy older men. We hypothesised that the replacement of protein by carbohydrate and fat 
would result in less suppression of subsequent energy intake, more rapid gastric emptying, 
more pronounced changes in plasma gut hormone concentrations (insulin, ghrelin, CCK, 
GLP-1), and that the addition of carbohydrate and fat would result in greater suppression of 
subsequent energy intake, slower gastric emptying, more pronounced changes in plasma gut 
hormone concentrations and decreased perceptions of appetite, compared to a ‘pure’ whey—
protein drink. 
 
SUBJECTS AND METHODS 
Subjects 
Thirteen older healthy men, 65 years or older [mean ± standard error of the mean (SEM); 
age: 75 ± 2 years; body weight: 79 ± 2 kg; height: 1.75 ± 0.01 m; BMI: 26 ± 1 kg/m2], were 
recruited by advertisement. Subjects were excluded if they failed to comprehend the study 
protocol, had donated blood in the 12 weeks prior to the study days, had known lactose 
intolerance or food allergies, or were undernourished [score < 24 on the Mini Nutritional 




Assessment (276)]. Further exclusion criteria were low plasma ferritin levels, diabetes, 
gallbladder or pancreatic disease, significant gastrointestinal symptoms (abdominal pain, 
gastro-esophageal reflux, diarrhea, or constipation) or surgery, depression [score ≥ 11 on the 
Geriatric Depression Questionnaire (275)], alcohol abuse, smoking, use of illicit substances 
or medications known to potentially affect energy intake, or had impaired cognitive function 
[score < 25 on Mini Mental State (274)]. The Royal Adelaide Hospital Human Research 
Ethics Committee approved the study protocol and the study was conducted in accordance 
with the Declaration of Helsinki. The study is a sub-analysis of a larger study, which is 
registered as a clinical trial with the Australian New Zealand Clinical Trial Registry 
(www.anzctr.org.au; ACTRN12614000846628). All subjects provided written informed 
consent prior to their inclusion. 
 
Protocol 
Subjects were studied on 4 occasions, separated by 3–14 days, to determine the effects of 
drinks (~450 mL) containing either: (i) 70 g whey protein (280 kcal; ‘P280’); (ii) 14 g whey 
protein, 28 g carbohydrate, 12.4 g fat (280 kcal; ‘M280’); (iii) 70 g protein, 28 g carbohydrate, 
12.4 g fat (504 kcal; ‘M504’); or (iv) an iso-palatable control drink (~2 kcal; ‘control’) on 
energy intake, gastric emptying, gut hormones, and perceptions of appetite and 
gastrointestinal symptoms, in a randomised (using the method of randomly permuted blocks; 
www.randomization.com), double-blind, cross-over design. 
Drinks were prepared on the morning of the study day, by homogenizing olive oil (Bertolli 
Australia Pty Ltd., Unilever Australasia, Sydney, NSW, Australia) and dissolving whey 
protein isolate (Fonterra Co-Operative Group Ltd., Palmerston North, New Zealand) and 
dextrose, in varying volumes of demineralised water and diet lime cordial (Bickford’s 
Australia Pty Ltd., Salisbury South, SA, Australia), to achieve the desired composition, by a 




research officer (SH) who was not involved in the data analysis. Both the investigator and 
the subject were blinded to the treatment. The drinks were matched for taste and served in a 
covered cup. 
Before each study day, subjects consumed a standardised meal [beef lasagne (McCain Foods 
Pty Ltd., Wendouree, VIC, Australia), containing ~591 kcal], at ~19:00 p.m. Thereafter, 
subjects fasted overnight from solids and liquids until they attended the laboratory at ~08:30 
a.m. Subjects refrained from strenuous physical activity for 24 h before the study day. 
Subjects removed all metal objects and were seated in an upright position on a wooden chair. 
An intravenous cannula was inserted for blood sampling and subsequent measurement of 
glucose and gut hormones. In each subject, blood samples and ultrasound measurements of 
gastric volume, and perceptions of appetite and gastrointestinal symptoms were performed 
before (during fasting) and after ingestion of the drink, until 180 min. Subjects were 
instructed to consume the drink within 2 min. At 180 min, each subject was presented with 
a standard, cold, buffet-style meal, in excess of what they were expected to consume (total 
energy content of 2.457 kcal; 19% protein, 50% carbohydrates, 31% fat), in a room by 
themselves to limit external distractions, and were allowed to eat for 30 min (180–210 min) 




The buffet-style meal consisted of bread, chicken, ham, cheese, margarine, mayonnaise, 
yoghurt, custard, fruit, fruit salad, orange juice, iced coffee and water (263). The amount 
eaten at the meal (g) was quantified by weighing the food before and after consumption. 
Energy intake (kcal), as intake at the buffet meal, and as the cumulative energy intake, 
defined as the sum of energy intake at the buffet meal and the energy content of the preload 




drink, proportions of protein, carbohydrate and fat (Foodworks version 8; Xyris Software 
Pty Ltd., Spring Hill, QLD, Australia), and change in energy intake at the buffet meal 
(expressed as % of energy intake of the control day) by a given protein load, compared to 
the control, were calculated. 
 
Gastric emptying 
Total gastric volume was measured by a Logiq™ 9 ultrasound system (GE Healthcare 
Technologies, Sydney, NSW, Australia) with TruScan Architecture [built-in magnetically-
sensored 3D positioning and orientation measurement (POM)], including a 3D sensor, 
attached to a 3.5C broad spectrum 2.5–4 MHz convex transducer, and a transmitter, placed 
at the level of the stomach, immediately behind the subject, at 0, 5, 15, 30, 45, 60, 75, 90, 
105, 120, 135, 150, 165 and 180 min (264). The stomach was scanned along its longitudinal 
axis, whilst the subject was holding their breath and sitting still. Stomach volumes were 
calculated using EchoPAC-3Dsoftware (GE Vingmed Sound, Horten, Norway). Intragastric 
retentions were calculated as total gastric volume minus fasting gastric volume (baseline) at 
each time point, and expressed as percentage of the maximal gastric volume (100%). Data 
were imput by linear interpolation when ultrasound images lacked sufficient clarity (263). 
The rate of gastric emptying was calculated during each 15-min interval in the early phase 
(i.e., 0–60 min), and the late phase (i.e., 60 min until 100% emptying time per individual). 
Fifty percent of the gastric emptying time (T50; min) and ‘complete’ (residual volume of the 
drink in the stomach was ≤5%) gastric emptying time (100% gastric emptying time; T100; 
min) were calculated (263). 
 




Blood Glucose and Plasma Insulin, Ghrelin, Cholecystokinin (CCK) and Glucagon-
Like Peptide-1 (GLP-1) Concentrations 
Blood samples were collected, at 0, 5, 15, 30, 45, 60, 90, 120, 150, 180 min, into ice-chilled, 
EDTA-coated tubes. No inhibitors were added (264). Plasma was obtained by centrifugation 
for 15 min, at 3200 rpm, at 4 °C, and samples were stored at −80 °C for further analysis of 
hormone concentrations. 
Blood glucose (millimoles per liter) was determined immediately after collection, by the 
glucose oxidase method, using a portable glucometer (Optium Xceed, Abbott Laboratories, 
Sydney, NSW, Australia). Intra- and inter-assay coefficients of variation were 2.6% and 
15.2%. 
Total plasma insulin (milliunits per liter) was measured by enzyme-linked immunosorbent 
assay (ELISA) immunoassay (10-1113; Mercodia, Uppsala, Sweden). The minimum 
detectable limit was 1.0 mU/L. Intra- and inter-assay coefficients of variation were 3.0% and 
6.8%. 
Total plasma ghrelin (picograms per milliliter) was measured using a radioimmunoassay 
(RIA) with some modifications to a published method (323). The radiolabel was supplied by 
Perkin Elmer (NEX388, Boston, MA, USA). The standard and samples were incubated with 
the antibody and radiolabel for 3–4 days, at 4 °C. The detection limit was 40 pg/mL. Intra- 
and inter-assay coefficients of variation were 5.1% and 10.1%. 
Plasma CCK-8 (picomoles per liter) was measured by RIA, using an adaption of a previous 
method (324). Samples were extracted in 66% ethanol; extracts were dried down and re-
suspended in assay buffer (50 mM phosphate, 10 mM EDTA, 2 g/L gelatin, pH = 7.4). 
Standards were prepared using synthetic sulphated CCK-8 (Sigma Chemical, St Louis, MO, 
USA), antibody (C2581, Lot 105H4852, Sigma Chemical) was added at a working dilution 
of 1/17,500 and sulphated CCK-8 125I-labeled with Bolton and Hunter reagent (Perkin 
Elmer, Boston, MA, USA) was used as tracer. Incubation was for 7 days at 4 °C. The 




antibody bound fraction was separated by the addition of dextran-coated charcoal containing 
gelatin (0.015 g gelatin, 0.09 g dextran, 0.15 g charcoal in 30 mL assay buffer), and the 
radioactivity was determined in the supernatants following centrifugation. The detection 
limit was 1 pmol/L. The intra- and inter-assay coefficients of variation were 8.1% and 
11.5%. 
Total plasma GLP-1 (picomoles per liter) was measured by RIA (GLPIT-36HK; Millipore, 
Billerica, MA, USA), with a detection limit of 3 pmol/L. Intra - and inter -assay coefficients 
of variation were 2.7% and 7.1%. 
Peak/nadir and time to peak/nadir concentrations for glucose, insulin, ghrelin, CCK and 
GLP-1 were calculated for the caloric drink conditions. 
 
Perceptions of appetite and gastrointestinal symptoms 
Perceptions of hunger, desire to eat, prospective consumption, fullness, nausea and bloating 
were rated using a visual analogue scale (VAS) questionnaire at 0, 5, 15, 30, 45, 60, 75, 90, 
105, 120, 135, 150, 165, 180, 210 min (47). The questionnaire consisted of 100-mm 
horizontal lines, where 0 represented that the sensation was ‘not felt at all’ and 100 
represented that the sensation was ‘felt the greatest’. Subjects placed a vertical mark on each 
horizontal line to indicate the strength of each sensation at the specified time points.  
 
Data analysis 
On the basis of our previous work, with an observed within-subject standard deviation (SD) 
of 267 kcal for suppression of energy intake by whey protein, and 31 min for gastric 
emptying half time (263), we calculated that 13 subjects would allow detection of a within-
group difference between treatments for suppression in energy intake of 272 kcal and T50 
of 35 min, with power equal to 0.8 and alpha equal to 0.05. 




Statistical analyses were performed using SPSS software (version 22; IBM, Armonk, NY, 
USA). Differences between study conditions for energy intake, gastric emptying, 
perceptions of appetite and gastrointestinal symptoms (visual analogue scores) and glucose 
and hormone concentrations were determined using one-way repeated-measures ANOVA, 
with the treatment as the within-subject factor. Post hoc comparisons were adjusted with the 
Bonferroni method. Interaction effects of time by treatment, for concentrations of blood 
glucose and plasma insulin, ghrelin, CCK and GLP-1, and perceptions of hunger, desire to 
eat, prospective food consumption, fullness, nausea and bloating, were determined using a 
two-way repeated measures ANOVA, with treatment and time as the within-subject factors. 
Within-subject correlations were determined using a general linear model with fixed slope 
and random intercept (277). Areas under the curve (AUC) for gastric emptying, perceptions 
of appetite and gastrointestinal symptoms, and concentrations of glucose, insulin, ghrelin, 
CCK and GLP-1, were calculated from baseline to 60 min (i.e., ‘early’ phase of gastric 
emptying) and 60 to 180 min (i.e., ‘late’ phase of gastric emptying), using the trapezoidal 
rule. Peak/nadir and time to peak/nadir perceptions of hunger, desire to eat, prospective food 
consumption, fullness, nausea and bloating were calculated for the all conditions. 
Assumptions of normality were verified for all outcomes before the statistical analysis. 




The study protocol was well-tolerated by all subjects. Baseline gastric volumes (mean ± 
SEM of four study days: 33  4 mL), blood glucose (5.7 ± 0.1 mmol/L), plasma insulin (5.1 ± 
1.8 mU/L), ghrelin (1659 ± 165 pg/mL), CCK (2.0 ± 0.2 pmol/L) and GLP-1 concentrations (15 
± 1 pmol/L), and perceptions of hunger (31 ± 13 mm), desire to eat (30 ± 12 mm), prospective 




food consumption (46 ± 14 mm), fullness (2 ± 1 mm), nausea (3 ± 1 mm) and bloating (3 ± 
1 mm), were not different between study days. 
 
Energy intake 
Ad libitum energy intake at the buffet meal (Figure 12.1) and energy percentages of protein, 
carbohydrate and fat were not different between study days (mean of four study days: energy 
intake: 994 ± 76 kcal, P = 0.53; protein: 20 ± 0.4%, P = 0.60; carbohydrate: 52 ± 1%, P = 
0.25; fat: 30 ± 1% P = 0.83). There was no suppression of energy intake by the caloric drinks, 
compared to the control (P > 0.05). Total energy intake (drink plus meal) was higher after 
all caloric drinks, compared to the control (P < 0.001; post hoc tests versus control (972  
87 kcal): P280 (1300  95kcal) P < 0.001; M280 (1306  76 kcal) P = 0.003; M504 (1461  76 
kcal) P < 0.001). 
  
 
Figure 12.1: Left: mean [ standard error of the mean (SEM)] energy intake at the buffet 
meal (kcal) in healthy older men (n = 13) after drinks (~450 mL; energy content of the drink 
as the striped part of each bar) containing either: (i) 70 g whey protein (280 kcal; ‘P280’); (ii) 
14 g protein, 28 g carbohydrate, 12.4 g fat (280 kcal; ‘M280’); (iii) 70 g protein, 28 g 
carbohydrate, 12.4 g fat (504 kcal; ‘M504’); or (iv) an iso-palatable control drink (~2 kcal; 
‘control’). Right: mean (SEM) suppression of energy intake after caloric drinks (P280, M280 
and M504) compared to control. a,b p < 0.05 Total energy intakes (meal plus drink) for P280, 
M280 and M504 (b) were higher compared to the control (a). 
 
Gastric emptying 
In four subjects, the quality of ultrasound stomach images was insufficient to determine 
gastric emptying in one or more conditions, and all data related to gastric emptying in these 




subjects were, therefore, excluded from the analysis. The control and the M280 drink 
emptied in an overall non-linear pattern, whereas the pattern of emptying of P280 and M504 
was linear (Figure 12.2). Gastric emptying of P280 and M504 was slower (P < 0.001), and 
gastric retention greater (P < 0.001), than M280, with 50% gastric emptying times being 
~three-fold higher (P < 0.001, Table 12.1). 
 
 
Figure 12.2: Mean (  SEM) gastric retention (%) in healthy older men (n = 9), after 
drinks containing either: (i) 70 g whey protein (280 kcal; ‘P280’; dashed line with open 
circles); (ii) 14 g protein, 28 g carbohydrate, 12.4 g fat (280 kcal; ‘M280’; solid line with 
open circles); (iii) 70 g protein, 28 g carbohydrate, 12.4 g fat (504 kcal; ‘M504’; solid line 
with closed circles); or (iv) an iso-palatable control drink (~2 kcal; ‘control’; dotted line). 
Gastric emptying half time (T50) was higher after P280 and M504, compared to M280 and 
control (*P < 0.05). 
 
Table 12.1: Gastric emptying parameters after drink ingestion in healthy older men 
Gastric emptying parameters Control P280 M280 M504 
50% emptying time (T50; min) 12  2 a 78  11 b 26  2 a 93  13 b 
100% emptying time (T100; 
min) 
58  7 a 180  0 b 120  8 c 170  7 b 
Gastric retention (%)     
     AUC0-60min 1546  200 a 4666  222 b 2979  83 c 4871  240 b 
     AUC60-180min 94  42 a 3907  559 b 552  122 c 4331  771 b 
Rate of gastric emptying (kcal/min) 1 
     Early phase  2.0  0.3 a 3.7  0.1 b 3.1  0.6 b 
     Late phase  1.1  0.1a 1.3  0.3 a 2.2  0.3 b 
Amount emptied (%) 
     at 60 min 98  1 a 61  11 b 86  4 a 56  12 b 
     at 180 min 100  0 a 89  3 b 100  0 a 85  5 b 
** * *
 




Mean ( SEM) 50% and 100% emptying time (min), gastric retention (%), rate of gastric 
emptying (kcal/min) and amount emptied (%) at 60 and 180 min in healthy older men (n = 
9), after drinks containing either: (i) 70 g whey protein (280 kcal; ‘P280’); (ii) 14 g protein, 
28 g carbohydrate, 12.4 g fat (280 kcal; ‘M280’); (iii) 70 g protein, 28 g carbohydrate, 12.4 
g fat (504 kcal; ‘M504’); or (iv) an iso-palatable control drink (~2 kcal; ‘control’). 
1 The rate 
of gastric emptying was calculated as the mean of rates of emptying during each 15-min 
interval, respectively, in the early phase (i.e., 0–60 min) and late phase (i.e., 60 min until 
100% emptying time per individual). Different letters indicate a significant difference (P < 
0.05) between drink conditions; gastric emptying time and retention and amount emptied 
were higher after P280 and M504 (
b) than M280 (
a,c) and control (a), rate of gastric emptying 
was higher after M504 (
b) and M280 (




Blood glucose concentrations increased after M280 and M504, returned to baseline ~60 min, 
and stayed below baseline until the buffet meal (interaction effect of time by drink condition: 
P < 0.001). Peak glucose concentrations were higher after M280 and M504, compared to P280 
(P = 0.001, Table 12.2). Early phase AUC0–60 min glucose concentrations were higher after 
M280 and M504, compared to the control, and after M280, compared to P280 (P < 0.001, Figure 
12.3). Late phase AUC60–180 min glucose concentrations were lower after M280 than the control 
(drink condition effect: P < 0.001). Glucose concentrations at 180 min were lower after M280 
compared to control and M504 (P = 0.003). 
 
Insulin 
Plasma insulin concentrations increased after all caloric drinks (P280, M280 and M504; 
interaction effect of time by drink condition: P = 0.038). The mixed-macronutrient drinks 
evoked a rapid increase in insulin, insulin peak concentrations were higher after M280 and 
M504 compared to P280 (P < 0.001, Table 12.2), and the drinks containing 70 g of whey 
protein (P280 and M504) remained elevated (Figure 12.3). Early phase AUC0–60 min insulin 
concentrations were higher after M504, compared to P280 (P = 0.008). 
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Figure 12.3: Mean ( SEM) concentrations of blood glucose and plasma insulin, ghrelin, 
cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1) in healthy older men (n = 13), 
after drinks containing either: (i) 70 g whey protein (280 kcal; ‘P280’; dashed line with open 
circles); (ii) 14 g protein, 28 g carbohydrate, 12.4 g fat (280 kcal; ‘M280’; solid line with open 
circles); (iii) 70 g protein, 28 g carbohydrate, 12.4 g fat (504 kcal; ‘M504’; solid line with 
closed circles); or (iv) an iso-palatable control drink (~2 kcal; ‘control’; dotted line). There 
was an interaction effect of time by drink condition for concentrations of blood glucose (P 
< 0.001), insulin (P = 0.038), ghrelin (P < 0.001), CCK (P < 0.001) and GLP-1 (P < 0.001). 
Different letters indicates significant difference (P < 0.05) in area under the curves (0–60 or 
60–180 min) between drink-conditions: control vs. P280 vs. M280 vs. M504. 
 





Plasma ghrelin concentrations decreased after all caloric drinks (P280, M280 and M504; 
interaction effect of time by drink condition: P < 0.001). Nadir ghrelin concentrations were 
lower after P280 and M504, compared to M280, (P = 0.001, Table 12.2), and remained 
suppressed after P280 and M504 (Figure 12.3). Late phase AUC60–180 min ghrelin 
concentrations were lower after all caloric drinks, compared to the control, and after P280 
and M504, compared to M280 (P < 0.001). Ghrelin concentrations at 180 min were lower 
after M504 and P280, compared to the control and M280 (P < 0.001). 
 
CCK 
Plasma CCK concentrations increased after all caloric drinks (P280, M280 and M504; 
interaction effect of time by drink condition: P < 0.001). Peak CCK concentrations were 
higher after P280 and M504, compared to M280 (P < 0.001, Table 12.2), and remained elevated 
after P280 and M504 (Figure 12.3). Early phase AUC0–60 min CCK concentrations were higher 
after the caloric drinks, compared to the control (P < 0.001). Late phase AUC60–180 min CCK 
concentrations were higher after the caloric drinks, compared to the control, and after P280 
and M504, compared to M280 (P < 0.001). CCK concentrations at 180 min were higher after 
P280 and M504, compared to the control and M280 (P < 0.001). 
 
GLP-1 
Plasma GLP-1 concentrations increased after all caloric drinks (P280, M280 and M504; 
interaction effect of time by drink condition: P < 0.001, Figure 12.3). Early phase AUC0–60 
min GLP-1 concentrations were higher after P280 and M504, compared to the control and M280 
(P < 0.001). Late phase AUC60–180 min GLP-1 concentrations were higher after all caloric 
drinks, compared to the control, and after P280 and M504, compared to M280 (P < 0.001). GLP-




1 concentrations at 180 min were higher after the caloric drinks, compared to the control, 
and after P280 and M504, compared to M280 (P < 0.001). 
 
Perceptions of appetite and gastrointestinal symptoms 
Early phase AUC0–60 min and late phase AUC60–180 min perceptions of hunger, desire to eat, 
prospective food consumption, fullness, nausea, and bloating were not different between 
study days (P > 0.05, Figure 12.4). Hunger (mean decrease over four study visits: 9 ± 2 mm, 
time to nadir: 29 ± 7 min, time effect: P < 0.001), desire to eat (9 ± 1 mm, 21 ± 5 min, P < 
0.001) and prospective food consumption (11 ± 2 mm, 35 ± 7 min, P < 0.001) initially 
decreased after drink ingestion and increased thereafter to ratings higher than baseline, 
immediately before the buffet meal (180 min). Fullness (mean increase over four study days: 
16 ± 5 mm, time to peak: 38 ± 8 min, P = 0.001) increased after the drink to return to baseline 
thereafter. Nausea and bloating did not change over time (nausea: P = 0.51, bloating: P = 
0.10). 
 
Correlations between gastric retention and hormones  
Plasma insulin (AUC 0–180 min; r = 0.41 P = 0.029) ghrelin (r = −0.70 P < 0.001), CCK (r 
= 0.76 P < 0.001) and GLP-1 (r = 0.78 P < 0.001) concentrations were, within subjects, 
related to gastric emptying (AUC 0–180 min). 
  




Table 12.2: Glucose, insulin, ghrelin, CCK and GLP-1 after drink ingestion in healthy 
older men 
 Control Protein280kcal Mixed280kcal Mixed504kcal 
Peak/nadir concentration     
     Glucose 5.9±0.1a 6.1±0.1a,b 7.4±0.3b 7.2±0.3b 
     Insulin 7±3a 39±17a,b 56±18a,b 67±18b 
     Ghrelin 2171±240a 1855±183a 2194±251b 1862±198b 
     CCK 2.7±0.2a 3.9±0.3b 3.1±0.3a,b 3.9±0.3b 
     GLP-1 19±1a 39±3b 25±2a 36±3b 
Time to peak/nadir     
     Glucose 42±13 20±5 29±3 22±2 
     Insulin 15±3a 53±7b 39±3b 44±7b 
     Ghrelin 44±13a 126±14b 58±7a 114±18b 
     CCK 39±15a 87±16a,b 45±12a,b 99±16b 
     GLP-1 87±22a 138±13a,b 98±18a,b 155±7b 
180-min concentration     
     Glucose 5.5±0.1a 5.3±0.4a 4.9±0.4b 5.5±0.4a 
     Insulin 3.9±1.9 21±13 3.8±1.6 32±9 
     Ghrelin 2069±257a 1302±137a,b 2091±259a 1254±117b 
     CCK 1.8±0.1a 3.0±0.2b 1.9±0.2a 3.0±0.3b 
     GLP-1 16±1a 35±2b 21±2a 33±3b 
Mean ( SEM) peak/nadir concentrations, time to peak/nadir (min) and 180-min 
concentrations of blood glucose and plasma insulin, ghrelin, CCK and GLP-1 in healthy 
older men (n = 13), after drinks containing either: (i) 70 g whey protein (280 kcal; ‘P280’), 
(ii) 14 g protein, 28g carbohydrate, 12.4 g fat (280 kcal; ‘M280’), (iii) 70 g protein, 28 g 
carbohydrate, 12.4 g fat (504 kcal; ‘M504’), or (iv) an iso-palatable control drink (~2 kcal; 
‘control’). a,b,c,d P < 0.05, post hoc test: different letter indicates significant difference 
between drink-conditions: control vs. P280 vs. M280 vs. M504. 
 




   
   
Figure 12.4: Mean ( SEM) visual analogue score (VAS, mm) of hunger, desire to eat, 
prospective food consumption, fullness, nausea and bloating in healthy older men (n = 13), 
after drinks containing either: (i) 70 g whey protein (280 kcal; ‘P280’; dashed line with open 
circles), (ii) 14 g protein, 28 g carbohydrate, 12.4 g fat (280 kcal; ‘M280’; solid line with open 
circles), (iii) 70 g protein, 28 g carbohydrate, 12.4 g fat (504 kcal; ‘M504’; solid line with 
closed circles), or (iv) an iso-palatable control drink (~2 kcal; ‘control’; dotted line). Effects 
of time were significant for hunger (P < 0.001), desire to eat (P < 0.001), prospective food 
consumption (P < 0.001) and fullness (P = 0.001). 
 
DISCUSSION 
This study examined the effects of substituting fat and protein for, or adding them to, whey 
protein, on energy intake, gastric emptying, blood glucose and plasma gut hormone 
concentrations, perceptions of appetite and gastrointestinal symptoms in healthy older men. 
The major novel observation is that ingestion of a whey protein drink of 280 kcal (P280: 70 
g protein) or a mixed macronutrient drink of 504 kcal (M504: 70 g protein, 28 g carbohydrate, 
12.4 g fat,) was associated with slower gastric emptying, lower ghrelin, and higher CCK and 
GLP-1 concentrations than an iso-caloric mixed-macronutrient drink (M280: 14 g protein, 28 
g carbohydrate, 12.4 g fat: 280 kcal). There was no suppression of energy intake or appetite 
by the caloric drinks, compared to the control. 
The use of high protein supplements by older people is widespread, and increasing, in 
response to greater awareness of the prevalence of undernutrition and sarcopenia in older 

































function (20, 271). If timing and preparation are optimised, it may be possible to give 
sufficient protein [probably at least 35 g (23)] to older people, to preserve, or increase muscle 
mass and function, without suppressing energy intake. Indeed, our observations suggest that 
optimal protein administration may increase overall energy intake in older people. None of 
the caloric drinks suppressed subsequent ad libitum energy intake at a buffet meal, compared 
to a non-caloric control, and consequently, there was an increase in total energy intake. This 
observation is consistent with our recent finding that the suppression of subsequent energy 
intake by oral ingestion and intraduodenal infusions of whey protein is less in healthy older 
men (~1%) than in young controls (~15–19%) (194, 263). Total energy intake (drink plus 
meal) was predictably increased most by the drink with the highest energy content (504 kcal) 
- a substantial increase of ~50% or 490 kcal, compared with an increase of ~34% or ~330 
kcal after both 280 kcal drinks. Comparable amounts of protein could reasonably be given 
as protein supplements several times during the day. We have reported that variation in the 
timing of protein ingestion does not affect energy intake at a subsequent meal in healthy 
older people, and that total energy intake is higher on the protein days compared to a control 
(366). These findings raise the intriguing possibility that appropriately designed protein 
supplements, administered in divided doses, might increase energy intake in undernourished 
people by meaningful amounts (>300–500 kcal/day), without the need to encourage and 
supervise additional energy intake. 
We, and others, have shown that healthy aging is associated with modest slowing of gastric 
emptying of both solids and liquids, although the rate of emptying generally remains within 
the relatively wide normal range for young subjects (i.e., ~1–4 kcal/min) (50, 74, 82, 263). 
In healthy older men, the addition of 28 g carbohydrate and 12.4 g fat to the 70 g (280 kcal) 
whey protein did not affect gastric emptying time; both P280 and M504 had comparable T50 
and T100 and therefore, the rate of gastric emptying was higher for M504 than P280 (e.g., 
initial rates of gastric emptying of ~3 and 2 kcal/min, respectively). Iso-caloric substitution 




of 56 g (224 kcal) protein with carbohydrate and fat resulted in faster gastric emptying; M280 
compared to P280 had lower T50 and T100 and thus a faster rate of gastric emptying (~4 vs. 
2 kcal/min). 
The M280 drink had emptied completely, and P280 and M504 were ~90% emptied immediately 
before the meal. It should be appreciated that, as the subjects were seated, it is possible that, 
despite being mixed for ~45 min prior to, until immediately before, consumption, the fat 
(olive oil) separated from the protein/carbohydrate solution, and emptied from the stomach 
slower than the aqueous phase, by ‘layering’ on the denser aqueous components (367). 
The hormones, insulin, ghrelin, GLP-1 and PYY, are secreted by the gastrointestinal tract, 
in response to the ingested nutrients. Plasma gut hormone concentrations were, within 
subjects, related to gastric retention; lower ghrelin, and higher insulin, CCK and GLP-1 
concentrations correlated with slower gastric emptying. Both drinks containing 70 g protein 
(P280 and M504) had comparable gut hormone responses, which were greater than the 
responses evoked by the M280 drink. These observations suggest that in healthy older men, 
gastric emptying and plasma gut hormone concentrations were more likely dependent on the 
amount of protein, rather than the energy content of the drink. 
In young subjects, the addition of protein to a glucose meal increases the insulin response 
(368-370). It has been reported that whey protein, which has a high content of insulinotropic 
amino acids (371), resulted, when compared to casein protein, in a higher increase of plasma 
insulin concentrations (372). In our study, both mixed-macronutrient drinks evoked a rapid 
increase in plasma insulin concentrations, while insulin remained elevated for longer in the 
drinks containing 70 g of whey protein. Glucose concentrations immediately before the meal 
were lower after M280 than M504, which is likely related to the M504 drink still being emptied 
from the stomach. 
In young people, it has been reported previously that effects were larger and more sustained 
after high compared to low protein on ghrelin concentrations (39, 365, 373-375), protein 




compared to glucose (39, 365), but not fat (376), on CCK concentrations, and protein 
compared to carbohydrate (235, 365, 377, 378) or fat (377-379) - in several studies but not 
all studies (380-382) - on GLP-1 concentrations. In our study, the drinks containing 70 g of 
protein resulted in a comparably more sustained lower decrease in ghrelin concentrations 
and higher increases in CCK and GLP-1 than M280, which is likely to be related to the 
potency of the higher content of whey protein, and for the M504 drink, an additional caloric 
content. 
Our study has several limitations. The subject numbers were relatively small. This applies 
particularly to the gastric emptying measurements (n = 9). Nevertheless, the findings were 
clear-cut. We studied only men, as they appear to have the greatest ability to regulate energy 
intake in response to energy manipulation (46) and in women, particularly the menstrual 
cycle may have a confounding effect on appetite and energy intake. We have also recently 
reported that there is no effect of gender on gastric emptying, concentrations of glucose or 
gut hormones, perceptions of appetite and gastrointestinal symptoms in older people (339). 
Energy intake at the buffet meal was assessed three hours after drink ingestion, to allow for 
complete emptying of the drinks from the stomach, and not during the remainder of the 
day—accordingly, potential compensatory changes in energy intake after lunch were not 
evaluated. While the drinks were palatable and matched for taste, we did not assess the 
subjects’ perceptions of taste and/or pleasantness of the drinks. Blood glucose was measured 
by a glucometer, which is less than optimal; however, the results appeared clear-cut. 
A drink containing 70 g whey-protein (280 kcal), and a mixed-macronutrient drink 
containing 70 g protein, 28 g carbohydrate and 12.4 g fat (504 kcal), were associated with 
slower gastric emptying time, lower ghrelin, and higher CCK and GLP-1 concentrations than 
a mixed-macronutrient drink containing 14 g protein, 28 g carbohydrate and 12.4 g fat (280 
kcal). The caloric drinks did not suppress energy intake, compared to the non-caloric control 
and, consequently, there was an increase in total energy intake, particularly with the mixed-




macronutrient drink with the highest caloric content. Our findings are likely to have 
implications for the composition of protein-rich supplements, for both undernourished and 
obese older people as well as for targeting gastric emptying and gut hormone responses by 
preload intakes, in relation to, for example, glycemic control in older people. 
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CHAPTER 13: CONCLUSIONS OF THE THESIS 
  
Conclusions  Chapter 13 
   
 
285 
The studies included in this thesis provide novel insights into the acute effects of dietary 
whey protein ingestion on energy intake, perceptions of appetite and gastrointestinal 
symptoms, gastric emptying, blood glucose and plasma gut hormone concentrations (i.e. 
insulin, glucagon, ghrelin, CCK, GIP, GLP-1 and PYY) in healthy older and younger men 
and women. 
 
Collectively, the studies described in this thesis have produced clear-cut and exciting results 
– whey protein ingestion is less suppressive of feeding behaviour in healthy older than 
younger adults, and may even increase overall energy intake in the elderly. These findings 
will aid the development of ways to effectively increase energy and protein intake in older 
adults at risk of undernutrition. 
 
Suppression of energy intake by whey protein, compared to control, was shown to be less in 
healthy older than younger men after 60-min intraduodenal infusions (bypassing 
‘orosensory’ and ‘intragastric’ factors) of partly-hydrolysed whey protein at loads lower than 
(0.5 kcal/min, 30 kcal, 8 g), similar to (1.5 kcal/min, 90 kcal, 24 g) and at the upper end (3 
kcal/min, 180 kcal, 48 g) of normal gastric emptying rates (i.e. 1-4 kcal/min; Chapter 5), 
and 3 hours after oral isolate whey protein ingestion [30 g (120 kcal) and 70 g (280 kcal), 
Chapters 7, 9 and 10]. Suppression of hunger during the intraduodenal protein infusions 
and of desire to eat and prospective food consumption after oral protein ingestion was less 
in the healthy older, compared to younger, men. Whey protein did not induce adverse 
gastrointestinal symptoms - nausea and bloating were not different after protein 
ingestion/infusion compared to control in older adults. 
 
The timing of protein ingestion did not affect energy intake in healthy older men; ad libitum 
energy intake at the buffet meal did not differ from control when 70 g whey protein was 




ingested orally either 3, 2 or 1 hour(s), or just before the meal (Chapter 8). Furthermore, 
substitution carbohydrates and fat for whey-protein or adding them to whey protein did not 
affect energy intake in older men; there was no suppression of energy intake by the caloric 
drinks compared to control (Chapter 12). 
 
Energy intake was dose-responsively suppressed by whey protein infusions (30, 90, 180 
kcal) compared to saline control infusion in younger men (7%, 17% and 33% suppression), 
whereas in healthy older men suppression was observed only with the highest protein-load 
infusion (7% and 6% increase and 17% suppression Chapter 5). Suppression of energy 
intake by 30 g and 70 g oral whey protein ingestion compared to a non-caloric control drink 
was 17% and 12% in younger men, whereas there was no suppression in older men and 
younger and older women (Chapters 7, 9 and 10). The lack of suppression of energy intake 
in healthy older adults is concordant with the concept of reduced responsiveness to the 
suppressive effects of nutrients on appetite and energy intake. 
 
Total energy intake (infusion/drink plus meal) was suppressed by protein compared to 
control in the younger men, while, in contrast, the older men and women exhibited dose-
dependent increases in total energy intakes (~10% and ~30% after 30 g and 70 g protein 
compared to control Chapters 7, 9 and 10). The protein doses used in these studies are 
likely to have the capacity to increase body weight, particularly when ingested several times 
per day. 
 
Gastrointestinal mechanisms are likely to play a role in the regulation of energy intake, 
particularly in the short-term after nutrient ingestion in younger, but not older, adults. 
Isolated pyloric, antral and duodenal pressure waves (Chapter 5), gastric emptying 
(Chapters 7, 9 and 10) and gut hormones (Chapters 6, 9-12) were dependent on the protein 




load in younger and older men. Older men (Chapter 7) and younger women (Chapter 10) 
had slightly slower gastric emptying than younger men, while gastric emptying was 
comparable in older men and women (Chapter 9). Plasma GIP concentrations were higher 
in healthy older compared to younger men after the intraduodenal protein infusions, while 
blood glucose, plasma ghrelin, CCK, GLP-1 and PYY concentrations were comparable 
between the age groups and the release of plasma insulin, glucagon and amino acid 
concentrations were delayed in the older compared to younger men (Chapter 6). After oral 
protein administration, plasma CCK and GIP were higher in older compared to young adults 
(Chapter 11). Older men and women had comparable plasma gut hormone concentrations 
after oral whey protein ingestion (Chapter 9), while younger women had higher blood 
glucose and lower plasma glucagon, CCK and GLP-1 concentrations than younger men 
(Chapter 10). The drink containing 70 g whey-protein was associated with lower ghrelin, 
and higher CCK and GLP-1 concentrations than an iso-caloric (280 kcal) mixed-
macronutrient drink containing 14 g protein, 28 g carbohydrate, 14 g fat, but comparable gut 
hormone responses compared to a drink containing 70 g protein, 28 g carbohydrate, 14 g fat 
(504 kcal; Chapter 12). 
 
From the results of the studies in the thesis, we can conclude that although older people are 
less hungry and eat less than younger adults (Chapter 3), they appear to be less susceptible 
to further suppression of appetite and eating behaviour by ingestion of energy and nutrients, 
including whey protein. Protein is the most satiating macronutrient in younger people, and 
high-protein diets promote and facilitate deliberate weight loss during energy restricting 
diets in younger adults. The demonstrated lack of suppression of energy intake and appetite 
by whey protein ingestion (3 hours to immediately before the meal) in older adults is an 
important finding, given that it alleviates concerns that administration of protein-enriched 
nutritional supplements could be counter-productive in older people, particularly those with, 




or at risk of under-nutrition, by suppressing subsequent food intake. Accordingly, 
administration of whey protein in doses sufficient to stimulate muscle protein synthesis (≥ 
~30 g), may be beneficial to preserve or increase muscle mass and function without 
decreasing appetite or energy intake. The finding that plasma gut hormone responses to whey 
protein are not blunted during healthy ageing is likely to have implications to the 
composition of dietary supplements for older people, and could potentially play an important 
role in the glycaemic control of older people. The observation of comparable gastrointestinal 
hormone response to protein in older people without suppression of energy intake, suggests 
that older people may experience less sensitivity to the anorexigenic effects of these 
hormones. 
 
The studies presented in this thesis have several strengths and limitations. The subject 
numbers were relatively small, and most studies included only men, however, we did not 
find any effects of gender on suppression of energy intake by whey protein in healthy older 
people (Chapter 9). We determined the effects of whey protein ingestion a protein source 
which is frequently used in high energy supplements due to its high leucine content and 
‘rapid’ digestion, when compared to other proteins such as casein. It has to be determined 
whether our observations apply to other proteins. It is also unknown whether suppression of 
protein ingestion occurs beyond 3 hours after intake, e.g., during the remainder of the day or 
during the next day, in healthy older adults. The main strength of the studies was their 
randomised cross over design in which the participants acted as their own control.  
 
The effect of ageing on the acute effect of suppression of energy intake by whey protein is a 
novel, and important, contribution to the current knowledge of energy intake regulation in 
older people. The outcomes from the studies dictate the need for future research, including 
determining the effects of long-term intake of whey protein supplements on 24-hour energy 




intake in older people. Also, although the results in this thesis support the use of protein 
supplements in older people at risk of undernutrition, the lack of suppression of energy intake 
suggests that the use of such supplements as a strategy to decrease energy intake in older 
obese individuals may not be effective; this warrants further investigation. Older people may 
be less sensitive to the orexigenic effects of ghrelin, and anorexigenic effects of insulin CCK, 
GLP-1 and PYY, however, except for CCK, there are no studies which have assessed the 
effects of ageing on the sensitivity to these hormones. There is evidence that diet induced 
thermogenesis is higher after high-protein compared to low-protein intake in younger adults; 
effects of protein intake on postprandial energy expenditure in older adults are poorly 
characterised, and this information is of major relevance to the understanding of postprandial 
protein metabolism in the ageing population. 
 
In conclusion, the main finding of this thesis was that the suppression of energy intake by 
whey protein was less in healthy older than younger adults, so that in the older adults 
compared with the younger controls whey protein ingestion increased overall energy intake 
more which support the use of ‘pure’ whey protein supplements in older people at risk of 
undernutrition. 
 






AgPR; Agouti-related peptide 
ANOVA; Analysis of variance 
AUC; Area under the curve 
BBP; Basal pyloric pressures 
BMI; Body mass index  
CCK; Cholecystokinin 
DPP-IV; dipeptyl peptidase-4 
EDTA; ethylenediaminetetraacetic acid 
ELISA, enzyme-linked immunosorbent assay 
GHS; Growth hormone secretagogue 
GIP; gastric inhibitory polypeptide/glucose-dependent insulinotropic peptide  
GLP-1; Glucagon-like peptide-1 
HOMA-IR; Homeostatic model assessment of insulin resistance 
ID; Intraduodenal 
IPPW; Isolated pyloric pressure wave 
MMC; migrating motor complex 
NPY; neuropeptide Y 
PRISMA; Preferred reporting items for systematic reviews and meta-analysis 
PYY; Peptide tyrosine tyrosine 
RIA, radioimmunoassay 
SD; Standard deviation 
SEM; Standard error of the mean 
SMD; Standard mean differences 




T50, 50% gastric emptying time 
TMPD; Transmucosal potential difference 
VAS, visual analogue scale 
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APPENDIX 1 
Table 3.1: Studies included in the meta-analysis. 




Age (Years)  
Young/Older 
Mean Body 





Outcomes Used for Meta-Analysis 
Alam et al. 2012  131/526 34 ± 9/69 ± 6 
62.4 ± 13.5/63.5 
± 10.2 † 
23.2 ± 2.2/22.3 
± 1.7 † 
Energy intake of 24-h food intake 
recalls 
Apolzan et al. 2009  24/32 25 ± 5/71 ± 6 
75.5 ± 21.1/74.1 
± 18.7 † 
25.2 ± 3.9/26.0 
± 5.1 † 
Energy intake of 24-h food intake 
recalls 
Arciero et al. 2009  
0 M; 10 F/0 M; 
10 F 
19 ± 2/55 ± 5 
62.5 ± 7.3/72.1 
± 9.4 * 
 
Energy intake of 3-day weighed food 
records 
Bell et al. 2003  
7 M; 5 F/12 M; 9 
F 
23 ± 3/68 ± 5 
70.4 ± 11.8/77.2 
± 13.7 † 
23.7 ± 2.4/26.6 
± 3.7 * 
Energy intake of 4-day weighed food 
records 
Cheng et al. 1978  8 M; 0 F/7 M; 0 F 26 ± 3/67 ± 5 
66.5 ± 7.2/61.6 
± 11.3 † 
 Energy intake of weighed food records 
Church et al. 1984  7 M; 8 F/6 M; 8 F 20-35/36-53 
45.0-95.3/52.6-
85.4 
 Energy intake of weighed food records 
Clarkston et al. 1997 
] 
10 M; 9 F/5 M; 9 
F 
30 ± 35/76 ± 
19 
 
25.3 ± 3.4/25.2 
± 1.7 † 
Hunger/fullness during fasting and 
postprandial (456 kcal oral mixed 
nutrient preload) conditions 
Cook et al. 1997,  
MacIntosh et al. 
1999 # 







- Energy intake of 5-day weighed food 
records  
- Energy intake during postprandial 
conditions ‡ (348 kcal intraduodenal 
lipid infusion)  
- Hunger/fullness during fasting 
conditions 
   
 
Davy et al. 2001  6 M; 0 F/5 M; 0 F 25 ± 2/63 ± 7 
79.0 ± 7.3/82.0 
± 8.9 † 
 
Energy intake of 4-day weighed food 
records 
Di Francesco et al. 
2010  
6 M; 6 F/5 M; 7 F 28 ± 2/75 ± 6  
18.9–26.5/21.1–
28.3 † 
Hunger during fasting and postprandial 
(800 kcal oral mixed nutrient preload) 
conditions ^ 
Di Francesco et al. 
2006  
4 M; 4 F/4 M; 4 F 30 ± 3/78 ± 3  
22.7–25.7/22.1–
29.4 † 
Hunger/fullness during fasting and 
postprandial (800 kcal oral mixed 
nutrient preload) conditions 
Di Francesco et al. 
2005  
5 M; 4 F/5 M; 5 F 32 ± 8/77 ± 3  
22.7–28.1/23.5–
29.3 
Hunger/fullness during fasting and 
postprandial ‡ (800 kcal oral mixed 
nutrient preload) conditions 
Drewnowski et al. 
1996  
12 M; 12 F/12 M; 
12 F 
23 ± 1/67 ± 2  
22.7 ± 1.0/24.5 
± 1.2 
Energy intake of 14-day weighed food 
records 
Flint et al. 2008  
16 M; 14 F/16 M; 
14 F 
25 ± 4/68 ± 5 
71.0 ± 10.4/73.8 
± 17.0 † 
24.6 ± 2.2/24.7 
± 2.2 † 
Energy intake of 4-day weighed food 
records 
Fukagawa et al. 
1990  
6 M; 0 F/6 M; 0 F 21 ± 2/72 ± 7   Energy intake of 14-day dietary recalls 
Giada et al. 1995  
24 M; 0 F/24 M; 
0 F 
24 ± 4/57 ± 6  
23.7 ± 2.4/26.8 
± 2.5 † 
Energy intake of 7-day weighed food 
records 
Howarth et al. 2007  
1021 M; 771 
F/491 M; 402 F 
39 ± 17/71 ± 
12 
 
25.2 ± 4.2/25.4 
± 6.0 † 
Energy intake of 24-h food intake 
recalls 
Ishikawa et al. 1999  
53 M; 16 F/50 M; 
32 F 
30-49/50-69 
69.2 ± 10.4/62.9 
± 8.6 
25.2 ± 3.0/25.0 
± 2.7 
Energy intake of 2-day weighed food 
records 
Keene et al. 1998  7 M; 5 F/4 M; 6 F 25/75   
Energy intake during postprandial 
conditions ‡ (447 kcal oral mixed 
nutrient preload) 
Kos et al. 1996  
0 M; 38 F/0 M; 
17 F 
29 ± 3/59 ± 4 
61.6 ± 9.7/57.4 
± 8.3 † 
21.7 ± 3.1/21.8 
± 2.8 † 
Energy intake of 4-day weighed food 
records 
Lieberman et al. 
1989  





Energy intake of 4-day weighed food 
records 
   
 
Macintosh et al. 
2001  




24.7 ± 2.4/25.0 
± 1.7 † 
- Energy intake during fasting 
conditions ‡  
- Energy intake of 3-day weighed food 
records  
- Hunger/fullness during fasting 
conditions 
Macintosh et al. 
2001  
6 M; 6 F/6 M; 6 F 23 ± 4/71 ± 5  
23.5 ± 2.8/24.1 
± 2.4 † 
- Energy intake during fasting 
conditions ‡  
- Energy intake of 3-day weighed food 
records  
- Hunger during fasting conditions 
Macintosh et al. 
2001  
13 M; 0 F/13 M; 
0 F 
24 ± 5/72 ± 6  
23.9 ± 2.2/23.5 
± 3.6 † 
- Energy intake during postprandial 
conditions ‡ (347 kcal intraduodenal 
lipid infusion)  
- Energy intake of 3-day weighed food 
records  
- Hunger/fullness during postprandial 
conditions ‡ (347 kcal intraduodenal 
lipid preload) 
McGandy et al. 1966  
13 M; 0 F/37 M; 
0 F 
20-34/75-99 
74.5 ± 1.2/70.9 
± 1.0 
 
Energy intake of 7-day weighed food 
records 
Morais et al. 2000  4 M; 3 F/3 M; 5 F 28 ± 5/72 ± 3 
63.5 ± 10.6/64.2 
± 10.2 † 
21.4 ± 2.1/24.8 
± 3.1 * 
Energy intake of 6-day weighed food 
records 
Morais et al. 1997  8 M; 7 F/8 M; 8 F 28 ± 5/73 ± 5 
62.6 ± 7.4/64.1 
± 8.7 † 
21.2 ± 1.8/23.8 
± 3.2 * 
Energy intake of 6-day weighed food 
records 
Moriguti et al. 2000  5 M; 6 F/9 M; 9 F 26 ± 3/68 ± 3 
65.6 ± 9.6/80.0 
± 14.9 * 
23.2 ± 1.6/27.5 
± 3.4 * 
Energy intake of provided food items (7 
days) 
Nagengast et al. 
1988  
5 M; 6 F/6 M; 5 F 22 ± 6/67 ± 5 
67.6 ± 5.0/69.1 
± 12.3 † 
 Food intake recalls 
Poehlman et al. 1990  
42 M; 0 F/26 M; 
0 F 
25 ± 5/67 ± 5 
75.5 ± 10.7/78.4 
± 7.6 † 
 
Energy intake of 3-day weighed food 
records 
   
 
Polito et al. 2005  
48 M; 47 F/103 
M; 96 F 
61 ± 4/74 ± 4 
71.5 ± 8.1/67.9 
± 9.0 
26.1 ± 2.4/25.3 
± 2.7 
Energy intake of 4-day weighed food 
records 







- Energy intake during fasting 
conditions ‡  
- Hunger/fullness during fasting 
conditions ^ 
Roberts et al. 1996  7 M; 0 F/9 M; 0 F 24 ± 1/70 ± 7 
76.2 ± 12.4/72.9 
± 9.3 † 
23.9 ± 3.4/23.4 
± 3.3 † 
Energy intake of provided food items 
(10 days) 
Roberts et al. 1994;  
1995 # 
17 M; 0 F/18 M; 
0 F 
23 ± 2/68 ± 6 
71.6 ± 11.1/78.8 
± 12.6 
23.4 ± 2.6/25.2 
± 3.6 
Energy intake of provided food items (7 
days) 
Rolls et al. 1995  
16 M; 0 F/16 M; 
0 F 
24 ± 5/69 ± 6 
74.0 ± 7.2/84.3 
± 12.8 * 
22.7 ± 2.0/26.2 
± 3.6 * 
- Energy intake during fasting and 
postprandial (510 kcal oral mixed 
nutrient preload) conditions  
- Hunger/fullness during fasting and 
postprandial ‡ (510 kcal oral mixed 
nutrient preload) conditions 
Rolls et al. 1991  
12 M; 12 F/12 M; 
12 F 
26 ± 4/75 ± 5 
68.9 ± 3.0/66.0 
± 3.2 
23.5 ± 3.0/24.1 
± 2.8 
Hunger/fullness during fasting 
conditions 
Sawaya et al. 2001  
9 M; 0 F/10 M; 0 
F 
23 ± 1/69 ± 1 
72.9 ± 2.7/74.7 
± 3.4 † 
22.7 ± 0.5/24.4 
± 0.9 † 
Hunger during fasting conditions 
Sawaya et al. 1996  
0 M; 10 F/0 M; 
10 F 
25 ± 4/74 ± 4 
54.8 ± 4.1/58.7 
± 9.8 † 
20.9 ± 1.9/24.1 
± 2.8 * 
Energy intake of 7-day weighed food 
records 
Schneider et al. 2008  5 M; 5 F/3 M; 6 F 34 ± 8/76 ± 9  
22.5 ± 2.9/23.6 
± 1.8 † 
Hunger/fullness during fasting 
conditions ‡ 
Serra-Prat et al. 
2013  
7 M; 12 F/13 M;7 
F 
38 ± 11/81 ± 8 
67.3 ± 9.0/72.6 
± 16.2 
23.7 ± 2.8/27.9 
± 4.9 † 
- Hunger during fasting and 
postprandial ‡ (400 kcal oral mixed 
nutrient preload) conditions  
Serra-Prat et al. 
2009 [66] 
7 M; 10 F/6 M; 4 
F 
40 ± 10/80 ± 8  
25.2 ± 3.3/26.7 
± 3.0 † 
- Hunger during fasting and 
postprandial ‡ (380 kcal oral mixed 
nutrient preload) conditions 
   
 
Soenen et al. 2014  
10 M; 0 F/10 M; 
0 F 
23 ± 4/74 ± 4 73 ± 7/79 ± 7 † 22 ± 2/26 ± 2 * 
- Energy intake during fasting and 
postprandial (180 kcal intraduodenal 
protein infusion)  
- Hunger/fullness during fasting and 
postprandial (180 kcal intraduodenal 
protein infusion) conditions 
Stafleu et al. 1994  
0 M; 97 F/0 M; 
97 F 
25 ± 3/76 ± 6 
64.2 ± 10.6/70.5 
± 10.7 
22.5 ± 3.5/26.8 
± 4.1 
Energy intake of food frequency 
questionnaires 
Sturm et al. 2004  6 M; 6 F/6 M; 6 F 24 ± 1/74 ± 1  
23.2 ± 2.1/24.1 
± 3.5 † 
- Energy intake during fasting and 
postprandial ‡ (750 kcal oral mixed 
nutrient preload) conditions  
- Energy intake of 3-day weighed food 
records  
- Hunger/fullness during fasting and 
postprandial ‡ (750 kcal oral mixed 
nutrient preload) conditions 
Sturm et al. 2003 0 M; 8 F/0 M; 8 F 22 ± 4/77 ± 3 
57.5 ± 5.4/58.0 
± 5.9 † 
20.5 ± 1.1/23.7 
± 2.3 * 
- Energy intake during fasting and 
postprandial (280 kcal oral mixed 
nutrient preload) conditions  
- Energy intake of 3-day weighed food 
records  
- Hunger/fullness during fasting and 
postprandial (280 kcal oral mixed 
nutrient preload) conditions ‡ 
Surrao et al. 1998  
0 M; 10 F/0 M; 
10 F 
25 ± 4/74 ± 4 
54.8 ± 4.1/58.7 
± 9.8 † 
20.9 ± 1.9/24.1 
± 2.5 * 
Energy intake of a 7-day weighed food 
record 
Temme et al. 2010  
413 M; 460 F/389 
M; 355 F 
   
Energy intakes of 24-h food intake 
recalls and food frequency 
questionnaires 
Toth et al. 1996  
18 M; 0 F/30 M; 
0 F 
23 ± 4/69 ± 5 79 ± 8/75 ± 5 †  
Energy intake of 3-day weighed food 
records 
   
 
Van Pelt et al. 2001  
71 M; 0 F/66 M; 
0 F 
27 ± 8/62 ± 8 
75.1 ± 16.0/77.4 
± 16.2 
23.4 ± 4.7/25.1 
± 4.4 
Energy intake of 4-day weighed food 
records 
Van Walleghen et al.  
2007  
14 M; 15 F/11 M; 
10 F 
25 ± 5/69 ± 9 
67.9 ± 1.7/70.8 
± 2.9 
23.3 ± 3.7/24.7 
± 3.2 
- Energy intake during fasting 
conditions ‡  
- Energy intake of 4-day weighed food 
records  
- Hunger/fullness during fasting 
conditions 
Van Walleghen et al.  
2007  
14 M; 15 F/13 M; 
12 F 
24 ± 5/68 ± 10 
67.6 ± 15.5/71.1 
± 16.5 
23.3 ± 4.3/24.6 
± 3.8 
- Energy intake during fasting and 
postprandial (476 kcal for males and 
360 kcal for females oral mixed nutrient 
preloads) conditions  
- Energy intake of 4-day weighed food 
records  
- Hunger/fullness during fasting and 
postprandial (476 kcal for males and 
360 kcal for females oral mixed nutrient 
preload) conditions ‡  
- Hunger/fullness during fasting 
conditions 
Vaughan et al. 1991  
33 M; 31 F/17 M; 
21 F 
24 ± 4/71 ± 6 
84.5 ± 23.1/71.2 
± 13.5 * 
 
Energy intake of provided food items (1 
day) 
Winkels et al. 2010  




75.8 ± 11.3/75.8 
± 7.6 
23.0 ± 2.3/24.5 
± 1.9 
Energy intake of provided food items 
(14 days) 
Wolk et al. 2004  
72 M; 0 F/94 M; 
0 F 
42–54/65–76  
25.6 ± 2.7/26.5 
± 3.7 
Energy intake of 24-h food intake 
recalls 
Wright et al. 1995  
41 M; 42 F/28 M; 
43 F 
20–64/74–90 
70.1 ± 10.4/64.8 
± 10.1 
 
Energy intake of 7-day weighed food 
records 
Wurtman et al. 1988  





 Energy intake of provided food items (5 
days) 
   
 
Yukawa et al. 2006  
8 M; 13 F/7 M; 
11 F 
25 ± 5/75 ± 4 
72.9 ± 12.4/73.6 
± 12.7 † 
24.7 ± 3.0/26.9 
± 3.0 * 
Energy intake of provided food items 
(14 days) 
Zandstra et al. 2000 
5 M; 28 F/6 M; 
18 F 
22 ± 2/76 ± 5 
71.0 ± 9.6/72.4 
± 8.9 
23.3 ± 2.3/26.6 
± 3.5 
Energy intake during fasting and 
postprandial (502 kcal for young 
subjects) or 430 kcal for older subjects 
oral mixed nutrient preload) conditions 
‡ 
Zhou et al. 2013 
49 M; 10 F/15 M; 
21 F 
20–29/50–59 
59.0 ± 10.8/69.0 
± 12.3 
21.7 ± 3.0/24.6 
± 3.1 
Fullness during fasting and postprandial 
(896 kcal oral mixed nutrient preload) 
conditions 
 
 
 
 
 
